https://biopharmsignal.com/index.md 2026-07-21 https://biopharmsignal.com/blog.md 2026-07-21 https://biopharmsignal.com/livefeed.md 2026-07-21 https://biopharmsignal.com/pdufa-calendar.md 2026-07-21 https://biopharmsignal.com/pricing.md 2026-07-21 https://biopharmsignal.com/sector.md 2026-07-21 https://biopharmsignal.com/compare.md 2026-07-21 https://biopharmsignal.com/compare/biopharmsignal-vs-biopharmcatalyst.md 2026-07-19 https://biopharmsignal.com/compare/biopharmsignal-vs-catalystalert.md 2026-07-19 https://biopharmsignal.com/compare/biopharmsignal-vs-biotechsign.md 2026-07-19 https://biopharmsignal.com/compare/biopharmsignal-vs-biopharmawatch.md 2026-07-19 https://biopharmsignal.com/compare/biopharmsignal-vs-bpiq-biopharmiq.md 2026-07-19 https://biopharmsignal.com/compare/biopharmsignal-vs-biotech-pulse.md 2026-07-19 https://biopharmsignal.com/compare/biopharmsignal-vs-marketbeat-fda-calendar.md 2026-07-19 https://biopharmsignal.com/compare/biopharmsignal-vs-google-alerts.md 2026-07-19 https://biopharmsignal.com/compare/biopharmsignal-vs-feedly.md 2026-07-19 https://biopharmsignal.com/blog/how-to-read-biotech-earnings-releases-when-revenue-is-not-the-main-story.md 2026-07-17 https://biopharmsignal.com/blog/how-to-monitor-biotech-reverse-splits-offerings-and-nasdaq-compliance-news.md 2026-07-16 https://biopharmsignal.com/blog/how-to-use-ticker-based-alerts-and-keyword-alerts-together.md 2026-07-15 https://biopharmsignal.com/blog/how-to-separate-commercial-launch-updates-from-clinical-development-news.md 2026-07-14 https://biopharmsignal.com/blog/how-to-follow-asco-esmo-and-medical-conference-news-as-a-biotech-investor.md 2026-07-13 https://biopharmsignal.com/blog/how-to-tell-whether-a-biotech-partnership-headline-changes-the-investment-story.md 2026-07-10 https://biopharmsignal.com/blog/how-to-build-a-watchlist-around-clinical-readout-dates.md 2026-07-09 https://biopharmsignal.com/blog/how-to-compare-two-biotech-press-releases-from-the-same-company.md 2026-07-08 https://biopharmsignal.com/blog/how-to-monitor-small-cap-biotech-financing-news-without-overreacting.md 2026-07-07 https://biopharmsignal.com/blog/how-to-track-fda-approval-risk-before-a-pdufa-date.md 2026-07-06 https://biopharmsignal.com/blog/why-small-teams-still-need-biotech-alert-tools.md 2026-06-10 https://biopharmsignal.com/blog/how-biotech-alerts-help-when-you-only-follow-a-few-companies.md 2026-06-09 https://biopharmsignal.com/blog/why-biotech-alerts-are-more-valuable-for-busy-people.md 2026-06-08 https://biopharmsignal.com/blog/what-types-of-biotech-news-people-tracking-clinical-progress-are-most-afraid-to-miss.md 2026-06-07 https://biopharmsignal.com/blog/fda-real-time-trial-data-ai-plan-could-change-biotech-timelines.md 2026-06-06 https://biopharmsignal.com/blog/why-biotech-investors-need-alerts-more-than-refreshing-pages.md 2026-06-05 https://biopharmsignal.com/blog/how-much-time-can-biotech-alerts-save.md 2026-06-04 https://biopharmsignal.com/blog/why-do-i-keep-missing-biotech-company-news.md 2026-06-03 https://biopharmsignal.com/blog/aacr-2026-is-still-moving-biotech-stocks-what-investors-should-watch.md 2026-06-02 https://biopharmsignal.com/blog/company-news-vs-event-news-in-biotech-which-is-more-efficient.md 2026-06-01 https://biopharmsignal.com/blog/pure-news-products-vs-event-alert-products.md 2026-05-31 https://biopharmsignal.com/blog/why-lightweight-biotech-tools-are-easier-to-use.md 2026-05-30 https://biopharmsignal.com/blog/why-some-biotech-users-only-need-alerts-not-a-database.md 2026-05-29 https://biopharmsignal.com/blog/how-do-biotech-news-products-differ-from-investment-research-products.md 2026-05-28 https://biopharmsignal.com/blog/alerting-vs-aggregation-in-biotech-news-products.md 2026-05-27 https://biopharmsignal.com/blog/what-should-a-researcher-biotech-information-tool-include.md 2026-05-26 https://biopharmsignal.com/blog/what-should-a-retail-biotech-news-product-include.md 2026-05-25 https://biopharmsignal.com/blog/who-are-biotech-information-products-for.md 2026-05-24 https://biopharmsignal.com/blog/how-to-choose-between-news-websites-email-newsletters-and-alert-tools.md 2026-05-23 https://biopharmsignal.com/blog/what-is-the-difference-between-biotech-news-and-biotech-alert-tools.md 2026-05-22 https://biopharmsignal.com/blog/how-to-use-tags-to-manage-biotech-news.md 2026-05-21 https://biopharmsignal.com/blog/how-to-let-a-team-view-the-same-biotech-news.md 2026-05-20 https://biopharmsignal.com/blog/how-to-build-a-biotech-news-archive-system.md 2026-05-19 https://biopharmsignal.com/blog/how-to-build-a-single-biotech-timeline-from-many-announcements.md 2026-05-18 https://biopharmsignal.com/blog/how-to-read-investor-presentations-in-biotech.md 2026-05-17 https://biopharmsignal.com/blog/how-to-pull-value-from-conference-coverage.md 2026-05-16 https://biopharmsignal.com/blog/how-to-scan-many-biotech-headlines-fast.md 2026-05-15 https://biopharmsignal.com/blog/how-to-set-different-news-priorities-for-different-stages-of-companies.md 2026-05-14 https://biopharmsignal.com/blog/how-to-tell-if-clinical-news-is-progress-or-noise.md 2026-05-13 https://biopharmsignal.com/blog/how-to-recognize-regulatory-language-in-biotech-news.md 2026-05-12 https://biopharmsignal.com/blog/how-to-understand-biotech-news-without-a-science-background.md 2026-05-11 https://biopharmsignal.com/blog/how-to-combine-multiple-news-sources-into-one-habit.md 2026-05-10 https://biopharmsignal.com/blog/how-to-use-a-timeline-to-understand-biotech-news.md 2026-05-09 https://biopharmsignal.com/blog/how-to-read-a-biotech-press-release.md 2026-05-08 https://biopharmsignal.com/blog/how-to-pull-key-points-from-a-company-news-release.md 2026-05-07 https://biopharmsignal.com/blog/how-to-reduce-noise-in-biotech-news.md 2026-05-06 https://biopharmsignal.com/blog/how-to-build-a-biotech-news-filtering-method.md 2026-05-05 https://biopharmsignal.com/blog/how-to-set-biotech-keyword-rules.md 2026-05-04 https://biopharmsignal.com/blog/how-to-turn-headlines-into-trackable-events.md 2026-05-03 https://biopharmsignal.com/blog/how-to-use-excel-for-clinical-trial-events.md 2026-05-02 https://biopharmsignal.com/blog/how-to-tell-if-an-fda-update-is-important.md 2026-05-01 https://biopharmsignal.com/blog/how-to-spot-a-real-biotech-catalyst.md 2026-04-30 https://biopharmsignal.com/blog/how-to-categorize-biotech-news-by-event-type.md 2026-04-29 https://biopharmsignal.com/blog/how-to-build-a-biotech-watchlist-from-company-names.md 2026-04-28 https://biopharmsignal.com/blog/how-to-build-a-biotech-news-reading-workflow.md 2026-04-27 https://biopharmsignal.com/blog/what-is-a-monoclonal-antibody.md 2026-04-26 https://biopharmsignal.com/blog/what-is-a-small-molecule.md 2026-04-25 https://biopharmsignal.com/blog/what-does-moa-mean-in-biotech-news.md 2026-04-24 https://biopharmsignal.com/blog/what-is-a-companion-diagnostic.md 2026-04-23 https://biopharmsignal.com/blog/what-is-combination-therapy.md 2026-04-22 https://biopharmsignal.com/blog/what-is-label-expansion.md 2026-04-21 https://biopharmsignal.com/blog/what-is-an-exclusivity-period.md 2026-04-20 https://biopharmsignal.com/blog/what-is-a-patent-cliff.md 2026-04-19 https://biopharmsignal.com/blog/what-is-a-biosimilar.md 2026-04-18 https://biopharmsignal.com/blog/what-is-best-in-class-drug.md 2026-04-17 https://biopharmsignal.com/blog/what-is-first-in-class-drug.md 2026-04-16 https://biopharmsignal.com/blog/what-is-line-of-therapy.md 2026-04-15 https://biopharmsignal.com/blog/what-is-an-indication.md 2026-04-14 https://biopharmsignal.com/blog/what-is-a-biomarker.md 2026-04-13 https://biopharmsignal.com/blog/what-is-a-surrogate-endpoint.md 2026-04-12 https://biopharmsignal.com/blog/what-is-a-secondary-endpoint.md 2026-04-11 https://biopharmsignal.com/blog/what-is-a-primary-endpoint.md 2026-04-10 https://biopharmsignal.com/blog/what-is-a-clinical-trial-endpoint.md 2026-04-09 https://biopharmsignal.com/blog/what-is-post-marketing-study.md 2026-04-08 https://biopharmsignal.com/blog/what-is-accelerated-approval.md 2026-04-07 https://biopharmsignal.com/blog/what-is-priority-review.md 2026-04-06 https://biopharmsignal.com/blog/what-is-fast-track-designation.md 2026-04-05 https://biopharmsignal.com/blog/what-is-breakthrough-therapy-designation.md 2026-04-04 https://biopharmsignal.com/blog/what-is-orphan-drug-designation.md 2026-04-03 https://biopharmsignal.com/blog/what-is-bla-in-biotech.md 2026-04-02 https://biopharmsignal.com/blog/what-is-nda-in-biotech.md 2026-04-01 https://biopharmsignal.com/blog/what-is-ind-in-drug-development.md 2026-03-31 https://biopharmsignal.com/blog/biotech-drug-development-overview-from-discovery-to-approval.md 2026-03-30 https://biopharmsignal.com/blog/why-biotech-is-ideal-for-event-driven-news-products.md 2026-03-29 https://biopharmsignal.com/blog/what-does-catalyst-mean-in-biotech-news.md 2026-03-28 https://biopharmsignal.com/blog/what-is-interim-data.md 2026-03-27 https://biopharmsignal.com/blog/what-is-top-line-data.md 2026-03-26 https://biopharmsignal.com/blog/what-is-data-lock.md 2026-03-25 https://biopharmsignal.com/blog/why-financing-news-matters-in-biotech.md 2026-03-24 https://biopharmsignal.com/blog/why-partnership-announcements-matter.md 2026-03-23 https://biopharmsignal.com/blog/news-to-track-before-and-after-commercialization.md 2026-03-22 https://biopharmsignal.com/blog/public-information-before-fda-approval.md 2026-03-21 https://biopharmsignal.com/blog/why-clinical-trial-dates-change.md 2026-03-20 https://biopharmsignal.com/blog/what-is-a-catalyst-window.md 2026-03-19 https://biopharmsignal.com/blog/why-biotech-news-clusters-around-key-dates.md 2026-03-18 https://biopharmsignal.com/blog/biotech-company-earnings-signals-to-watch.md 2026-03-17 https://biopharmsignal.com/blog/what-is-phase-3-data-release.md 2026-03-16 https://biopharmsignal.com/blog/what-is-phase-2-data-release.md 2026-03-15 https://biopharmsignal.com/blog/what-is-phase-1-data-release.md 2026-03-14 https://biopharmsignal.com/blog/what-is-a-clinical-trial-readout.md 2026-03-13 https://biopharmsignal.com/blog/what-is-a-crl.md 2026-03-12 https://biopharmsignal.com/blog/what-is-an-adcom.md 2026-03-11 https://biopharmsignal.com/blog/what-does-pdufa-mean.md 2026-03-10 https://biopharmsignal.com/blog/what-is-an-fda-calendar.md 2026-03-09 https://biopharmsignal.com/blog/what-is-a-biotech-catalyst.md 2026-03-08 https://biopharmsignal.com/company/FDMT.md 2026-05-31 https://biopharmsignal.com/company/INFI.md 2026-05-31 https://biopharmsignal.com/company/SRZN.md 2026-05-31 https://biopharmsignal.com/company/SGTX.md 2026-05-31 https://biopharmsignal.com/company/GOVX.md 2026-05-31 https://biopharmsignal.com/company/BEAT.md 2026-05-31 https://biopharmsignal.com/company/AMS.md 2026-05-31 https://biopharmsignal.com/company/TCON.md 2026-05-31 https://biopharmsignal.com/company/PCSA.md 2026-05-31 https://biopharmsignal.com/company/ATHX.md 2026-05-31 https://biopharmsignal.com/company/BIAF.md 2026-05-31 https://biopharmsignal.com/company/NRBO.md 2026-05-31 https://biopharmsignal.com/company/SIEN.md 2026-05-31 https://biopharmsignal.com/company/FRLN.md 2026-05-31 https://biopharmsignal.com/company/CMRA.md 2026-05-31 https://biopharmsignal.com/company/NEPH.md 2026-05-31 https://biopharmsignal.com/company/APRE.md 2026-05-31 https://biopharmsignal.com/company/ISPC.md 2026-05-31 https://biopharmsignal.com/company/POAI.md 2026-05-31 https://biopharmsignal.com/company/TLIS.md 2026-05-31 https://biopharmsignal.com/company/ITRM.md 2026-05-31 https://biopharmsignal.com/company/CLRB.md 2026-05-31 https://biopharmsignal.com/company/PRPO.md 2026-05-31 https://biopharmsignal.com/company/IMNN.md 2026-05-31 https://biopharmsignal.com/company/EVLO.md 2026-05-31 https://biopharmsignal.com/company/APDN.md 2026-05-31 https://biopharmsignal.com/company/IBIO.md 2026-05-31 https://biopharmsignal.com/company/ALIM.md 2026-05-31 https://biopharmsignal.com/company/MNPR.md 2026-05-31 https://biopharmsignal.com/company/CYCN.md 2026-05-31 https://biopharmsignal.com/company/CYTH.md 2026-05-31 https://biopharmsignal.com/company/CING.md 2026-05-31 https://biopharmsignal.com/company/CYAD.md 2026-05-31 https://biopharmsignal.com/company/APVO.md 2026-05-31 https://biopharmsignal.com/company/AMTI.md 2026-05-31 https://biopharmsignal.com/company/BPTH.md 2026-05-31 https://biopharmsignal.com/company/GLS.md 2026-05-31 https://biopharmsignal.com/company/TTNP.md 2026-05-31 https://biopharmsignal.com/company/OBSV.md 2026-05-31 https://biopharmsignal.com/company/ELOX.md 2026-05-31 https://biopharmsignal.com/company/NDRA.md 2026-05-31 https://biopharmsignal.com/company/PULM.md 2026-05-31 https://biopharmsignal.com/company/MYO.md 2026-05-31 https://biopharmsignal.com/company/LIPO.md 2026-05-31 https://biopharmsignal.com/company/ADXN.md 2026-05-31 https://biopharmsignal.com/company/AUVI.md 2026-05-31 https://biopharmsignal.com/company/PSTV.md 2026-05-31 https://biopharmsignal.com/company/BPTS.md 2026-05-31 https://biopharmsignal.com/company/AGLE.md 2026-05-31 https://biopharmsignal.com/company/JAGX.md 2026-05-31 https://biopharmsignal.com/company/HCTI.md 2026-05-31 https://biopharmsignal.com/company/FEMY.md 2026-05-31 https://biopharmsignal.com/company/VVOS.md 2026-05-31 https://biopharmsignal.com/company/CNTX.md 2026-05-31 https://biopharmsignal.com/company/STSS.md 2026-05-31 https://biopharmsignal.com/company/KTTA.md 2026-05-31 https://biopharmsignal.com/company/ADIL.md 2026-05-31 https://biopharmsignal.com/company/CELZ.md 2026-05-31 https://biopharmsignal.com/company/LIXT.md 2026-05-31 https://biopharmsignal.com/company/XCUR.md 2026-05-31 https://biopharmsignal.com/company/VRPX.md 2026-05-31 https://biopharmsignal.com/company/NEXI.md 2026-05-31 https://biopharmsignal.com/company/LABP.md 2026-05-31 https://biopharmsignal.com/company/BLCM.md 2026-05-31 https://biopharmsignal.com/company/GRAY.md 2026-05-31 https://biopharmsignal.com/company/HSCS.md 2026-05-31 https://biopharmsignal.com/company/WINT.md 2026-05-31 https://biopharmsignal.com/company/PTIX.md 2026-05-31 https://biopharmsignal.com/company/PTPI.md 2026-05-31 https://biopharmsignal.com/company/ONCR.md 2026-05-31 https://biopharmsignal.com/company/NURO.md 2026-05-31 https://biopharmsignal.com/company/NXGL.md 2026-05-31 https://biopharmsignal.com/company/PBLA.md 2026-05-31 https://biopharmsignal.com/company/AEMD.md 2026-05-31 https://biopharmsignal.com/company/ACRX.md 2026-05-31 https://biopharmsignal.com/company/ATXI.md 2026-05-31 https://biopharmsignal.com/company/CBIO.md 2026-05-31 https://biopharmsignal.com/company/GHSI.md 2026-05-31 https://biopharmsignal.com/company/CRVO.md 2026-05-31 https://biopharmsignal.com/company/EVOK.md 2026-05-31 https://biopharmsignal.com/company/HILS.md 2026-05-31 https://biopharmsignal.com/company/CYCC.md 2026-05-31 https://biopharmsignal.com/company/VTAK.md 2026-05-31 https://biopharmsignal.com/company/FRTX.md 2026-05-31 https://biopharmsignal.com/company/QNRX.md 2026-05-31 https://biopharmsignal.com/company/ALRN.md 2026-05-31 https://biopharmsignal.com/company/REVB.md 2026-05-31 https://biopharmsignal.com/company/BJDX.md 2026-05-31 https://biopharmsignal.com/company/XBIO.md 2026-05-31 https://biopharmsignal.com/company/RSLS.md 2026-05-31 https://biopharmsignal.com/company/ARDS.md 2026-05-31 https://biopharmsignal.com/company/NBSE.md 2026-05-31 https://biopharmsignal.com/company/SNPX.md 2026-05-31 https://biopharmsignal.com/company/BNTC.md 2026-05-31 https://biopharmsignal.com/company/AGRX.md 2026-05-31 https://biopharmsignal.com/company/PHIO.md 2026-05-31 https://biopharmsignal.com/company/SQL.md 2026-05-31 https://biopharmsignal.com/company/NAVB.md 2026-05-31 https://biopharmsignal.com/company/TTOO.md 2026-05-31 https://biopharmsignal.com/company/SINT.md 2026-05-31 https://biopharmsignal.com/company/OGEN.md 2026-05-31 https://biopharmsignal.com/company/ACON.md 2026-05-31 https://biopharmsignal.com/company/HOTH.md 2026-05-31 https://biopharmsignal.com/company/VRAX.md 2026-05-31 https://biopharmsignal.com/company/SNGX.md 2026-05-31 https://biopharmsignal.com/company/BIOL.md 2026-05-31 https://biopharmsignal.com/company/KTRA.md 2026-05-31 https://biopharmsignal.com/company/GRI.md 2026-05-31 https://biopharmsignal.com/company/SLRX.md 2026-05-31 https://biopharmsignal.com/company/HTGM.md 2026-05-31 https://biopharmsignal.com/company/KPRX.md 2026-05-31 https://biopharmsignal.com/company/CWBR.md 2026-05-31 https://biopharmsignal.com/company/RNAZ.md 2026-05-31 https://biopharmsignal.com/company/TMBR.md 2026-05-31 https://biopharmsignal.com/company/ARTL.md 2026-05-31 https://biopharmsignal.com/company/SNOA.md 2026-05-31 https://biopharmsignal.com/company/HSDT.md 2026-05-31 https://biopharmsignal.com/company/OPGN.md 2026-05-31 https://biopharmsignal.com/company/ATNF.md 2026-05-31 https://biopharmsignal.com/company/FWBI.md 2026-05-31 https://biopharmsignal.com/company/ENSC.md 2026-05-31 https://biopharmsignal.com/company/ENVB.md 2026-05-31 https://biopharmsignal.com/company/INBS.md 2026-05-31 https://biopharmsignal.com/company/AVGR.md 2026-05-31 https://biopharmsignal.com/company/NVIV.md 2026-05-31 https://biopharmsignal.com/company/INM.md 2026-05-31 https://biopharmsignal.com/company/ALLR.md 2026-05-31 https://biopharmsignal.com/company/TIVC.md 2026-05-31 https://biopharmsignal.com/company/LGMK.md 2026-05-31 https://biopharmsignal.com/company/ADTX.md 2026-05-31 https://biopharmsignal.com/company/JAN.md 2026-05-31 https://biopharmsignal.com/company/HSTO.md 2026-05-31 https://biopharmsignal.com/company/AMPE.md 2026-05-31 https://biopharmsignal.com/company/BRSH.md 2026-05-31 https://biopharmsignal.com/company/BBLG.md 2026-05-31 https://biopharmsignal.com/company/LADX.md 2026-05-31 https://biopharmsignal.com/company/THMO.md 2026-05-31 https://biopharmsignal.com/company/CFRX.md 2026-05-31 https://biopharmsignal.com/company/CRXT.md 2026-05-31 https://biopharmsignal.com/company/TCBP.md 2026-05-31 https://biopharmsignal.com/company/NBY.md 2026-05-31 https://biopharmsignal.com/company/SMFL.md 2026-05-31 https://biopharmsignal.com/company/BXRX.md 2026-05-31 https://biopharmsignal.com/company/DRMA.md 2026-05-31 https://biopharmsignal.com/company/EVFM.md 2026-05-31 https://biopharmsignal.com/company/STAB.md 2026-05-31 https://biopharmsignal.com/company/SCPS.md 2026-05-31 https://biopharmsignal.com/company/ARGS.md 2026-05-31 https://biopharmsignal.com/company/TENX.md 2026-05-31 https://biopharmsignal.com/company/ESMC.md 2026-05-31 https://biopharmsignal.com/company/MTP.md 2026-05-31 https://biopharmsignal.com/company/SGMT.md 2026-05-31 https://biopharmsignal.com/company/DRMT.md 2026-05-31 https://biopharmsignal.com/company/DECI.md 2026-05-31 https://biopharmsignal.com/company/CCBS.md 2026-05-31 https://biopharmsignal.com/company/ALZH.md 2026-05-31 https://biopharmsignal.com/company/BFRI.md 2026-05-31 https://biopharmsignal.com/company/VLA.md 2026-05-31 https://biopharmsignal.com/company/CRVW.md 2026-05-31 https://biopharmsignal.com/company/QBIO.md 2026-05-31 https://biopharmsignal.com/company/BHC.md 2026-05-31 https://biopharmsignal.com/company/MATAS.md 2026-05-31 https://biopharmsignal.com/company/GRD1R.md 2026-05-31 https://biopharmsignal.com/company/PASO.md 2026-05-31 https://biopharmsignal.com/company/INTS.md 2026-05-31 https://biopharmsignal.com/company/BSEM.md 2026-05-31 https://biopharmsignal.com/company/CDXI.md 2026-05-31 https://biopharmsignal.com/company/ENDV.md 2026-05-31 https://biopharmsignal.com/company/CMXC.md 2026-05-31 https://biopharmsignal.com/company/MLNTQ.md 2026-05-31 https://biopharmsignal.com/company/IVOB.md 2026-05-31 https://biopharmsignal.com/company/ELGXQ.md 2026-05-31 https://biopharmsignal.com/company/DNCE.md 2026-05-31 https://biopharmsignal.com/company/CSTX.md 2026-05-31 https://biopharmsignal.com/company/MKT.md 2026-05-31 https://biopharmsignal.com/company/INKT.md 2026-05-31 https://biopharmsignal.com/company/RBOT.md 2026-05-31 https://biopharmsignal.com/company/NGEN.md 2026-05-31 https://biopharmsignal.com/company/SANION.md 2026-05-31 https://biopharmsignal.com/company/RCKT.md 2026-05-31 https://biopharmsignal.com/company/BDX.md 2026-05-31 https://biopharmsignal.com/company/EGTX.md 2026-05-31 https://biopharmsignal.com/company/BSLN.md 2026-05-31 https://biopharmsignal.com/company/BAVN.md 2026-05-31 https://biopharmsignal.com/company/RYZB.md 2026-05-31 https://biopharmsignal.com/company/KNSA.md 2026-05-31 https://biopharmsignal.com/company/AVDL.md 2026-05-31 https://biopharmsignal.com/company/KALV.md 2026-05-31 https://biopharmsignal.com/company/IOVA.md 2026-05-31 https://biopharmsignal.com/company/ARCT.md 2026-05-31 https://biopharmsignal.com/company/PDSB.md 2026-05-31 https://biopharmsignal.com/company/XENE.md 2026-05-31 https://biopharmsignal.com/company/BTAI.md 2026-05-31 https://biopharmsignal.com/company/AXSM.md 2026-05-31 https://biopharmsignal.com/company/IMMP.md 2026-05-31 https://biopharmsignal.com/company/ALKS.md 2026-05-31 https://biopharmsignal.com/company/IMAB.md 2026-05-31 https://biopharmsignal.com/company/NKGN.md 2026-05-31 https://biopharmsignal.com/company/APTO.md 2026-05-31 https://biopharmsignal.com/company/MIST.md 2026-05-31 https://biopharmsignal.com/company/BIVI.md 2026-05-31 https://biopharmsignal.com/company/VYNE.md 2026-05-31 https://biopharmsignal.com/company/VRTX.md 2026-05-31 https://biopharmsignal.com/company/ELDN.md 2026-05-31 https://biopharmsignal.com/company/VERA.md 2026-05-31 https://biopharmsignal.com/company/MBRX.md 2026-05-31 https://biopharmsignal.com/company/CGEN.md 2026-05-31 https://biopharmsignal.com/company/ELTX.md 2026-05-31 https://biopharmsignal.com/company/SLS.md 2026-05-31 https://biopharmsignal.com/company/MDNA.md 2026-05-31 https://biopharmsignal.com/company/FLGT.md 2026-05-31 https://biopharmsignal.com/company/ONCY.md 2026-05-31 https://biopharmsignal.com/company/TLSA.md 2026-05-31 https://biopharmsignal.com/company/CUE.md 2026-05-31 https://biopharmsignal.com/company/ATXS.md 2026-05-31 https://biopharmsignal.com/company/LPCN.md 2026-05-31 https://biopharmsignal.com/company/ATRA.md 2026-05-31 https://biopharmsignal.com/company/CRMD.md 2026-05-31 https://biopharmsignal.com/company/CKPT.md 2026-05-31 https://biopharmsignal.com/company/DARE.md 2026-05-31 https://biopharmsignal.com/company/ALDX.md 2026-05-31 https://biopharmsignal.com/company/CALT.md 2026-05-31 https://biopharmsignal.com/company/GKOS.md 2026-05-31 https://biopharmsignal.com/company/GLPG.md 2026-05-31 https://biopharmsignal.com/company/AGIO.md 2026-05-31 https://biopharmsignal.com/company/GRCL.md 2026-05-31 https://biopharmsignal.com/company/SGMO.md 2026-05-31 https://biopharmsignal.com/company/THTX.md 2026-05-31 https://biopharmsignal.com/company/EQ.md 2026-05-31 https://biopharmsignal.com/company/FUSN.md 2026-05-31 https://biopharmsignal.com/company/PTN.md 2026-05-31 https://biopharmsignal.com/company/KZIA.md 2026-05-31 https://biopharmsignal.com/company/HCM.md 2026-05-31 https://biopharmsignal.com/company/BGNE.md 2026-05-31 https://biopharmsignal.com/company/SLRN.md 2026-05-31 https://biopharmsignal.com/company/ADAG.md 2026-05-31 https://biopharmsignal.com/company/AUPH.md 2026-05-31 https://biopharmsignal.com/company/VRNA.md 2026-05-31 https://biopharmsignal.com/company/KYTX.md 2026-05-31 https://biopharmsignal.com/company/ADVM.md 2026-05-31 https://biopharmsignal.com/company/ONVO.md 2026-05-31 https://biopharmsignal.com/company/NRSN.md 2026-05-31 https://biopharmsignal.com/company/LCTX.md 2026-05-31 https://biopharmsignal.com/company/COYA.md 2026-05-31 https://biopharmsignal.com/company/MLTX.md 2026-05-31 https://biopharmsignal.com/company/ACAD.md 2026-05-31 https://biopharmsignal.com/company/SLN.md 2026-05-31 https://biopharmsignal.com/company/ASLN.md 2026-05-31 https://biopharmsignal.com/company/CYBN.md 2026-05-31 https://biopharmsignal.com/company/ENTX.md 2026-05-31 https://biopharmsignal.com/company/CNTB.md 2026-05-31 https://biopharmsignal.com/company/BDRX.md 2026-05-31 https://biopharmsignal.com/company/AIM.md 2026-05-31 https://biopharmsignal.com/company/IXHL.md 2026-05-31 https://biopharmsignal.com/company/CLPT.md 2026-05-31 https://biopharmsignal.com/company/PTCT.md 2026-05-31 https://biopharmsignal.com/company/NVCR.md 2026-05-31 https://biopharmsignal.com/company/ANL.md 2026-05-31 https://biopharmsignal.com/company/SONN.md 2026-05-31 https://biopharmsignal.com/company/TAK.md 2026-05-31 https://biopharmsignal.com/company/ENLV.md 2026-05-31 https://biopharmsignal.com/company/SUPN.md 2026-05-31 https://biopharmsignal.com/company/PMN.md 2026-05-31 https://biopharmsignal.com/company/IBRX.md 2026-05-31 https://biopharmsignal.com/company/OCEA.md 2026-05-31 https://biopharmsignal.com/company/MRKR.md 2026-05-31 https://biopharmsignal.com/company/CATX.md 2026-05-31 https://biopharmsignal.com/company/ZVRA.md 2026-05-31 https://biopharmsignal.com/company/CALC.md 2026-05-31 https://biopharmsignal.com/company/CORT.md 2026-05-31 https://biopharmsignal.com/company/ABUS.md 2026-05-31 https://biopharmsignal.com/company/BRNS.md 2026-05-31 https://biopharmsignal.com/company/ETON.md 2026-05-31 https://biopharmsignal.com/company/BHVN.md 2026-05-31 https://biopharmsignal.com/company/UNCY.md 2026-05-31 https://biopharmsignal.com/company/ATHE.md 2026-05-31 https://biopharmsignal.com/company/EVGN.md 2026-05-31 https://biopharmsignal.com/company/CARM.md 2026-05-31 https://biopharmsignal.com/company/IMRN.md 2026-05-31 https://biopharmsignal.com/company/PPBT.md 2026-05-31 https://biopharmsignal.com/company/RNAC.md 2026-05-31 https://biopharmsignal.com/company/SELB.md 2026-05-31 https://biopharmsignal.com/company/YS.md 2026-05-31 https://biopharmsignal.com/company/RARE.md 2026-05-31 https://biopharmsignal.com/company/SPRY.md 2026-05-31 https://biopharmsignal.com/company/BNOX.md 2026-05-31 https://biopharmsignal.com/company/RPTX.md 2026-05-31 https://biopharmsignal.com/company/EGRX.md 2026-05-31 https://biopharmsignal.com/company/BIIB.md 2026-05-31 https://biopharmsignal.com/company/PRFX.md 2026-05-31 https://biopharmsignal.com/company/CMMB.md 2026-05-31 https://biopharmsignal.com/company/PYPD.md 2026-05-31 https://biopharmsignal.com/company/VIRI.md 2026-05-31 https://biopharmsignal.com/company/INDV.md 2026-05-31 https://biopharmsignal.com/company/NGNE.md 2026-05-31 https://biopharmsignal.com/company/MYMD.md 2026-05-31 https://biopharmsignal.com/company/AMRX.md 2026-05-31 https://biopharmsignal.com/company/NMRA.md 2026-05-31 https://biopharmsignal.com/company/NKTR.md 2026-05-31 https://biopharmsignal.com/company/THAR.md 2026-05-31 https://biopharmsignal.com/company/TNGX.md 2026-05-31 https://biopharmsignal.com/company/DRTS.md 2026-05-31 https://biopharmsignal.com/company/ZLAB.md 2026-05-31 https://biopharmsignal.com/company/OVID.md 2026-05-31 https://biopharmsignal.com/company/KALA.md 2026-05-31 https://biopharmsignal.com/company/ASMB.md 2026-05-31 https://biopharmsignal.com/company/PXMD.md 2026-05-31 https://biopharmsignal.com/company/BIOR.md 2026-05-31 https://biopharmsignal.com/company/TIL.md 2026-05-31 https://biopharmsignal.com/company/VERU.md 2026-05-31 https://biopharmsignal.com/company/MURA.md 2026-05-31 https://biopharmsignal.com/company/RLMD.md 2026-05-31 https://biopharmsignal.com/company/GYRE.md 2026-05-31 https://biopharmsignal.com/company/CRGX.md 2026-05-31 https://biopharmsignal.com/company/XOMA.md 2026-05-31 https://biopharmsignal.com/company/CGON.md 2026-05-31 https://biopharmsignal.com/company/MDWD.md 2026-05-31 https://biopharmsignal.com/company/TLPH.md 2026-05-31 https://biopharmsignal.com/company/TSBX.md 2026-05-31 https://biopharmsignal.com/company/DERM.md 2026-05-31 https://biopharmsignal.com/company/SYRE.md 2026-05-31 https://biopharmsignal.com/company/LENZ.md 2026-05-31 https://biopharmsignal.com/company/QTTB.md 2026-05-31 https://biopharmsignal.com/company/CRDL.md 2026-05-31 https://biopharmsignal.com/company/PTGX.md 2026-05-31 https://biopharmsignal.com/company/DNA.md 2026-05-31 https://biopharmsignal.com/company/ALEC.md 2026-05-31 https://biopharmsignal.com/company/MLYS.md 2026-05-31 https://biopharmsignal.com/company/RXST.md 2026-05-31 https://biopharmsignal.com/company/CHRS.md 2026-05-31 https://biopharmsignal.com/company/AMAM.md 2026-05-31 https://biopharmsignal.com/company/GNLX.md 2026-05-31 https://biopharmsignal.com/company/RAPT.md 2026-05-31 https://biopharmsignal.com/company/BCYC.md 2026-05-31 https://biopharmsignal.com/company/NVAX.md 2026-05-31 https://biopharmsignal.com/company/EXAI.md 2026-05-31 https://biopharmsignal.com/company/EWTX.md 2026-05-31 https://biopharmsignal.com/company/LXRX.md 2026-05-31 https://biopharmsignal.com/company/IRON.md 2026-05-31 https://biopharmsignal.com/company/PIII.md 2026-05-31 https://biopharmsignal.com/company/IRMD.md 2026-05-31 https://biopharmsignal.com/company/AORT.md 2026-05-31 https://biopharmsignal.com/company/ACRS.md 2026-05-31 https://biopharmsignal.com/company/TYRA.md 2026-05-31 https://biopharmsignal.com/company/LYEL.md 2026-05-31 https://biopharmsignal.com/company/JANX.md 2026-05-31 https://biopharmsignal.com/company/ANAB.md 2026-05-31 https://biopharmsignal.com/company/AMWL.md 2026-05-31 https://biopharmsignal.com/company/HLVX.md 2026-05-31 https://biopharmsignal.com/company/IGMS.md 2026-05-31 https://biopharmsignal.com/company/AVTE.md 2026-05-31 https://biopharmsignal.com/company/AGEN.md 2026-05-31 https://biopharmsignal.com/company/AMRN.md 2026-05-31 https://biopharmsignal.com/company/PHAT.md 2026-05-31 https://biopharmsignal.com/company/FATE.md 2026-05-31 https://biopharmsignal.com/company/STOK.md 2026-05-31 https://biopharmsignal.com/company/OSUR.md 2026-05-31 https://biopharmsignal.com/company/SHCR.md 2026-05-31 https://biopharmsignal.com/company/MTLS.md 2026-05-31 https://biopharmsignal.com/company/HUMA.md 2026-05-31 https://biopharmsignal.com/company/SGHT.md 2026-05-31 https://biopharmsignal.com/company/ITOS.md 2026-05-31 https://biopharmsignal.com/company/MESO.md 2026-05-31 https://biopharmsignal.com/company/THRX.md 2026-05-31 https://biopharmsignal.com/company/OCUL.md 2026-05-31 https://biopharmsignal.com/company/LQDA.md 2026-05-31 https://biopharmsignal.com/company/MXCT.md 2026-05-31 https://biopharmsignal.com/company/BTMD.md 2026-05-31 https://biopharmsignal.com/company/OMGA.md 2026-05-31 https://biopharmsignal.com/company/CYH.md 2026-05-31 https://biopharmsignal.com/company/LUNG.md 2026-05-31 https://biopharmsignal.com/company/GHRS.md 2026-05-31 https://biopharmsignal.com/company/BLUE.md 2026-05-31 https://biopharmsignal.com/company/EBS.md 2026-05-31 https://biopharmsignal.com/company/MRNS.md 2026-05-31 https://biopharmsignal.com/company/MGNX.md 2026-05-31 https://biopharmsignal.com/company/CMPX.md 2026-05-31 https://biopharmsignal.com/company/NRIX.md 2026-05-31 https://biopharmsignal.com/company/TCMD.md 2026-05-31 https://biopharmsignal.com/company/ERAS.md 2026-05-31 https://biopharmsignal.com/company/BFLY.md 2026-05-31 https://biopharmsignal.com/company/TNYA.md 2026-05-31 https://biopharmsignal.com/company/CNTA.md 2026-05-31 https://biopharmsignal.com/company/DSGN.md 2026-05-31 https://biopharmsignal.com/company/NVTA.md 2026-05-31 https://biopharmsignal.com/company/CLOV.md 2026-05-31 https://biopharmsignal.com/company/TARS.md 2026-05-31 https://biopharmsignal.com/company/SRRK.md 2026-05-31 https://biopharmsignal.com/company/AXGN.md 2026-05-31 https://biopharmsignal.com/company/ALVR.md 2026-05-31 https://biopharmsignal.com/company/CUTR.md 2026-05-31 https://biopharmsignal.com/company/SIGA.md 2026-05-31 https://biopharmsignal.com/company/RCEL.md 2026-05-31 https://biopharmsignal.com/company/SCPH.md 2026-05-31 https://biopharmsignal.com/company/OABI.md 2026-05-31 https://biopharmsignal.com/company/CERS.md 2026-05-31 https://biopharmsignal.com/company/VNDA.md 2026-05-31 https://biopharmsignal.com/company/WVE.md 2026-05-31 https://biopharmsignal.com/company/TRDA.md 2026-05-31 https://biopharmsignal.com/company/CMPS.md 2026-05-31 https://biopharmsignal.com/company/AURA.md 2026-05-31 https://biopharmsignal.com/company/CGEM.md 2026-05-31 https://biopharmsignal.com/company/ALLK.md 2026-05-31 https://biopharmsignal.com/company/VYGR.md 2026-05-31 https://biopharmsignal.com/company/OCS.md 2026-05-31 https://biopharmsignal.com/company/ALPN.md 2026-05-31 https://biopharmsignal.com/company/PEPG.md 2026-05-31 https://biopharmsignal.com/company/NUVB.md 2026-05-31 https://biopharmsignal.com/company/ANGO.md 2026-05-31 https://biopharmsignal.com/company/PNTG.md 2026-05-31 https://biopharmsignal.com/company/ASRT.md 2026-05-31 https://biopharmsignal.com/company/CABA.md 2026-05-31 https://biopharmsignal.com/company/VIGL.md 2026-05-31 https://biopharmsignal.com/company/ATAI.md 2026-05-31 https://biopharmsignal.com/company/XERS.md 2026-05-31 https://biopharmsignal.com/company/STRO.md 2026-05-31 https://biopharmsignal.com/company/AUTL.md 2026-05-31 https://biopharmsignal.com/company/SENS.md 2026-05-31 https://biopharmsignal.com/company/SMTI.md 2026-05-31 https://biopharmsignal.com/company/PGEN.md 2026-05-31 https://biopharmsignal.com/company/NGM.md 2026-05-31 https://biopharmsignal.com/company/DBVT.md 2026-05-31 https://biopharmsignal.com/company/OMER.md 2026-05-31 https://biopharmsignal.com/company/PHVS.md 2026-05-31 https://biopharmsignal.com/company/SOPH.md 2026-05-31 https://biopharmsignal.com/company/GBIO.md 2026-05-31 https://biopharmsignal.com/company/PRLD.md 2026-05-31 https://biopharmsignal.com/company/PLSE.md 2026-05-31 https://biopharmsignal.com/company/RPHM.md 2026-05-31 https://biopharmsignal.com/company/AIRS.md 2026-05-31 https://biopharmsignal.com/company/NAUT.md 2026-05-31 https://biopharmsignal.com/company/YMAB.md 2026-05-31 https://biopharmsignal.com/company/OTLK.md 2026-05-31 https://biopharmsignal.com/company/URGN.md 2026-05-31 https://biopharmsignal.com/company/HRTX.md 2026-05-31 https://biopharmsignal.com/company/ICVX.md 2026-05-31 https://biopharmsignal.com/company/MGTX.md 2026-05-31 https://biopharmsignal.com/company/ACET.md 2026-05-31 https://biopharmsignal.com/company/KPTI.md 2026-05-31 https://biopharmsignal.com/company/GOCO.md 2026-05-31 https://biopharmsignal.com/company/VAXX.md 2026-05-31 https://biopharmsignal.com/company/AVIR.md 2026-05-31 https://biopharmsignal.com/company/ORGO.md 2026-05-31 https://biopharmsignal.com/company/ACRV.md 2026-05-31 https://biopharmsignal.com/company/ANNX.md 2026-05-31 https://biopharmsignal.com/company/VOR.md 2026-05-31 https://biopharmsignal.com/company/VRCA.md 2026-05-31 https://biopharmsignal.com/company/INGN.md 2026-05-31 https://biopharmsignal.com/company/ZIMV.md 2026-05-31 https://biopharmsignal.com/company/GLUE.md 2026-05-31 https://biopharmsignal.com/company/OLMA.md 2026-05-31 https://biopharmsignal.com/company/CRBU.md 2026-05-31 https://biopharmsignal.com/company/INZY.md 2026-05-31 https://biopharmsignal.com/company/KOD.md 2026-05-31 https://biopharmsignal.com/company/CVRX.md 2026-05-31 https://biopharmsignal.com/company/IKNA.md 2026-05-31 https://biopharmsignal.com/company/ALXO.md 2026-05-31 https://biopharmsignal.com/company/AKYA.md 2026-05-31 https://biopharmsignal.com/company/MOLN.md 2026-05-31 https://biopharmsignal.com/company/IPHA.md 2026-05-31 https://biopharmsignal.com/company/ALT.md 2026-05-31 https://biopharmsignal.com/company/NVCT.md 2026-05-31 https://biopharmsignal.com/company/TELA.md 2026-05-31 https://biopharmsignal.com/company/SLQT.md 2026-05-31 https://biopharmsignal.com/company/ORIC.md 2026-05-31 https://biopharmsignal.com/company/ADAP.md 2026-05-31 https://biopharmsignal.com/company/CARA.md 2026-05-31 https://biopharmsignal.com/company/MASS.md 2026-05-31 https://biopharmsignal.com/company/PMVP.md 2026-05-31 https://biopharmsignal.com/company/CDXS.md 2026-05-31 https://biopharmsignal.com/company/SEER.md 2026-05-31 https://biopharmsignal.com/company/FHTX.md 2026-05-31 https://biopharmsignal.com/company/RLYB.md 2026-05-31 https://biopharmsignal.com/company/NKTX.md 2026-05-31 https://biopharmsignal.com/company/SVRA.md 2026-05-31 https://biopharmsignal.com/company/QIPT.md 2026-05-31 https://biopharmsignal.com/company/BNGO.md 2026-05-31 https://biopharmsignal.com/company/IFRX.md 2026-05-31 https://biopharmsignal.com/company/EYPT.md 2026-05-31 https://biopharmsignal.com/company/INO.md 2026-05-31 https://biopharmsignal.com/company/WGS.md 2026-05-31 https://biopharmsignal.com/company/GNFT.md 2026-05-31 https://biopharmsignal.com/company/RANI.md 2026-05-31 https://biopharmsignal.com/company/IMRX.md 2026-05-31 https://biopharmsignal.com/company/FENC.md 2026-05-31 https://biopharmsignal.com/company/LRMR.md 2026-05-31 https://biopharmsignal.com/company/RIGL.md 2026-05-31 https://biopharmsignal.com/company/AADI.md 2026-05-31 https://biopharmsignal.com/company/CELC.md 2026-05-31 https://biopharmsignal.com/company/CTXR.md 2026-05-31 https://biopharmsignal.com/company/ABOS.md 2026-05-31 https://biopharmsignal.com/company/XFOR.md 2026-05-31 https://biopharmsignal.com/company/BGXX.md 2026-05-31 https://biopharmsignal.com/company/AKBA.md 2026-05-31 https://biopharmsignal.com/company/THRD.md 2026-05-31 https://biopharmsignal.com/company/AVAH.md 2026-05-31 https://biopharmsignal.com/company/IPSC.md 2026-05-31 https://biopharmsignal.com/company/LBPH.md 2026-05-31 https://biopharmsignal.com/company/KZR.md 2026-05-31 https://biopharmsignal.com/company/FULC.md 2026-05-31 https://biopharmsignal.com/company/NBTX.md 2026-05-31 https://biopharmsignal.com/company/TRVI.md 2026-05-31 https://biopharmsignal.com/company/ACIU.md 2026-05-31 https://biopharmsignal.com/company/GRPH.md 2026-05-31 https://biopharmsignal.com/company/MACK.md 2026-05-31 https://biopharmsignal.com/company/KRMD.md 2026-05-31 https://biopharmsignal.com/company/LMDXF.md 2026-05-31 https://biopharmsignal.com/company/SMLR.md 2026-05-31 https://biopharmsignal.com/company/RVPH.md 2026-05-31 https://biopharmsignal.com/company/ADCT.md 2026-05-31 https://biopharmsignal.com/company/EYEN.md 2026-05-31 https://biopharmsignal.com/company/PRQR.md 2026-05-31 https://biopharmsignal.com/company/XAIR.md 2026-05-31 https://biopharmsignal.com/company/OCGN.md 2026-05-31 https://biopharmsignal.com/company/GMDA.md 2026-05-31 https://biopharmsignal.com/company/JSPR.md 2026-05-31 https://biopharmsignal.com/company/CCCC.md 2026-05-31 https://biopharmsignal.com/company/ACHV.md 2026-05-31 https://biopharmsignal.com/company/AUGX.md 2026-05-31 https://biopharmsignal.com/company/BCAB.md 2026-05-31 https://biopharmsignal.com/company/ASXC.md 2026-05-31 https://biopharmsignal.com/company/ADXS.md 2026-05-31 https://biopharmsignal.com/company/GTHX.md 2026-05-31 https://biopharmsignal.com/company/INMB.md 2026-05-31 https://biopharmsignal.com/company/PBYI.md 2026-05-31 https://biopharmsignal.com/company/PSTX.md 2026-05-31 https://biopharmsignal.com/company/MREO.md 2026-05-31 https://biopharmsignal.com/company/GLSI.md 2026-05-31 https://biopharmsignal.com/company/GRTX.md 2026-05-31 https://biopharmsignal.com/company/ZURA.md 2026-05-31 https://biopharmsignal.com/company/PRPH.md 2026-05-31 https://biopharmsignal.com/company/ANVS.md 2026-05-31 https://biopharmsignal.com/company/STXS.md 2026-05-31 https://biopharmsignal.com/company/AFMD.md 2026-05-31 https://biopharmsignal.com/company/ABSI.md 2026-05-31 https://biopharmsignal.com/company/MNMD.md 2026-05-31 https://biopharmsignal.com/company/GOSS.md 2026-05-31 https://biopharmsignal.com/company/EPIX.md 2026-05-31 https://biopharmsignal.com/company/HLTH.md 2026-05-31 https://biopharmsignal.com/company/BDSX.md 2026-05-31 https://biopharmsignal.com/company/TRML.md 2026-05-31 https://biopharmsignal.com/company/AQST.md 2026-05-31 https://biopharmsignal.com/company/CTSO.md 2026-05-31 https://biopharmsignal.com/company/OCUP.md 2026-05-31 https://biopharmsignal.com/company/IVA.md 2026-05-31 https://biopharmsignal.com/company/ESPR.md 2026-05-31 https://biopharmsignal.com/company/APYX.md 2026-05-31 https://biopharmsignal.com/company/DRRX.md 2026-05-31 https://biopharmsignal.com/company/RNLX.md 2026-05-31 https://biopharmsignal.com/company/VXRT.md 2026-05-31 https://biopharmsignal.com/company/FONR.md 2026-05-31 https://biopharmsignal.com/company/STTK.md 2026-05-31 https://biopharmsignal.com/company/ATYR.md 2026-05-31 https://biopharmsignal.com/company/PYXS.md 2026-05-31 https://biopharmsignal.com/company/BCTX.md 2026-05-31 https://biopharmsignal.com/company/GALT.md 2026-05-31 https://biopharmsignal.com/company/KRON.md 2026-05-31 https://biopharmsignal.com/company/GNTA.md 2026-05-31 https://biopharmsignal.com/company/CTMX.md 2026-05-31 https://biopharmsignal.com/company/CVM.md 2026-05-31 https://biopharmsignal.com/company/ANTX.md 2026-05-31 https://biopharmsignal.com/company/SERA.md 2026-05-31 https://biopharmsignal.com/company/ATHA.md 2026-05-31 https://biopharmsignal.com/company/SCYX.md 2026-05-31 https://biopharmsignal.com/company/MDXH.md 2026-05-31 https://biopharmsignal.com/company/BCLI.md 2026-05-31 https://biopharmsignal.com/company/MNOV.md 2026-05-31 https://biopharmsignal.com/company/PSNL.md 2026-05-31 https://biopharmsignal.com/company/SLDB.md 2026-05-31 https://biopharmsignal.com/company/CLLS.md 2026-05-31 https://biopharmsignal.com/company/AKLI.md 2026-05-31 https://biopharmsignal.com/company/HOWL.md 2026-05-31 https://biopharmsignal.com/company/HYPR.md 2026-05-31 https://biopharmsignal.com/company/STRM.md 2026-05-31 https://biopharmsignal.com/company/SEEL.md 2026-05-31 https://biopharmsignal.com/company/SPRO.md 2026-05-31 https://biopharmsignal.com/company/CAPR.md 2026-05-31 https://biopharmsignal.com/company/ELEV.md 2026-05-31 https://biopharmsignal.com/company/FBIO.md 2026-05-31 https://biopharmsignal.com/company/ARAV.md 2026-05-31 https://biopharmsignal.com/company/CDTX.md 2026-05-31 https://biopharmsignal.com/company/GLYC.md 2026-05-31 https://biopharmsignal.com/company/DTIL.md 2026-05-31 https://biopharmsignal.com/company/ELYM.md 2026-05-31 https://biopharmsignal.com/company/SPRB.md 2026-05-31 https://biopharmsignal.com/company/BLPH.md 2026-05-31 https://biopharmsignal.com/company/ATOS.md 2026-05-31 https://biopharmsignal.com/company/BLI.md 2026-05-31 https://biopharmsignal.com/company/XLO.md 2026-05-31 https://biopharmsignal.com/company/RZLT.md 2026-05-31 https://biopharmsignal.com/company/FORA.md 2026-05-31 https://biopharmsignal.com/company/VSTM.md 2026-05-31 https://biopharmsignal.com/company/LYRA.md 2026-05-31 https://biopharmsignal.com/company/APLT.md 2026-05-31 https://biopharmsignal.com/company/HOOK.md 2026-05-31 https://biopharmsignal.com/company/CRDF.md 2026-05-31 https://biopharmsignal.com/company/OSA.md 2026-05-31 https://biopharmsignal.com/company/IMUX.md 2026-05-31 https://biopharmsignal.com/company/AXDX.md 2026-05-31 https://biopharmsignal.com/company/DMTK.md 2026-05-31 https://biopharmsignal.com/company/CRIS.md 2026-05-31 https://biopharmsignal.com/company/OMIC.md 2026-05-31 https://biopharmsignal.com/company/CYT.md 2026-05-31 https://biopharmsignal.com/company/MYNZ.md 2026-05-31 https://biopharmsignal.com/company/ETAO.md 2026-05-31 https://biopharmsignal.com/company/CLNN.md 2026-05-31 https://biopharmsignal.com/company/XTNT.md 2026-05-31 https://biopharmsignal.com/company/IMNM.md 2026-05-31 https://biopharmsignal.com/company/BDTX.md 2026-05-31 https://biopharmsignal.com/company/LUCD.md 2026-05-31 https://biopharmsignal.com/company/CLSD.md 2026-05-31 https://biopharmsignal.com/company/NWBO.md 2026-05-31 https://biopharmsignal.com/company/LGVN.md 2026-05-31 https://biopharmsignal.com/company/DCTH.md 2026-05-31 https://biopharmsignal.com/company/GANX.md 2026-05-31 https://biopharmsignal.com/company/SONX.md 2026-05-31 https://biopharmsignal.com/company/INAB.md 2026-05-31 https://biopharmsignal.com/company/CSBR.md 2026-05-31 https://biopharmsignal.com/company/STIM.md 2026-05-31 https://biopharmsignal.com/company/PRAX.md 2026-05-31 https://biopharmsignal.com/company/SYRS.md 2026-05-31 https://biopharmsignal.com/company/BOLT.md 2026-05-31 https://biopharmsignal.com/company/PIRS.md 2026-05-31 https://biopharmsignal.com/company/CRVS.md 2026-05-31 https://biopharmsignal.com/company/ICCM.md 2026-05-31 https://biopharmsignal.com/company/ANEB.md 2026-05-31 https://biopharmsignal.com/company/IOBT.md 2026-05-31 https://biopharmsignal.com/company/FIXX.md 2026-05-31 https://biopharmsignal.com/company/LTRN.md 2026-05-31 https://biopharmsignal.com/company/ABEO.md 2026-05-31 https://biopharmsignal.com/company/PASG.md 2026-05-31 https://biopharmsignal.com/company/TCRX.md 2026-05-31 https://biopharmsignal.com/company/VANI.md 2026-05-31 https://biopharmsignal.com/company/OKYO.md 2026-05-31 https://biopharmsignal.com/company/ALGS.md 2026-05-31 https://biopharmsignal.com/company/GLTO.md 2026-05-31 https://biopharmsignal.com/company/MOVE.md 2026-05-31 https://biopharmsignal.com/company/TRNR.md 2026-05-31 https://biopharmsignal.com/company/HCWB.md 2026-05-31 https://biopharmsignal.com/company/PAVM.md 2026-05-31 https://biopharmsignal.com/company/ALZN.md 2026-05-31 https://biopharmsignal.com/company/HEPA.md 2026-05-31 https://biopharmsignal.com/company/SABS.md 2026-05-31 https://biopharmsignal.com/company/LFVN.md 2026-05-31 https://biopharmsignal.com/company/SNSE.md 2026-05-31 https://biopharmsignal.com/company/PMCB.md 2026-05-31 https://biopharmsignal.com/company/ARMP.md 2026-05-31 https://biopharmsignal.com/company/CADL.md 2026-05-31 https://biopharmsignal.com/company/XGN.md 2026-05-31 https://biopharmsignal.com/company/CGTX.md 2026-05-31 https://biopharmsignal.com/company/SNTI.md 2026-05-31 https://biopharmsignal.com/company/MEIP.md 2026-05-31 https://biopharmsignal.com/company/LPTX.md 2026-05-31 https://biopharmsignal.com/company/TSHA.md 2026-05-31 https://biopharmsignal.com/company/DMAC.md 2026-05-31 https://biopharmsignal.com/company/NXTC.md 2026-05-31 https://biopharmsignal.com/company/LVTX.md 2026-05-31 https://biopharmsignal.com/company/NRXP.md 2026-05-31 https://biopharmsignal.com/company/NLSP.md 2026-05-31 https://biopharmsignal.com/company/CRBP.md 2026-05-31 https://biopharmsignal.com/company/GNPX.md 2026-05-31 https://biopharmsignal.com/company/BCDA.md 2026-05-31 https://biopharmsignal.com/company/BCEL.md 2026-05-31 https://biopharmsignal.com/company/KA.md 2026-05-31 https://biopharmsignal.com/company/CCEL.md 2026-05-31 https://biopharmsignal.com/company/TXMD.md 2026-05-31 https://biopharmsignal.com/company/ACHL.md 2026-05-31 https://biopharmsignal.com/company/UTRS.md 2026-05-31 https://biopharmsignal.com/company/AQB.md 2026-05-31 https://biopharmsignal.com/company/ICCC.md 2026-05-31 https://biopharmsignal.com/company/AWH.md 2026-05-31 https://biopharmsignal.com/company/SYBX.md 2026-05-31 https://biopharmsignal.com/company/BYSI.md 2026-05-31 https://biopharmsignal.com/company/SURF.md 2026-05-31 https://biopharmsignal.com/company/AZYO.md 2026-05-31 https://biopharmsignal.com/company/SSKN.md 2026-05-31 https://biopharmsignal.com/company/NCNA.md 2026-05-31 https://biopharmsignal.com/company/IRIX.md 2026-05-31 https://biopharmsignal.com/company/RMTI.md 2026-05-31 https://biopharmsignal.com/company/STSA.md 2026-05-31 https://biopharmsignal.com/company/EVAX.md 2026-05-31 https://biopharmsignal.com/company/ACXP.md 2026-05-31 https://biopharmsignal.com/company/GRNA.md 2026-05-31 https://biopharmsignal.com/company/COSM.md 2026-05-31 https://biopharmsignal.com/company/RPID.md 2026-05-31 https://biopharmsignal.com/company/TARA.md 2026-05-31 https://biopharmsignal.com/company/AVTX.md 2026-05-31 https://biopharmsignal.com/company/VINC.md 2026-05-31 https://biopharmsignal.com/company/OMED.md 2026-05-31 https://biopharmsignal.com/company/UBX.md 2026-05-31 https://biopharmsignal.com/company/SLNO.md 2026-05-31 https://biopharmsignal.com/company/VIRX.md 2026-05-31 https://biopharmsignal.com/company/CASI.md 2026-05-31 https://biopharmsignal.com/company/IMMX.md 2026-05-31 https://biopharmsignal.com/company/TNXP.md 2026-05-31 https://biopharmsignal.com/company/BTCY.md 2026-05-31 https://biopharmsignal.com/company/BFRG.md 2026-05-31 https://biopharmsignal.com/company/ANPC.md 2026-05-31 https://biopharmsignal.com/company/NERV.md 2026-05-31 https://biopharmsignal.com/company/AVRO.md 2026-05-31 https://biopharmsignal.com/company/NOVN.md 2026-05-31 https://biopharmsignal.com/company/MIRO.md 2026-05-31 https://biopharmsignal.com/company/MBIO.md 2026-05-31 https://biopharmsignal.com/company/ORPH.md 2026-05-31 https://biopharmsignal.com/company/LNSR.md 2026-05-31 https://biopharmsignal.com/company/TRVN.md 2026-05-31 https://biopharmsignal.com/company/ONTX.md 2026-05-31 https://biopharmsignal.com/company/ORGS.md 2026-05-31 https://biopharmsignal.com/company/AXLA.md 2026-05-31 https://biopharmsignal.com/company/ABVC.md 2026-05-31 https://biopharmsignal.com/company/LUMO.md 2026-05-31 https://biopharmsignal.com/company/VAPO.md 2026-05-31 https://biopharmsignal.com/company/ECOR.md 2026-05-31 https://biopharmsignal.com/company/COCP.md 2026-05-31 https://biopharmsignal.com/company/RNXT.md 2026-05-31 https://biopharmsignal.com/company/TFFP.md 2026-05-31 https://biopharmsignal.com/company/VTGN.md 2026-05-31 https://biopharmsignal.com/company/AFIB.md 2026-05-31 https://biopharmsignal.com/company/NTRB.md 2026-05-31 https://biopharmsignal.com/company/RGLS.md 2026-05-31 https://biopharmsignal.com/company/IDRA.md 2026-05-31 https://biopharmsignal.com/company/LSTA.md 2026-05-31 https://biopharmsignal.com/company/ICU.md 2026-05-31 https://biopharmsignal.com/company/BTTX.md 2026-05-31 https://biopharmsignal.com/company/ANGN.md 2026-05-31 https://biopharmsignal.com/company/MITO.md 2026-05-31 https://biopharmsignal.com/company/CNTG.md 2026-05-31 https://biopharmsignal.com/company/EFTR.md 2026-05-31 https://biopharmsignal.com/company/NMRD.md 2026-05-31 https://biopharmsignal.com/company/FBRX.md 2026-05-31 https://biopharmsignal.com/company/NMTC.md 2026-05-31 https://biopharmsignal.com/company/AGE.md 2026-05-31 https://biopharmsignal.com/company/HARP.md 2026-05-31 https://biopharmsignal.com/company/TPST.md 2026-05-31 https://biopharmsignal.com/company/TNON.md 2026-05-31 https://biopharmsignal.com/company/ACST.md 2026-05-31 https://biopharmsignal.com/company/INDP.md 2026-05-31 https://biopharmsignal.com/company/HGEN.md 2026-05-31 https://biopharmsignal.com/company/BRLI.md 2026-05-31 https://biopharmsignal.com/company/IKT.md 2026-05-31 https://biopharmsignal.com/company/BRTX.md 2026-05-31 https://biopharmsignal.com/company/VCNX.md 2026-05-31 https://biopharmsignal.com/company/MODD.md 2026-05-31 https://biopharmsignal.com/company/FNCH.md 2026-05-31 https://biopharmsignal.com/company/ONCT.md 2026-05-31 https://biopharmsignal.com/company/SQZ.md 2026-05-31 https://biopharmsignal.com/company/IGC.md 2026-05-31 https://biopharmsignal.com/company/MGRX.md 2026-05-31 https://biopharmsignal.com/company/NHWK.md 2026-05-31 https://biopharmsignal.com/company/AEON.md 2026-05-31 https://biopharmsignal.com/company/APGE.md 2026-05-31 https://biopharmsignal.com/company/UNH.md 2026-05-31 https://biopharmsignal.com/company/JNJ.md 2026-05-31 https://biopharmsignal.com/company/LLY.md 2026-05-31 https://biopharmsignal.com/company/NVO.md 2026-05-31 https://biopharmsignal.com/company/MRK.md 2026-05-31 https://biopharmsignal.com/company/ABBV.md 2026-05-31 https://biopharmsignal.com/company/AZN.md 2026-05-31 https://biopharmsignal.com/company/NVS.md 2026-05-31 https://biopharmsignal.com/company/PFE.md 2026-05-31 https://biopharmsignal.com/company/BMY.md 2026-05-31 https://biopharmsignal.com/company/SNY.md 2026-05-31 https://biopharmsignal.com/company/AMGN.md 2026-05-31 https://biopharmsignal.com/company/TMO.md 2026-05-31 https://biopharmsignal.com/company/ELV.md 2026-05-31 https://biopharmsignal.com/company/SYK.md 2026-05-31 https://biopharmsignal.com/company/ISRG.md 2026-05-31 https://biopharmsignal.com/company/GILD.md 2026-05-31 https://biopharmsignal.com/company/REGN.md 2026-05-31 https://biopharmsignal.com/company/BSX.md 2026-05-31 https://biopharmsignal.com/company/GSK.md 2026-05-31 https://biopharmsignal.com/company/HUM.md 2026-05-31 https://biopharmsignal.com/company/EW.md 2026-05-31 https://biopharmsignal.com/company/MRNA.md 2026-05-31 https://biopharmsignal.com/company/KVUE.md 2026-05-31 https://biopharmsignal.com/company/DXCM.md 2026-05-31 https://biopharmsignal.com/company/A.md 2026-05-31 https://biopharmsignal.com/company/ALC.md 2026-05-31 https://biopharmsignal.com/company/GEHC.md 2026-05-31 https://biopharmsignal.com/company/KR.md 2026-05-31 https://biopharmsignal.com/company/IQV.md 2026-05-31 https://biopharmsignal.com/company/RMD.md 2026-05-31 https://biopharmsignal.com/company/MTD.md 2026-05-31 https://biopharmsignal.com/company/ZBH.md 2026-05-31 https://biopharmsignal.com/company/VEEV.md 2026-05-31 https://biopharmsignal.com/company/GMAB.md 2026-05-31 https://biopharmsignal.com/company/ALNY.md 2026-05-31 https://biopharmsignal.com/company/BNTX.md 2026-05-31 https://biopharmsignal.com/company/ARGX.md 2026-05-31 https://biopharmsignal.com/company/CAH.md 2026-05-31 https://biopharmsignal.com/company/HOLX.md 2026-05-31 https://biopharmsignal.com/company/COO.md 2026-05-31 https://biopharmsignal.com/company/BMRN.md 2026-05-31 https://biopharmsignal.com/company/WAT.md 2026-05-31 https://biopharmsignal.com/company/MOH.md 2026-05-31 https://biopharmsignal.com/company/AXON.md 2026-05-31 https://biopharmsignal.com/company/RVTY.md 2026-05-31 https://biopharmsignal.com/company/DGX.md 2026-05-31 https://biopharmsignal.com/company/INCY.md 2026-05-31 https://biopharmsignal.com/company/SNN.md 2026-05-31 https://biopharmsignal.com/company/FMS.md 2026-05-31 https://biopharmsignal.com/company/EPAM.md 2026-05-31 https://biopharmsignal.com/company/TECH.md 2026-05-31 https://biopharmsignal.com/company/EXAS.md 2026-05-31 https://biopharmsignal.com/company/TFX.md 2026-05-31 https://biopharmsignal.com/company/SRPT.md 2026-05-31 https://biopharmsignal.com/company/LEGN.md 2026-05-31 https://biopharmsignal.com/company/BRKR.md 2026-05-31 https://biopharmsignal.com/company/AGL.md 2026-05-31 https://biopharmsignal.com/company/APLS.md 2026-05-31 https://biopharmsignal.com/company/QGEN.md 2026-05-31 https://biopharmsignal.com/company/HSIC.md 2026-05-31 https://biopharmsignal.com/company/VTRS.md 2026-05-31 https://biopharmsignal.com/company/TEVA.md 2026-05-31 https://biopharmsignal.com/company/SWAV.md 2026-05-31 https://biopharmsignal.com/company/MASI.md 2026-05-31 https://biopharmsignal.com/company/UTHR.md 2026-05-31 https://biopharmsignal.com/company/CRL.md 2026-05-31 https://biopharmsignal.com/company/NBIX.md 2026-05-31 https://biopharmsignal.com/company/RDY.md 2026-05-31 https://biopharmsignal.com/company/JAZZ.md 2026-05-31 https://biopharmsignal.com/company/XRAY.md 2026-05-31 https://biopharmsignal.com/company/RGEN.md 2026-05-31 https://biopharmsignal.com/company/THC.md 2026-05-31 https://biopharmsignal.com/company/ROIV.md 2026-05-31 https://biopharmsignal.com/company/RCM.md 2026-05-31 https://biopharmsignal.com/company/PRI.md 2026-05-31 https://biopharmsignal.com/company/DOCS.md 2026-05-31 https://biopharmsignal.com/company/MEDP.md 2026-05-31 https://biopharmsignal.com/company/CTLT.md 2026-05-31 https://biopharmsignal.com/company/ACHC.md 2026-05-31 https://biopharmsignal.com/company/TXG.md 2026-05-31 https://biopharmsignal.com/company/EHC.md 2026-05-31 https://biopharmsignal.com/company/EXEL.md 2026-05-31 https://biopharmsignal.com/company/ITCI.md 2026-05-31 https://biopharmsignal.com/company/NTRA.md 2026-05-31 https://biopharmsignal.com/company/GMED.md 2026-05-31 https://biopharmsignal.com/company/MDGL.md 2026-05-31 https://biopharmsignal.com/company/ASND.md 2026-05-31 https://biopharmsignal.com/company/GRFS.md 2026-05-31 https://biopharmsignal.com/company/ENSG.md 2026-05-31 https://biopharmsignal.com/company/CERE.md 2026-05-31 https://biopharmsignal.com/company/OPCH.md 2026-05-31 https://biopharmsignal.com/company/IONS.md 2026-05-31 https://biopharmsignal.com/company/TGTX.md 2026-05-31 https://biopharmsignal.com/company/MMSI.md 2026-05-31 https://biopharmsignal.com/company/PRGO.md 2026-05-31 https://biopharmsignal.com/company/PCVX.md 2026-05-31 https://biopharmsignal.com/company/ICUI.md 2026-05-31 https://biopharmsignal.com/company/CRSP.md 2026-05-31 https://biopharmsignal.com/company/ARWR.md 2026-05-31 https://biopharmsignal.com/company/TDOC.md 2026-05-31 https://biopharmsignal.com/company/SHC.md 2026-05-31 https://biopharmsignal.com/company/IART.md 2026-05-31 https://biopharmsignal.com/company/HALO.md 2026-05-31 https://biopharmsignal.com/company/PRTA.md 2026-05-31 https://biopharmsignal.com/company/YOU.md 2026-05-31 https://biopharmsignal.com/company/EVH.md 2026-05-31 https://biopharmsignal.com/company/IRTC.md 2026-05-31 https://biopharmsignal.com/company/NTLA.md 2026-05-31 https://biopharmsignal.com/company/SEM.md 2026-05-31 https://biopharmsignal.com/company/NARI.md 2026-05-31 https://biopharmsignal.com/company/CNMD.md 2026-05-31 https://biopharmsignal.com/company/CERT.md 2026-05-31 https://biopharmsignal.com/company/NEOG.md 2026-05-31 https://biopharmsignal.com/company/CYTK.md 2026-05-31 https://biopharmsignal.com/company/DNLI.md 2026-05-31 https://biopharmsignal.com/company/AMN.md 2026-05-31 https://biopharmsignal.com/company/PRVA.md 2026-05-31 https://biopharmsignal.com/company/FOLD.md 2026-05-31 https://biopharmsignal.com/company/BPMC.md 2026-05-31 https://biopharmsignal.com/company/PGNY.md 2026-05-31 https://biopharmsignal.com/company/VIR.md 2026-05-31 https://biopharmsignal.com/company/LFST.md 2026-05-31 https://biopharmsignal.com/company/EVO.md 2026-05-31 https://biopharmsignal.com/company/AZTA.md 2026-05-31 https://biopharmsignal.com/company/SAGE.md 2026-05-31 https://biopharmsignal.com/company/PACB.md 2026-05-31 https://biopharmsignal.com/company/IMGN.md 2026-05-31 https://biopharmsignal.com/company/OMCL.md 2026-05-31 https://biopharmsignal.com/company/INMD.md 2026-05-31 https://biopharmsignal.com/company/IMCR.md 2026-05-31 https://biopharmsignal.com/company/AXNX.md 2026-05-31 https://biopharmsignal.com/company/OLK.md 2026-05-31 https://biopharmsignal.com/company/AMED.md 2026-05-31 https://biopharmsignal.com/company/RVMD.md 2026-05-31 https://biopharmsignal.com/company/INSM.md 2026-05-31 https://biopharmsignal.com/company/IMVT.md 2026-05-31 https://biopharmsignal.com/company/ALVO.md 2026-05-31 https://biopharmsignal.com/company/BEAM.md 2026-05-31 https://biopharmsignal.com/company/HIMS.md 2026-05-31 https://biopharmsignal.com/company/MORF.md 2026-05-31 https://biopharmsignal.com/company/GH.md 2026-05-31 https://biopharmsignal.com/company/TMDX.md 2026-05-31 https://biopharmsignal.com/company/VKTX.md 2026-05-31 https://biopharmsignal.com/company/KRYS.md 2026-05-31 https://biopharmsignal.com/company/ATRC.md 2026-05-31 https://biopharmsignal.com/company/VTYX.md 2026-05-31 https://biopharmsignal.com/company/PROK.md 2026-05-31 https://biopharmsignal.com/company/AKRO.md 2026-05-31 https://biopharmsignal.com/company/BBIO.md 2026-05-31 https://biopharmsignal.com/company/HRMY.md 2026-05-31 https://biopharmsignal.com/company/NUVL.md 2026-05-31 https://biopharmsignal.com/company/ACLX.md 2026-05-31 https://biopharmsignal.com/company/AMLX.md 2026-05-31 https://biopharmsignal.com/company/SDGR.md 2026-05-31 https://biopharmsignal.com/company/DYN.md 2026-05-31 https://biopharmsignal.com/company/PCRX.md 2026-05-31 https://biopharmsignal.com/company/CVAC.md 2026-05-31 https://biopharmsignal.com/company/CPRX.md 2026-05-31 https://biopharmsignal.com/company/GDRX.md 2026-05-31 https://biopharmsignal.com/company/AMPH.md 2026-05-31 https://biopharmsignal.com/company/ATEC.md 2026-05-31 https://biopharmsignal.com/company/EYE.md 2026-05-31 https://biopharmsignal.com/company/FGEN.md 2026-05-31 https://biopharmsignal.com/company/EMBC.md 2026-05-31 https://biopharmsignal.com/company/SILK.md 2026-05-31 https://biopharmsignal.com/company/XNCR.md 2026-05-31 https://biopharmsignal.com/company/VCYT.md 2026-05-31 https://biopharmsignal.com/company/IRWD.md 2026-05-31 https://biopharmsignal.com/company/BCRX.md 2026-05-31 https://biopharmsignal.com/company/TMCI.md 2026-05-31 https://biopharmsignal.com/company/CLDX.md 2026-05-31 https://biopharmsignal.com/company/VCEL.md 2026-05-31 https://biopharmsignal.com/company/KYMR.md 2026-05-31 https://biopharmsignal.com/company/USPH.md 2026-05-31 https://biopharmsignal.com/company/SWTX.md 2026-05-31 https://biopharmsignal.com/company/LMAT.md 2026-05-31 https://biopharmsignal.com/company/FNA.md 2026-05-31 https://biopharmsignal.com/company/RCUS.md 2026-05-31 https://biopharmsignal.com/company/GERN.md 2026-05-31 https://biopharmsignal.com/company/SNDX.md 2026-05-31 https://biopharmsignal.com/company/HLF.md 2026-05-31 https://biopharmsignal.com/company/PRME.md 2026-05-31 https://biopharmsignal.com/company/ALHC.md 2026-05-31 https://biopharmsignal.com/company/ADUS.md 2026-05-31 https://biopharmsignal.com/company/SMMT.md 2026-05-31 https://biopharmsignal.com/company/LGND.md 2026-05-31 https://biopharmsignal.com/company/FIGS.md 2026-05-31 https://biopharmsignal.com/company/RLAY.md 2026-05-31 https://biopharmsignal.com/company/MDRX.md 2026-05-31 https://biopharmsignal.com/company/PLRX.md 2026-05-31 https://biopharmsignal.com/company/ZNTL.md 2026-05-31 https://biopharmsignal.com/company/USNA.md 2026-05-31 https://biopharmsignal.com/company/KROS.md 2026-05-31 https://biopharmsignal.com/company/ETNB.md 2026-05-31 https://biopharmsignal.com/company/TVTX.md 2026-05-31 https://biopharmsignal.com/company/PRCT.md 2026-05-31 https://biopharmsignal.com/company/CRNX.md 2026-05-31 https://biopharmsignal.com/company/BMEA.md 2026-05-31 https://biopharmsignal.com/company/INBX.md 2026-05-31 https://biopharmsignal.com/company/MD.md 2026-05-31 https://biopharmsignal.com/company/MODN.md 2026-05-31 https://biopharmsignal.com/company/CDMO.md 2026-05-31 https://biopharmsignal.com/company/NAMS.md 2026-05-31 https://biopharmsignal.com/company/VRDN.md 2026-05-31 https://biopharmsignal.com/company/IDYA.md 2026-05-31 https://biopharmsignal.com/company/RXRX.md 2026-05-31 https://biopharmsignal.com/company/ATRI.md 2026-05-31 https://biopharmsignal.com/company/SANA.md 2026-05-31 https://biopharmsignal.com/company/NRC.md 2026-05-31 https://biopharmsignal.com/company/QURE.md 2026-05-31 https://biopharmsignal.com/company/MNKD.md 2026-05-31 https://biopharmsignal.com/company/REPL.md 2026-05-31 https://biopharmsignal.com/company/VERV.md 2026-05-31 https://biopharmsignal.com/company/MIRM.md 2026-05-31 https://biopharmsignal.com/company/ME.md 2026-05-31 https://biopharmsignal.com/company/OM.md 2026-05-31 https://biopharmsignal.com/company/NVRO.md 2026-05-31 https://biopharmsignal.com/company/SAVA.md 2026-05-31 https://biopharmsignal.com/company/DAWN.md 2026-05-31 https://biopharmsignal.com/company/ADPT.md 2026-05-31 https://biopharmsignal.com/company/RYTM.md 2026-05-31 https://biopharmsignal.com/company/MRUS.md 2026-05-31 https://biopharmsignal.com/company/ALLO.md 2026-05-31 https://biopharmsignal.com/company/ARDX.md 2026-05-31 https://biopharmsignal.com/company/VREX.md 2026-05-31 https://biopharmsignal.com/company/ARQT.md 2026-05-31 https://biopharmsignal.com/company/NHC.md 2026-05-31 https://biopharmsignal.com/company/ACCD.md 2026-05-31 https://biopharmsignal.com/company/SIBN.md 2026-05-31 https://biopharmsignal.com/company/CCRN.md 2026-05-31 https://biopharmsignal.com/company/COGT.md 2026-05-31 https://biopharmsignal.com/company/GPCR.md 2026-05-31 https://biopharmsignal.com/company/BLFS.md 2026-05-31 https://biopharmsignal.com/company/HROW.md 2026-05-31 https://biopharmsignal.com/company/SLP.md 2026-05-31 https://biopharmsignal.com/company/MRSN.md 2026-05-31 https://biopharmsignal.com/company/PRTC.md 2026-05-31 https://biopharmsignal.com/company/RGNX.md 2026-05-31 https://biopharmsignal.com/company/ELVN.md 2026-05-31 https://biopharmsignal.com/company/RNA.md 2026-05-31 https://biopharmsignal.com/company/ADMA.md 2026-05-31 https://biopharmsignal.com/company/MOR.md 2026-05-31 https://biopharmsignal.com/company/KURA.md 2026-05-31 https://biopharmsignal.com/company/TWST.md 2026-05-31 https://biopharmsignal.com/company/INVA.md 2026-05-31 https://biopharmsignal.com/company/ANIP.md 2026-05-31 https://biopharmsignal.com/company/MODV.md 2026-05-31 https://biopharmsignal.com/company/IMTX.md 2026-05-31 https://biopharmsignal.com/company/TERN.md 2026-05-31 https://biopharmsignal.com/company/HSTM.md 2026-05-31 https://biopharmsignal.com/company/ENTA.md 2026-05-31 https://biopharmsignal.com/company/TBPH.md 2026-05-31 https://biopharmsignal.com/company/MCRB.md 2026-05-31 https://biopharmsignal.com/company/HCAT.md 2026-05-31 https://biopharmsignal.com/company/EHAB.md 2026-05-31 https://biopharmsignal.com/company/MDXG.md 2026-05-31 https://biopharmsignal.com/company/BLTE.md 2026-05-31 https://biopharmsignal.com/company/EDIT.md 2026-05-31 https://biopharmsignal.com/company/SRNGU.md 2026-04-27 https://biopharmsignal.com/company/MEETING.md 2026-04-27 https://biopharmsignal.com/sector/biopharma.md 2026-05-31 https://biopharmsignal.com/sector/oncology.md 2026-05-31 https://biopharmsignal.com/sector/biologics.md 2026-05-31 https://biopharmsignal.com/sector/large-molecule-drugs.md 2026-05-31 https://biopharmsignal.com/sector/novel-therapies.md 2026-05-31 https://biopharmsignal.com/sector/pharmaceuticals.md 2026-05-31 https://biopharmsignal.com/sector/immunotherapy.md 2026-05-31 https://biopharmsignal.com/sector/cns.md 2026-05-31 https://biopharmsignal.com/sector/life-science-tools.md 2026-05-31 https://biopharmsignal.com/sector/gene-therapy.md 2026-05-31 https://biopharmsignal.com/sector/medtech.md 2026-05-31 https://biopharmsignal.com/sector/stem-cells.md 2026-05-31 https://biopharmsignal.com/sector/small-molecule-drugs.md 2026-05-31 https://biopharmsignal.com/sector/diagnostics.md 2026-05-31 https://biopharmsignal.com/sector/car-t-therapy.md 2026-05-31 https://biopharmsignal.com/sector/cardio-metabolic.md 2026-05-31 https://biopharmsignal.com/sector/vaccines.md 2026-05-31 https://biopharmsignal.com/sector/antibody-drugs.md 2026-05-31 https://biopharmsignal.com/sector/nucleic-acid-drugs.md 2026-05-31 https://biopharmsignal.com/sector/ophthalmology.md 2026-05-31 https://biopharmsignal.com/sector/rare-disease-gene-therapy.md 2026-05-31 https://biopharmsignal.com/sector/rare-disease.md 2026-05-31 https://biopharmsignal.com/sector/infectious-disease.md 2026-05-31 https://biopharmsignal.com/sector/apis.md 2026-05-31 https://biopharmsignal.com/sector/hematology.md 2026-05-31 https://biopharmsignal.com/sector/respiratory.md 2026-05-31 https://biopharmsignal.com/sector/adcs.md 2026-05-31 https://biopharmsignal.com/sector/mrna-vaccines.md 2026-05-31 https://biopharmsignal.com/sector/generics.md 2026-05-31 https://biopharmsignal.com/sector/inherited-retinal-disease-gene-therapy.md 2026-05-31 https://biopharmsignal.com/sector/protacs.md 2026-05-31 https://biopharmsignal.com/sector/recombinant-protein-vlp-vaccines.md 2026-05-31 https://biopharmsignal.com/sector/cancer-peptide-vaccines.md 2026-05-31 https://biopharmsignal.com/sector/inactivated-vaccines.md 2026-05-31 https://biopharmsignal.com/sector/stem-cell-therapy-for-cardiac-disease.md 2026-05-31 https://biopharmsignal.com/sector/tumor-mrna-vaccines.md 2026-05-31 https://biopharmsignal.com/sector/exosomes.md 2026-05-31 https://biopharmsignal.com/sector/tcr-t-therapy.md 2026-05-31 https://biopharmsignal.com/sector/tumor-dna-vaccines.md 2026-05-31 https://biopharmsignal.com/sector/tumor-synthetic-peptide-vaccines.md 2026-05-31 https://biopharmsignal.com/sector/tumor-dc-vaccines.md 2026-05-31 https://biopharmsignal.com/sector/liposomes.md 2026-05-31 https://biopharmsignal.com/pdufa-calendar/2026/december.md 2026-07-21 https://biopharmsignal.com/pdufa-calendar/2026/july.md 2026-07-21 https://biopharmsignal.com/pdufa-calendar/2026/june.md 2026-07-21 https://biopharmsignal.com/pdufa-calendar/2026/november.md 2026-07-21 https://biopharmsignal.com/pdufa-calendar/2026/september.md 2026-07-21 https://biopharmsignal.com/pdufa-calendar/2027/january.md 2026-07-21 https://biopharmsignal.com/pdufa-calendar/ACHV.md 2026-07-21 https://biopharmsignal.com/pdufa-calendar/ARQT.md 2026-07-21 https://biopharmsignal.com/pdufa-calendar/CELC.md 2026-07-21 https://biopharmsignal.com/pdufa-calendar/COGT.md 2026-07-21 https://biopharmsignal.com/pdufa-calendar/GILD.md 2026-07-21 https://biopharmsignal.com/pdufa-calendar/IONS.md 2026-07-21 https://biopharmsignal.com/pdufa-calendar/LNTH.md 2026-07-21 https://biopharmsignal.com/pdufa-calendar/MNKD.md 2026-07-21 https://biopharmsignal.com/pdufa-calendar/MRK.md 2026-07-21 https://biopharmsignal.com/pdufa-calendar/NUVB.md 2026-07-21 https://biopharmsignal.com/pdufa-calendar/OTLK.md 2026-07-21 https://biopharmsignal.com/pdufa-calendar/RARE.md 2026-07-21 https://biopharmsignal.com/pdufa-calendar/SMMT.md 2026-07-21 https://biopharmsignal.com/pdufa-calendar/SPRO.md 2026-07-21 https://biopharmsignal.com/pdufa-calendar/UNCY.md 2026-07-21 https://biopharmsignal.com/pdufa-calendar/VERA.md 2026-07-21 https://biopharmsignal.com/pdufa-calendar/VNDA.md 2026-07-21 https://biopharmsignal.com/pdufa-calendar/VRDN.md 2026-07-21 https://biopharmsignal.com/pdufa-calendar/VTRS.md 2026-07-21 https://biopharmsignal.com/news/GSK/viiv-healthcare-to-present-phase-iiib-data-comparing-dovato-with-biktarvy-in-tre-1ff3f640.md 2026-07-21 https://biopharmsignal.com/news/USNA/usana-health-sciences-renews-four-year-partnership-with-nordiq-canada-deepening--7aaacadb.md 2026-07-20 https://biopharmsignal.com/news/HLF/herbalife-cfo-to-participate-in-maxim-group-health-wellness-longevity-virtual-co-145c5335.md 2026-07-20 https://biopharmsignal.com/news/BMY/bristol-myers-squibb-to-build-the-most-powerful-ai-factory-in-life-sciences-with-eb3e7bda.md 2026-07-20 https://biopharmsignal.com/news/GSK/european-medicines-agency-accepts-submission-to-update-bexsero-label-for-1-dose--8906d096.md 2026-07-20 https://biopharmsignal.com/news/FMS/fresenius-medical-care-introduces-therapywise-analytics-for-kidney-replacement-t-6fa82f2a.md 2026-07-20 https://biopharmsignal.com/news/IDYA/ideaya-biosciences-announces-esmo-2026-presentations-for-darovasertib-and-ide849-3e0620d8.md 2026-07-17 https://biopharmsignal.com/news/GSK/gsk-provides-an-update-on-calm-1-and-calm-2-phase-iii-trials-for-camlipixant-in--0e112206.md 2026-07-17 https://biopharmsignal.com/news/INBX/inhibrx-announces-amended-loan-agreement-with-oxford-finance-expanding-total-fac-d29cd85b.md 2026-07-16 https://biopharmsignal.com/news/INSM/insmed-announces-positive-12-month-data-from-the-ongoing-open-label-extension-st-7880862e.md 2026-07-16 https://biopharmsignal.com/news/PRI/primerica-schedules-second-quarter-2026-financial-results-webcast-8557ad05.md 2026-07-15 https://biopharmsignal.com/news/GSK/gsk-completes-acquisition-of-nuvalent-inc-c44954f4.md 2026-07-15 https://biopharmsignal.com/news/BRKR/bruker-expands-infection-detection-portfolio-with-acquisition-of-metagenomic-mng-36c3ebd1.md 2026-07-15 https://biopharmsignal.com/news/USNA/usana-schedules-second-quarter-2026-earnings-release-and-conference-call-d0dc753b.md 2026-07-14 https://biopharmsignal.com/news/IRWD/ironwood-appoints-dr-jeffrey-silber-chief-medical-officer-and-head-of-research-a-b6d13a27.md 2026-07-14 https://biopharmsignal.com/news/HLF/herbalife-named-to-time-s-list-of-america-s-best-companies-2026-14afe60c.md 2026-07-13 https://biopharmsignal.com/news/BMY/u-s-food-and-drug-administration-accepts-bristol-myers-squibb-s-new-drug-applica-b21b9788.md 2026-07-13 https://biopharmsignal.com/news/GSK/jemperli-dostarlimab-achieves-sustained-clinical-complete-responses-in-dmmr-msi--18610cf7.md 2026-07-13 https://biopharmsignal.com/news/DGX/one-in-five-american-workers-tested-had-a-positive-hair-drug-test-in-2025-signal-cb4ae34e.md 2026-07-10 https://biopharmsignal.com/news/GSK/gsk-s-licensor-hansoh-pharma-announces-positive-phase-iii-results-for-ris-rez-in-b379a2b1.md 2026-07-10 https://biopharmsignal.com/news/EHC/encompass-health-announces-date-of-2026-second-quarter-earnings-call-6ef36947.md 2026-07-09 https://biopharmsignal.com/news/GSK/roy-jakobs-to-join-gsk-board-as-non-executive-director-560f2019.md 2026-07-09 https://biopharmsignal.com/news/DGX/quest-diagnostics-now-the-largest-clinical-reference-lab-to-extend-oncology-test-e734c702.md 2026-07-08 https://biopharmsignal.com/news/AZTA/azenta-completes-sale-of-b-medical-systems-869ef834.md 2026-07-08 https://biopharmsignal.com/news/TECH/bio-techne-launches-expanded-r-d-systems-ai-engineered-designer-protein-portfoli-21b908e1.md 2026-07-08 https://biopharmsignal.com/news/UNH/corbus-pharmaceuticals-appoints-leonardo-viana-nicacio-m-d-as-chief-medical-offi-7e9400c6.md 2026-07-06 https://biopharmsignal.com/news/NAMS/newamsterdam-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4-3a377d4b.md 2026-07-02 https://biopharmsignal.com/news/NAMS/newamsterdam-pharma-announces-upcoming-presentations-at-the-alzheimer-s-associat-5f8e7eb9.md 2026-07-01 https://biopharmsignal.com/news/SYK/stryker-to-announce-second-quarter-2026-financial-results-94b73874.md 2026-07-01 https://biopharmsignal.com/news/HLF/herbalife-to-announce-second-quarter-2026-results-on-august-5-b85d8156.md 2026-07-01 https://biopharmsignal.com/news/USNA/kevin-guest-world-cup-determination-shows-the-power-of-grit-preparation-persiste-ce0b681d.md 2026-07-01 https://biopharmsignal.com/news/PRGO/perrigo-announces-appointment-of-two-new-independent-directors-to-board-47cee7b5.md 2026-06-30 https://biopharmsignal.com/news/PRI/primerica-household-budget-index-hbi-gas-prices-continued-to-weigh-on-purchasing-cd4ad354.md 2026-06-30 https://biopharmsignal.com/news/YOU/your-travel-day-super-hero-has-arrived-clear-teams-up-with-marvel-animation-s-x--1b04f659.md 2026-06-29 https://biopharmsignal.com/news/DGX/quest-diagnostics-foundation-commits-nearly-5-million-to-improving-health-outcom-a6539690.md 2026-06-29 https://biopharmsignal.com/news/YOU/clear-to-strengthen-caller-verification-in-contact-centers-with-aws-a6b19977.md 2026-06-29 https://biopharmsignal.com/news/IDYA/ideaya-biosciences-announces-inducement-grants-under-nasdaq-listing-rule-5635-c--9011f3a6.md 2026-06-26 https://biopharmsignal.com/news/TECH/merck-kgaa-darmstadt-germany-agrees-to-acquire-bio-techne-strengthening-leadersh-50e2ac1c.md 2026-06-25 https://biopharmsignal.com/news/DGX/quest-diagnostics-receives-new-york-state-approval-for-haystack-mrd-broadening-p-b4f0a6c5.md 2026-06-24 https://biopharmsignal.com/news/GSK/gsk-announces-commencement-of-tender-offer-to-acquire-nuvalent-inc-67201c53.md 2026-06-24 https://biopharmsignal.com/news/VKTX/viking-therapeutics-announces-initiation-of-phase-1-study-to-evaluate-novel-amyl-743d8a79.md 2026-06-24 https://biopharmsignal.com/news/INSM/insmed-appoints-samuele-butera-as-senior-vice-president-general-manager-global-r-5bfb9a1f.md 2026-06-23 https://biopharmsignal.com/news/DGX/uti-causing-bacteria-resistant-to-current-drugs-finds-national-study-by-hackensa-7470e6b9.md 2026-06-18 https://biopharmsignal.com/news/BMY/bristol-myers-squibb-to-report-results-for-second-quarter-2026-on-july-30-2026-e7e58681.md 2026-06-18 https://biopharmsignal.com/news/BMY/bristol-myers-squibb-announces-dividend-f5175d84.md 2026-06-17 https://biopharmsignal.com/news/GSK/utebzi-tebipenem-pivoxil-approved-in-the-us-for-adults-with-complicated-urinary--23a9b29e.md 2026-06-17 https://biopharmsignal.com/news/IDYA/ideaya-biosciences-announces-yujiro-s-hata-elected-chairman-of-its-board-of-dire-49a534d1.md 2026-06-17 https://biopharmsignal.com/news/YOU/clear-launches-at-indianapolis-international-airport-e04b0732.md 2026-06-16 https://biopharmsignal.com/news/USNA/usana-celebrates-10-years-of-making-the-world-a-better-place-during-world-servic-f04545e5.md 2026-06-16 https://biopharmsignal.com/news/INBX/inhibrx-announces-u-s-fda-acceptance-of-bla-for-ozekibart-in-patients-with-conve-d0380d86.md 2026-06-15 https://biopharmsignal.com/news/IDYA/ideaya-biosciences-announces-ide892-a-potential-best-in-class-mta-cooperative-pr-8351a4df.md 2026-06-15 https://biopharmsignal.com/news/GSK/gsk-s-momelotinib-granted-orphan-drug-designations-in-the-us-and-eu-for-vexas-sy-c6603aa7.md 2026-06-12 https://biopharmsignal.com/news/PRI/survey-reveals-85-of-canadians-trust-professional-financial-advice-over-social-m-49637e88.md 2026-06-11 https://biopharmsignal.com/news/VKTX/viking-therapeutics-announces-appointment-of-hubert-c-chen-m-d-as-chief-medical--ca51f016.md 2026-06-11 https://biopharmsignal.com/news/IDYA/ideaya-announces-closing-of-public-offering-including-full-exercise-of-underwrit-b9bc3239.md 2026-06-10 https://biopharmsignal.com/news/FMS/interwell-health-delivers-strong-quality-scores-and-shared-savings-in-cms-value--e2c55e86.md 2026-06-10 https://biopharmsignal.com/news/EHC/eastside-rehabilitation-hospital-now-open-in-georgia-cc955c09.md 2026-06-09 https://biopharmsignal.com/news/GSK/gsk-enters-agreement-to-acquire-nuvalent-inc-11ce8091.md 2026-06-09 https://biopharmsignal.com/news/PRGO/perrigo-announces-leadership-transition-fef2604a.md 2026-06-08 https://biopharmsignal.com/news/BMY/mariska-hargitay-partners-with-bristol-myers-squibb-for-investigating-myeloma-aw-222e93ab.md 2026-06-08 https://biopharmsignal.com/news/USNA/usana-s-celavive-contouring-face-neck-cr-me-named-among-canada-s-top-skincare-pr-f27928e1.md 2026-06-08 https://biopharmsignal.com/news/NXGL/nexgel-to-present-at-planet-microcap-conference-las-vegas-on-june-16th-18th.md 2026-06-04 https://biopharmsignal.com/news/XBIO/xenetic-biosciences-inc-announces-that-its-collaboration-partner-received-approval-from-the-israeli-ministry-of-health-to-conduct-exploratory-investigator-initiated-study-of-dnase-i-in-combination-with-anti-cd19-car-t-cells-in-large-b-cell-lymphoma.md 2026-06-04 https://biopharmsignal.com/news/RNXT/renovorx-ceo-shaun-bagai-to-present-at-the-iaccess-alpha-virtual-best-ideas-summer-investment-conference-2026-on-june-23rd.md 2026-06-04 https://biopharmsignal.com/news/ARVN/arvinas-joins-the-michael-j-fox-foundation-s-lite-and-ppmi-programs-to-advance-new-therapies-targeting-lrrk2-for-parkinson-s-disease.md 2026-06-04 https://biopharmsignal.com/news/AMRX/amneal-announces-u-s-fda-approval-of-romidepsin-injection-solution.md 2026-06-04 https://biopharmsignal.com/news/STSA/satsuma-pharmaceuticals-announces-presentation-of-two-clinical-program-abstracts-at-the-american-headache-society-s-68th-annual-scientific-meeting.md 2026-06-04 https://biopharmsignal.com/news/AVCO/avalon-globocare-appoints-seasoned-ai-and-finance-executive-as-chief-financial-officer.md 2026-06-04 https://biopharmsignal.com/news/LPCN/lipocine-inc-to-host-virtual-kol-event-highlighting-unmet-needs-in-postpartum-depression-and-the-clinical-profile-of-lpcn-1154.md 2026-06-04 https://biopharmsignal.com/news/PSTV/plus-therapeutics-announces-cap-accreditation-of-cnsider-diagnostics-clinical-laboratory.md 2026-06-04 https://biopharmsignal.com/news/GHRS/gh-research-announces-publication-of-phase-2a-postpartum-depression-results.md 2026-06-04 https://biopharmsignal.com/news/ANTX/an2-therapeutics-reports-positive-enabling-data-supporting-advancement-of-oral-an2-502998-to-phase-2-study-for-chronic-chagas-disease.md 2026-06-04 https://biopharmsignal.com/news/SNDX/syndax-announces-private-placement-of-250-0-million-of-convertible-senior-notes.md 2026-06-04 https://biopharmsignal.com/news/INSM/insmed-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4.md 2026-06-04 https://biopharmsignal.com/news/OPCH/option-care-health-appoints-robert-okunski-as-vice-president-investor-relations.md 2026-06-04 https://biopharmsignal.com/news/BRKR/bruker-showcases-expanding-microbiology-and-infection-diagnostics-portfolio-at-asm-microbe-2026.md 2026-06-04 https://biopharmsignal.com/news/REGN/regeneron-to-highlight-progress-across-its-metabolic-disease-ophthalmology-and-rare-disease-pipelines-at-ada-and-endo.md 2026-06-04 https://biopharmsignal.com/news/ALKS/alkermes-to-present-new-data-on-alixorexton-and-lumryzr-sodium-oxybate-at-sleep-2026-highlighting-breadth-of-sleep-medicine-research.md 2026-06-04 https://biopharmsignal.com/news/USNA/usana-earns-dual-best-of-state-honors-for-product-innovation-and-development.md 2026-06-04 https://biopharmsignal.com/news/TECH/bio-techne-and-refeyn-close-critical-gap-in-bispecific-antibody-and-biosimilar-characterization.md 2026-06-04 https://biopharmsignal.com/news/SEER/seer-files-definitive-proxy-materials-and-mails-letter-to-stockholders.md 2026-06-03 https://biopharmsignal.com/news/MD/pediatrix-medical-group-announces-publication-of-new-research-addressing-urgent-questions-in-neonatology.md 2026-06-03 https://biopharmsignal.com/news/HLF/herbalife-named-to-three-2026-usa-today-most-trusted-brands-lists.md 2026-06-03 https://biopharmsignal.com/news/KPTI/karyopharm-to-participate-in-webcast-featuring-endometrial-cancer-key-opinion-leader-on-june-8-2026.md 2026-06-03 https://biopharmsignal.com/news/ALKS/alkermes-to-participate-in-the-goldman-sachs-47th-annual-global-healthcare-conference.md 2026-06-03 https://biopharmsignal.com/news/IOVA/iovance-s-amtagvir-lifileucel-granted-approval-for-the-treatment-of-advanced-melanoma-in-australia.md 2026-06-03 https://biopharmsignal.com/news/ELVN/enliven-therapeutics-to-host-webcast-conference-call-to-discuss-phase-1-elvn-001-clinical-data-being-presented-at-eha-2026-congress.md 2026-06-03 https://biopharmsignal.com/news/ALHC/alignment-healthcare-named-to-the-fortune-1000-2026-list-for-second-consecutive-year.md 2026-06-03 https://biopharmsignal.com/news/MKT/maia-biotechnology-receives-fda-clearance-to-open-u-s-enrollment-in-ongoing-phase-2-thio-101-trial-expansion.md 2026-06-03 https://biopharmsignal.com/news/INAB/in8bio-announces-publication-in-nature-communications-highlighting-advances-in-gamma-delta-t-cell-engineering-and-combination-therapies.md 2026-06-03 https://biopharmsignal.com/news/NBIX/neurocrine-biosciences-to-present-new-two-year-crenessityr-crinecerfont-data-on-key-clinical-and-patient-reported-outcome-measures-at-endo-2026.md 2026-06-03 https://biopharmsignal.com/news/LIXT/lixte-biotechnology-announces-16-566-027-registered-direct-offering-priced-at-the-market-under-nasdaq-rules-strengthening-balance-sheet-for-next-phase-of-strategic-growth.md 2026-06-03 https://biopharmsignal.com/news/ARQT/new-expert-consensus-provides-age-specific-guidance-for-improving-care-for-individuals-with-genital-psoriasis-published-in-the-american-journal-of-clinical-dermatology.md 2026-06-03 https://biopharmsignal.com/news/PRME/prime-medicine-to-present-at-goldman-sachs-47th-annual-global-healthcare-conference.md 2026-06-03 https://biopharmsignal.com/news/BMEA/biomea-fusion-announces-research-collaboration-with-university-of-leicester-to-evaluate-icovamenib-in-combination-with-semaglutide-in-obesity.md 2026-06-03 https://biopharmsignal.com/news/NAMS/newamsterdam-pharma-announces-upcoming-presentations-at-the-national-lipid-association-nla-2026-scientific-sessions.md 2026-06-03 https://biopharmsignal.com/news/CTMX/cytomx-announces-expansion-of-strategic-research-collaboration-with-regeneron-in-the-field-of-conditional-bispecific-therapeutics-for-the-treatment-of-cancer.md 2026-06-03 https://biopharmsignal.com/news/DYN/dyne-therapeutics-announces-completion-of-enrollment-in-registrational-expansion-cohort-of-achieve-trial-of-z-basivarsen-for-myotonic-dystrophy-type-1-dm1.md 2026-06-03 https://biopharmsignal.com/news/TGTX/tg-therapeutics-announces-positive-results-from-phase-1-trial-evaluating-subcutaneous-briumvir-ublituximab-xiiy.md 2026-06-03 https://biopharmsignal.com/news/TNYA/tenaya-therapeutics-announces-interim-data-from-mypeaktm-1-showing-treatment-of-mybpc3-associated-hcm-with-tn-201-gene-therapy-resulted-in-consistent-signs-of-cardiac-remodeling-and-reductions-in-symptoms.md 2026-06-03 https://biopharmsignal.com/news/CABA/cabaletta-bio-announces-new-rese-cel-data-and-development-updates-across-autoimmune-portfolio-including-encouraging-early-pc-free-lupus-findings-at-eular-2026-congress.md 2026-06-03 https://biopharmsignal.com/news/PNTG/pennant-expands-senior-living-presence-with-pleasant-hill-california-community.md 2026-06-03 https://biopharmsignal.com/news/MDNA/medicenna-s-mdna11-potential-in-earlier-line-melanoma-setting-highlighted-in-presentation-of-the-neo-cyt-trial-at-asco-2026.md 2026-06-03 https://biopharmsignal.com/news/KURA/kura-oncology-highlights-darlifarnib-s-potential-as-a-foundational-combination-platform-for-kras-mutant-cancers-and-outlines-development-strategy.md 2026-06-03 https://biopharmsignal.com/news/MLYS/mineralys-therapeutics-announces-pricing-of-150-million-underwritten-offering-of-common-stock.md 2026-06-03 https://biopharmsignal.com/news/MNKD/mannkind-enters-data-rich-development-period-with-completion-of-randomization-in-phase-1b-inflo-1-study-and-enrollment-of-first-patient-in-phase-2-inflo-2-trial-for-nintedanib-dpi-in-patients-with-ipf.md 2026-06-03 https://biopharmsignal.com/news/MLYS/mineralys-therapeutics-announces-repurchase-of-royalty-obligations-in-tanabe-license-agreement-and-concurrent-financing.md 2026-06-03 https://biopharmsignal.com/news/IDYA/ideaya-biosciences-announces-clinical-collaboration-with-roche-in-mtap-deleted-ras-mutant-pancreatic-cancer.md 2026-06-03 https://biopharmsignal.com/news/FMS/fresenius-medical-care-launches-kinexus-worldwide-a-unified-digital-platform-to-support-home-dialysis.md 2026-06-03 https://biopharmsignal.com/news/TNYA/tenaya-therapeutics-to-announce-new-interim-data-from-mypeaktm-1-phase-1b-2-trial-of-tn-201-for-adults-with-mybpc3-associated-hcm-on-wednesday-june-3-2026.md 2026-06-02 https://biopharmsignal.com/news/STIM/neuronetics-appoints-robert-greene-as-senior-vice-president-sales.md 2026-06-02 https://biopharmsignal.com/news/PCVX/vaxcyte-doses-first-participant-in-phase-1-study-evaluating-vax-a1-for-the-prevention-of-disease-caused-by-group-a-streptococcus-in-healthy-adults.md 2026-06-02 https://biopharmsignal.com/news/IBIO/ibio-to-participate-in-upcoming-healthcare-investor-conferences.md 2026-06-02 https://biopharmsignal.com/news/SNDX/syndax-highlights-revuforjr-revumenib-data-presented-at-asco-2026-including-an-oral-presentation-of-post-transplant-data.md 2026-06-02 https://biopharmsignal.com/news/BJDX/bluejay-diagnostics-announces-up-to-23-6-million-private-placement-priced-at-the-market-under-nasdaq-rules.md 2026-06-02 https://biopharmsignal.com/news/BRKR/bruker-launches-new-timsmrms-mass-spectrometry-platform-for-unique-ultra-complex-mixture-applications-in-the-energy-industry.md 2026-06-02 https://biopharmsignal.com/news/KPTI/karyopharm-s-phase-3-sentry-trial-of-selinexor-plus-ruxolitinib-in-myelofibrosis-selected-for-late-breaking-oral-presentation-at-eha-2026.md 2026-06-02 https://biopharmsignal.com/news/MKT/maia-biotechnology-announces-open-market-purchases-by-ceo-and-director.md 2026-06-02 https://biopharmsignal.com/news/MOH/molina-healthcare-announces-second-quarter-2026-earnings-release-and-conference-call-dates.md 2026-06-02 https://biopharmsignal.com/news/BCLI/brainstorm-cell-therapeutics-announces-publication-calling-for-updated-fda-approaches-to-als-rare-diseases-and-regenerative-medicine.md 2026-06-02 https://biopharmsignal.com/news/KPTI/karyopharm-to-present-results-from-phase-3-sentry-trial-of-selinexor-plus-ruxolitinib-in-myelofibrosis-in-late-breaking-oral-presentation-at-asco-2026-with-simultaneous-publication-in-the-journal-of-clinical-oncology.md 2026-06-02 https://biopharmsignal.com/news/KURA/kura-oncology-and-kyowa-kirin-announce-publication-in-blood-of-ziftomenib-plus-venetoclax-azacitidine-combination-in-patients-with-r-r-npm1-m-aml.md 2026-06-02 https://biopharmsignal.com/news/STIM/neuronetics-highlights-continued-advancements-in-tms-research-at-ctmss-2026.md 2026-06-02 https://biopharmsignal.com/news/ICCM/icecure-medical-announces-1-for-30-reverse-share-split-to-support-nasdaq-compliance.md 2026-06-02 https://biopharmsignal.com/news/ACHV/achieve-life-sciences-appoints-jeffrey-farrow-and-reid-waldman-md-to-board-of-directors.md 2026-06-02 https://biopharmsignal.com/news/CADL/candel-therapeutics-announces-publication-in-the-lancet-oncology-of-pivotal-phase-3-data-demonstrating-significant-improvement-in-disease-free-survival-with-aglatimagene-besadenovec-can-2409-in-localized-prostate-cancer.md 2026-06-02 https://biopharmsignal.com/news/AEMD/aethlon-medical-to-release-fiscal-year-end-financial-results-and-host-conference-call-on-june-10-2026.md 2026-06-02 https://biopharmsignal.com/news/IRON/disc-medicine-presents-updated-positive-data-from-rally-mf-phase-2-trial-in-patients-with-myelofibrosis-mf-and-anemia-at-the-2026-american-society-of-clinical-oncology-asco-annual-meeting.md 2026-06-02 https://biopharmsignal.com/news/PROK/prokidney-appoints-kenneth-locke-as-chief-technical-officer.md 2026-06-02 https://biopharmsignal.com/news/ALHC/alignment-healthcare-shows-how-earlier-coordinated-care-leads-to-better-health-and-fewer-emergencies-in-2025-impact-report.md 2026-06-02 https://biopharmsignal.com/news/URGN/urogen-announces-agreement-resolving-patent-litigation-relating-to-jelmytor-mitomycin-for-pyelocalyceal-solution.md 2026-06-02 https://biopharmsignal.com/news/TCMD/tactile-medical-launches-next-generation-afflovestr-airway-clearance-therapy.md 2026-06-02 https://biopharmsignal.com/news/BMY/izalontamab-brengitecan-iza-bren-demonstrates-statistically-significant-and-clinically-meaningful-improvements-in-overall-survival-and-progression-free-survival-in-patients-with-triple-negative-breast-cancer-and-esophageal-squamous-cell-carcinoma.md 2026-06-02 https://biopharmsignal.com/news/BIAF/multidisciplinary-physician-panel-to-share-real-world-benefits-of-bioaffinity-technologies-noninvasive-cypath-lung-cancer-test-in-upcoming-society-for-advanced-bronchoscopy-webinar.md 2026-06-02 https://biopharmsignal.com/news/BFRG/bullfrog-ai-announces-new-commercial-leadership-team-to-execute-growth-strategy-for-its-integrated-pharma-ai-platform.md 2026-06-02 https://biopharmsignal.com/news/TGTX/tg-therapeutics-to-participate-in-the-goldman-sachs-47th-annual-healthcare-conference.md 2026-06-02 https://biopharmsignal.com/news/IART/integra-lifesciences-to-present-at-the-2026-jefferies-global-healthcare-conference.md 2026-06-02 https://biopharmsignal.com/news/AVAH/aveanna-healthcare-holdings-completes-acquisition-of-family-first-homecare-and-updates-full-year-2026-guidance.md 2026-06-02 https://biopharmsignal.com/news/ARWR/arrowhead-pharmaceuticals-to-participate-in-upcoming-june-2026-events.md 2026-06-02 https://biopharmsignal.com/news/HLF/herbalife-chief-financial-officer-to-present-at-east-coast-ideas-conference-on-june-11.md 2026-06-02 https://biopharmsignal.com/news/KTTA/pasithea-therapeutics-announces-orphan-drug-designation-by-fda-of-pas-004-for-treatment-of-amyotrophic-lateral-sclerosis-als.md 2026-06-02 https://biopharmsignal.com/news/IBIO/ibio-becomes-a-clinical-stage-company-with-first-participant-dosed-in-phase-1-clinical-trial-of-ibio-600-in-adults-with-obesity.md 2026-06-02 https://biopharmsignal.com/news/BEAT/heartbeam-announces-new-peer-reviewed-article-demonstrating-potential-to-help-identify-heart-attack-risk-at-home.md 2026-06-02 https://biopharmsignal.com/news/BJDX/bluejay-diagnostics-and-argonaut-manufacturing-services-announce-strategic-partnership.md 2026-06-02 https://biopharmsignal.com/news/PSNL/personalis-highlights-early-colorectal-cancer-recurrence-detection-and-ultrasensitive-mrd-performance-across-a-broad-set-of-tumor-types-at-asco-2026.md 2026-06-02 https://biopharmsignal.com/news/ENLV/enlivex-to-present-quality-longevity-model-powered-by-prediction-markets-treasury-at-proof-of-talk-2026.md 2026-06-02 https://biopharmsignal.com/news/MESO/asx-ceo-connect-presentation.md 2026-06-02 https://biopharmsignal.com/news/FLGT/fulgent-presents-updated-fid-007-data-at-asco-2026.md 2026-06-01 https://biopharmsignal.com/news/EMBC/embecta-to-participate-in-investor-events.md 2026-06-01 https://biopharmsignal.com/news/PCRX/pacira-biosciences-highlights-leading-independent-proxy-advisory-firm-iss-recommendation-to-vote-for-all-of-pacira-s-director-nominees.md 2026-06-01 https://biopharmsignal.com/news/SRPT/sarepta-therapeutics-to-participate-in-upcoming-investor-conferences.md 2026-06-01 https://biopharmsignal.com/news/PRAX/praxis-precision-medicines-provides-vormatrigine-program-update.md 2026-06-01 https://biopharmsignal.com/news/URGN/urogen-pharma-to-present-at-the-goldman-sachs-47th-annual-global-healthcare-conference.md 2026-06-01 https://biopharmsignal.com/news/LUNG/pulmonx-corporation-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4.md 2026-06-01 https://biopharmsignal.com/news/NERV/minerva-neurosciences-establishes-scientific-advisory-board-to-advance-development-of-roluperidone-and-future-pipeline-programs.md 2026-06-01 https://biopharmsignal.com/news/SERA/sera-prognostics-announces-board-transition.md 2026-06-01 https://biopharmsignal.com/news/KPTI/karyopharm-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4.md 2026-06-01 https://biopharmsignal.com/news/IBRX/immunitybio-presents-new-clinical-and-comparative-data-across-lung-and-bladder-cancer-at-asco-2026.md 2026-06-01 https://biopharmsignal.com/news/IDYA/ideaya-biosciences-and-servier-provide-complete-data-from-phase-2-3-registrational-optimum-02-trial-of-the-darovasertib-combination-in-first-line-hla-a2-01-negative-metastatic-uveal-melanoma-in-a-late-breaking-oral-presentation-at-asco.md 2026-06-01 https://biopharmsignal.com/news/XBIO/xenetic-biosciences-showcases-compelling-asco-2026-data-demonstrating-dnase-i-significantly-enhances-car-t-cell-persistence-tumor-control-and-survival.md 2026-06-01 https://biopharmsignal.com/news/XGN/exagen-announces-publication-of-systematic-review-confirming-robust-real-world-performance-of-avise-lupus.md 2026-06-01 https://biopharmsignal.com/news/LIXT/lixte-biotechnology-announces-strategic-transformation-into-ai-energy-infrastructure-equipment-and-services-stuart-d-porter-founder-of-denham-capital-to-join-board-of-directors.md 2026-06-01 https://biopharmsignal.com/news/OTLK/outlook-therapeutics-announces-resubmission-of-biologics-license-application-to-u-s-fda-for-ons-5010-lytenavatm-bevacizumab-vikg.md 2026-06-01 https://biopharmsignal.com/news/INAB/in8bio-presents-updated-overall-survival-data-surpassing-19-5-months-for-deltex-dri-in-newly-diagnosed-glioblastoma-at-asco-2026.md 2026-06-01 https://biopharmsignal.com/news/IRON/disc-medicine-launches-expanded-access-program-for-bitopertin-for-epp-patients.md 2026-06-01 https://biopharmsignal.com/news/FATE/fate-therapeutics-showcases-clinical-data-for-ft836-at-the-american-society-of-cancer-oncology-annual-meeting.md 2026-06-01 https://biopharmsignal.com/news/PYPD/polypid-completes-new-drug-application-submission-to-fda-for-d-plex.md 2026-06-01 https://biopharmsignal.com/news/GLSI/greenwich-lifesciences-presents-flamingo-01-phase-iii-trial-open-label-data-published-at-asco-meeting-2026.md 2026-06-01 https://biopharmsignal.com/news/CLRB/cellectar-biosciences-to-highlight-compelling-new-efficacy-data-from-phase-2b-clover-wam-study-of-iopofosine-i-131-in-r-r-waldenstroem-macroglobulinemia-at-the-american-society-of-clinical-oncology-annual-meeting.md 2026-06-01 https://biopharmsignal.com/news/ALXO/alx-oncology-to-present-at-the-2026-jefferies-global-healthcare-conference-in-new-york.md 2026-06-01 https://biopharmsignal.com/news/LYEL/lyell-immunopharma-announces-participation-in-goldman-sachs-47th-annual-global-healthcare-conference-2026.md 2026-06-01 https://biopharmsignal.com/news/APRE/aprea-therapeutics-presents-updated-phase-1-data-on-wee1-inhibitor-apr-1051-at-asco-2026-demonstrating-early-monotherapy-activity-and-manageable-tolerability-in-advanced-solid-tumors.md 2026-06-01 https://biopharmsignal.com/news/NCNA/nucana-appoints-ian-webster-as-chief-financial-officer.md 2026-06-01 https://biopharmsignal.com/news/IMTX/immatics-presents-clinical-activity-and-response-dynamics-of-anzu-cel-prame-cell-therapy-at-2026-asco-annual-meeting.md 2026-06-01 https://biopharmsignal.com/news/CRL/charles-river-laboratories-to-present-at-william-blair-and-jefferies-conferences.md 2026-06-01 https://biopharmsignal.com/news/AMRX/amneal-to-participate-in-goldman-sachs-47th-annual-global-healthcare-conference-2026.md 2026-06-01 https://biopharmsignal.com/news/RLYB/rallybio-corporation-and-avenzo-therapeutics-announce-merger-agreement-to-advance-next-generation-oncology-therapies-and-215-million-concurrent-private-placement.md 2026-06-01 https://biopharmsignal.com/news/BTMD/biote-appoints-komal-bajaj-md-ms-as-chief-medical-officer.md 2026-06-01 https://biopharmsignal.com/news/MKT/maia-biotechnology-presents-trial-in-progress-poster-for-pivotal-phase-3-clinical-trial-of-novel-telomere-targeting-agent-at-2026-annual-meeting-of-american-society-of-clinical-oncology.md 2026-06-01 https://biopharmsignal.com/news/TGTX/tg-therapeutics-announces-publication-of-post-hoc-data-from-the-phase-3-ultimate-i-and-ii-trials-in-treatment-naive-patients-with-relapsing-forms-of-ms-published-in-frontiers-in-immunology.md 2026-06-01 https://biopharmsignal.com/news/IMRX/immuneering-presents-compelling-17-3-month-median-overall-survival-and-favorable-tolerability-with-atebimetinib-chemotherapy-in-first-line-pancreatic-cancer-patients-at-asco.md 2026-06-01 https://biopharmsignal.com/news/NTLA/intellia-therapeutics-to-report-additional-phase-3-haelo-data-for-lonvoguran-ziclumeran-lonvo-z-in-late-breaking-oral-presentation-at-eaaci-2026.md 2026-06-01 https://biopharmsignal.com/news/IOVA/iovance-biotherapeutics-announces-clearance-of-investigational-new-drug-ind-application-for-il-12-tethered-til-therapy-iov-5001.md 2026-06-01 https://biopharmsignal.com/news/KPTI/karyopharm-to-host-investor-conference-call-featuring-expert-perspectives-on-the-phase-3-sentry-trial-in-myelofibrosis-following-2026-asco-presentation.md 2026-06-01 https://biopharmsignal.com/news/USNA/kevin-guest-encourages-professionals-to-prioritize-wellness-during-professional-wellness-month.md 2026-06-01 https://biopharmsignal.com/news/SNDX/syndax-to-host-randd-day-highlighting-its-late-stage-programs-and-early-stage-assets-on-july-14-2026.md 2026-06-01 https://biopharmsignal.com/news/OPCH/option-care-health-awarded-time-s-world-s-most-impactful-companies-2026-ranking.md 2026-06-01 https://biopharmsignal.com/news/BRKR/bruker-announces-major-strides-in-4d-proteomics-performance-further-advances-in-intact-and-top-down-functional-proteoform-analysis-and-innovations-in-hybrid-qual-quant-4d-metabolomics-all-to-enable-deeper-insights-into-disease-biology.md 2026-06-01 https://biopharmsignal.com/news/MNPR/monopar-presents-phase-2-alxn1840-data-demonstrating-liver-disease-stabilization-and-neurologic-improvement-in-treatment-experienced-wilson-disease-patients-at-easl-2026.md 2026-06-01 https://biopharmsignal.com/news/BMY/u-s-food-and-drug-administration-accepts-for-priority-review-bristol-myers-squibb-s-supplemental-new-drug-application-for-camzyos-mavacamten-to-treat-adolescents-with-symptomatic-obstructive-hypertrophic-cardiomyopathy-ohcm.md 2026-06-01 https://biopharmsignal.com/news/BMY/bristol-myers-squibb-announces-opdivor-nivolumab-in-combination-with-avd-receives-expanded-eu-label-with-approval-in-frontline-advanced-classical-hodgkin-lymphoma.md 2026-06-01 https://biopharmsignal.com/news/YOU/concierge-powered-by-clear-launched-at-mia-to-elevate-travel-experiences-at-florida-s-busiest-airport-for-international-passengers.md 2026-06-01 https://biopharmsignal.com/news/ENLV/allocetra-shows-durable-6-month-efficacy-in-knee-osteoarthritis-phase-iia-trial-oral-presentation-at-eular-2026.md 2026-06-01 https://biopharmsignal.com/news/IMTX/immatics-presents-data-on-ima401-magea4-8-bispecific-at-2026-asco-annual-meeting-with-simultaneous-publication-in-nature-medicine-supporting-development-of-ima401-ima402-combination-in-lung-cancer.md 2026-05-31 https://biopharmsignal.com/news/RVMD/revolution-medicines-announces-asco-plenary-presentation-highlighting-unprecedented-results-from-pivotal-phase-3-rasolute-302-clinical-trial-of-daraxonrasib-in-previously-treated-metastatic-pancreatic-cancer.md 2026-05-31 https://biopharmsignal.com/news/REPL/replimune-presents-final-first-in-human-data-for-rp2-in-advanced-solid-tumors-during-oral-presentation-at-the-2026-american-society-of-clinical-oncology-annual-meeting.md 2026-05-31 https://biopharmsignal.com/news/IMCR/immunocore-presents-updated-phase-1-data-of-brenetafusp-in-patients-with-heavily-pretreated-advanced-melanoma.md 2026-05-31 https://biopharmsignal.com/news/BMY/global-data-for-biontech-and-bristol-myers-squibb-s-pd-l1xvegf-a-bispecific-pumitamig-shows-encouraging-efficacy-in-patients-with-non-small-cell-lung-cancer-in-rosetta-lung-02-trial.md 2026-05-30 https://biopharmsignal.com/news/MLYS/mineralys-therapeutics-presents-new-data-from-the-phase-3-launch-htn-trial-of-lorundrostat-in-participants-with-hypertension-and-chronic-kidney-disease-at-european-meeting-on-hypertension-and-cardiovascular-protection-esh-2026.md 2026-05-30 https://biopharmsignal.com/news/EXEL/exelixis-announces-results-from-subgroup-analysis-of-phase-3-cabinet-pivotal-trial-evaluating-cabometyxr-cabozantinib-in-non-functional-and-functional-neuroendocrine-tumors-at-asco-2026.md 2026-05-30 https://biopharmsignal.com/news/IMTX/immatics-presents-clinical-activity-of-ima203cd8-prame-cell-therapy-in-hard-to-treat-gynecologic-cancers-at-2026-asco-annual-meeting.md 2026-05-30 https://biopharmsignal.com/news/COGT/cogent-biosciences-announces-detailed-clinical-data-from-peak-phase-3-trial-with-bezuclastinib-in-combination-with-sunitinib-in-gastrointestinal-stromal-tumors-gist-at-2026-american-society-of-clinical-oncology-asco-annual-meeting.md 2026-05-30 https://biopharmsignal.com/news/REPL/replimune-presents-3-year-landmark-overall-survival-analysis-from-ignyte-clinical-trial-during-oral-presentation-at-the-2026-american-society-of-clinical-oncology-annual-meeting.md 2026-05-30 https://biopharmsignal.com/news/CORT/corcept-presents-new-data-at-asco-2026-lifyorlitm-overall-survival-across-all-subgroups-of-patients-with-platinum-resistant-ovarian-cancer-including-those-with-recent-taxane-exposure.md 2026-05-29 https://biopharmsignal.com/news/ARVN/arvinas-to-present-at-jefferies-global-healthcare-conference.md 2026-05-29 https://biopharmsignal.com/news/KNSA/kiniksa-pharmaceuticals-to-present-at-upcoming-investor-conferences.md 2026-05-29 https://biopharmsignal.com/news/OCS/oculis-announces-topline-results-from-diamond-phase-3-trials-with-ocs-01-in-diabetic-macular-edema.md 2026-05-29 https://biopharmsignal.com/news/MNKD/mannkind-to-host-conference-call-today-to-discuss-afrezza-pediatric-approval.md 2026-05-29 https://biopharmsignal.com/news/MNKD/mannkind-announces-fda-approval-of-afrezzar-the-first-and-only-inhaled-mealtime-insulin-for-use-in-children-and-adolescents-aged-6-and-older-living-with-diabetes.md 2026-05-29 https://biopharmsignal.com/news/TPST/tempest-therapeutics-announces-warrant-exercise-for-approximately-2-million-in-gross-proceeds.md 2026-05-29 https://biopharmsignal.com/news/TNYA/tenaya-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference-2026.md 2026-05-29 https://biopharmsignal.com/news/SABS/sab-bio-to-present-data-on-sab-142-at-the-american-diabetes-association-s-2026-scientific-sessions-and-focis-2026-annual-meeting.md 2026-05-29 https://biopharmsignal.com/news/EHC/encompass-health-to-build-36-bed-inpatient-rehabilitation-hospital-in-bridgeport-west-virginia.md 2026-05-29 https://biopharmsignal.com/news/BMY/bristol-myers-squibb-announces-celmod-mezigdomide-reduces-risk-of-disease-progression-or-death-by-more-than-50-vs-standard-of-care-in-relapsed-or-refractory-multiple-myeloma.md 2026-05-29 https://biopharmsignal.com/news/REPL/replimune-announces-planned-rp1-bla-resubmission-following-productive-discussion-with-fda.md 2026-05-29 https://biopharmsignal.com/news/ADPT/at-asco-and-eha-2026-new-data-reinforce-the-pivotal-role-of-clonoseqr-mrd-testing-across-hematology-clinical-practice-and-research.md 2026-05-29 https://biopharmsignal.com/news/SEER/seer-files-itc-complaint-against-nanomics.md 2026-05-29 https://biopharmsignal.com/news/CAPR/capricor-therapeutics-expands-commercial-leadership-team.md 2026-05-29 https://biopharmsignal.com/news/ALLO/allogene-therapeutics-announces-planned-ceo-succession.md 2026-05-28 https://biopharmsignal.com/news/ISRG/intuitive-announces-new-chief-commercial-and-marketing-officer-taylor-patton.md 2026-05-28 https://biopharmsignal.com/news/TNXP/tonix-pharmaceuticals-presented-retrospective-u-s-real-world-claims-analysis-of-opioid-use-in-patients-with-fibromyalgia-at-the-2026-american-society-of-clinical-psychopharmacology-ascp-annual-meeting.md 2026-05-28 https://biopharmsignal.com/news/PCRX/leading-independent-proxy-advisory-firm-glass-lewis-recommends-stockholders-vote-for-all-of-pacira-s-director-nominees.md 2026-05-28 https://biopharmsignal.com/news/ASMB/assembly-biosciences-announces-upcoming-investor-conference-presentations.md 2026-05-28 https://biopharmsignal.com/news/IRWD/ironwood-pharmaceuticals-to-participate-in-the-jefferies-global-healthcare-confe-b815d20d.md 2026-05-28 https://biopharmsignal.com/news/EBS/emergent-biosolutions-receives-64-5-million-contract-modification-for-batr-botulism-antitoxin-heptavalent-a-b-c-d-e-f-g-equine-to-support-u-s-biodefense-strategy.md 2026-05-28 https://biopharmsignal.com/news/OTLK/outlook-therapeutics-announces-pricing-of-5-0-million-registered-direct-offering-priced-at-the-market-under-nasdaq-rules.md 2026-05-28 https://biopharmsignal.com/news/REGN/regeneron-s-ebola-antibody-recommended-by-world-health-organization-for-investigational-use-in-response-to-current-bundibugyo-ebolavirus-outbreak.md 2026-05-28 https://biopharmsignal.com/news/ANGO/angiodynamics-expands-patient-access-to-nanoknife-ire-for-prostate-and-liver-cancer-as-medicare-coverage-framework-takes-effect.md 2026-05-28 https://biopharmsignal.com/news/JAGX/jaguar-health-research-in-ethnobotanical-medicine-helps-advance-crofelemer-development-for-genetically-defined-rare-congenital-gastrointestinal-disorders.md 2026-05-28 https://biopharmsignal.com/news/MDNA/medicenna-announces-closing-of-public-offering-of-units-raising-cdn-4-44-million-to-support-lead-programs.md 2026-05-28 https://biopharmsignal.com/news/PGNY/new-progyny-study-shows-growing-demand-for-human-guidance-in-an-increasingly-digital-healthcare-system.md 2026-05-28 https://biopharmsignal.com/news/BTMD/biote-names-bob-peterson-current-chief-financial-and-chief-business-officer-as-interim-ceo.md 2026-05-28 https://biopharmsignal.com/news/VANI/vivani-medical-ceo-adam-mendelsohn-to-present-at-the-jefferies-global-healthcare-conference-on-june-4-2026.md 2026-05-28 https://biopharmsignal.com/news/RNXT/renovorx-announces-fda-orphan-drug-designation-granted-oxaliplatin-for-the-treatment-of-pancreatic-cancer.md 2026-05-28 https://biopharmsignal.com/news/VRCA/verrica-to-participate-in-the-jefferies-global-healthcare-conference.md 2026-05-28 https://biopharmsignal.com/news/APVO/aptevo-therapeutics-appoints-mary-j-janatpour-ph-d-as-senior-vice-president-and-chief-scientific-officer.md 2026-05-28 https://biopharmsignal.com/news/AVAH/aveanna-healthcare-announces-successful-debt-repricing.md 2026-05-28 https://biopharmsignal.com/news/DSGN/design-therapeutics-to-participate-in-2026-jefferies-global-healthcare-conference.md 2026-05-28 https://biopharmsignal.com/news/COGT/cogent-biosciences-announces-fda-acceptance-of-new-drug-application-nda-with-priority-review-for-bezuclastinib-in-combination-with-sunitinib-for-patients-with-gist.md 2026-05-28 https://biopharmsignal.com/news/NAMS/newamsterdam-pharma-to-participate-at-upcoming-investor-conferences-in-june.md 2026-05-28 https://biopharmsignal.com/news/BNGO/bionano-announces-full-retirement-of-outstanding-senior-secured-convertible-debentures.md 2026-05-28 https://biopharmsignal.com/news/CRSP/crispr-therapeutics-to-participate-in-upcoming-investor-conferences.md 2026-05-28 https://biopharmsignal.com/news/GSK/bepirovirsen-achieves-unprecedented-functional-cure-rates-with-potential-to-redefine-treatment-for-chronic-hepatitis-b.md 2026-05-28 https://biopharmsignal.com/news/BCLI/brainstorm-cell-therapeutics-appoints-former-fda-associate-commissioner-peter-j-pitts-to-board-of-directors.md 2026-05-28 https://biopharmsignal.com/news/TGTX/tg-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference.md 2026-05-28 https://biopharmsignal.com/news/KPTI/karyopharm-to-participate-at-the-2026-jefferies-global-healthcare-conference.md 2026-05-28 https://biopharmsignal.com/news/BTAI/bioxcel-therapeutics-presents-new-data-from-serenity-at-home-phase-3-trial-for-agitation-associated-with-bipolar-disorders-or-schizophrenia-at-2026-ascp-annual-meeting.md 2026-05-28 https://biopharmsignal.com/news/ENTA/enanta-pharmaceuticals-to-present-at-the-jefferies-global-healthcare-conference.md 2026-05-28 https://biopharmsignal.com/news/RLMD/relmada-therapeutics-to-present-at-the-jefferies-global-healthcare-conference.md 2026-05-28 https://biopharmsignal.com/news/KALV/kalvista-pharmaceuticals-presents-new-data-highlighting-the-burden-of-injectable-on-demand-treatment-in-young-children-with-hereditary-angioedema.md 2026-05-28 https://biopharmsignal.com/news/ENLV/enlivex-treasury-portfolio-update-rain-holdings-valued-at-approximately-1-16-billion-rain-foundation-appoints-industry-leaders-to-advisory-board.md 2026-05-28 https://biopharmsignal.com/news/FMS/fresenius-medical-care-launches-first-tranche-of-its-share-buyback-program-of-up-to-eur-600-million.md 2026-05-28 https://biopharmsignal.com/news/PRI/primerica-household-budget-indextm-hbitm-rising-gas-prices-limit-purchasing-power-of-middle-income-americans-in-april.md 2026-05-28 https://biopharmsignal.com/news/NKTR/nektar-therapeutics-to-participate-in-the-2026-jefferies-global-healthcare-conference-in-new-york.md 2026-05-27 https://biopharmsignal.com/news/CVRX/cvrx-to-present-at-the-goldman-sachs-47th-annual-global-healthcare-conference.md 2026-05-27 https://biopharmsignal.com/news/DMAC/diamedica-therapeutics-to-present-at-the-jefferies-global-healthcare-conference-2026.md 2026-05-27 https://biopharmsignal.com/news/SUPN/supernus-pharmaceuticals-to-participate-in-june-investor-conferences.md 2026-05-27 https://biopharmsignal.com/news/CLPT/clearpoint-neuro-enters-into-10-year-focused-ultrasound-development-partnership-with-sungkyunkwan-university-south-korea-further-expanding-our-drug-delivery-ecosystem-and-global-footprint.md 2026-05-27 https://biopharmsignal.com/news/PCRX/pacira-biosciences-mails-letter-to-stockholders-reiterating-confidence-in-the-company-s-strategic-direction-and-highly-qualified-nominees.md 2026-05-27 https://biopharmsignal.com/news/CRBU/caribou-biosciences-to-participate-in-the-2026-jefferies-global-healthcare-conference.md 2026-05-27 https://biopharmsignal.com/news/ORIC/oricr-pharmaceuticals-to-participate-in-upcoming-investor-conferences.md 2026-05-27 https://biopharmsignal.com/news/SANA/sana-biotechnology-to-present-at-june-2026-investor-conferences.md 2026-05-27 https://biopharmsignal.com/news/PLSE/pulse-biosciences-to-present-at-the-goldman-sachs-47th-annual-global-healthcare-conference-2026.md 2026-05-27 https://biopharmsignal.com/news/EXEL/exelixis-to-webcast-fireside-chats-as-part-of-upcoming-investor-conferences-in-june.md 2026-05-27 https://biopharmsignal.com/news/MNKD/mannkind-to-present-at-jefferies-global-healthcare-conference.md 2026-05-27 https://biopharmsignal.com/news/IRWD/fda-approves-use-of-linzessr-linaclotide-in-pediatric-patients-two-years-of-age-and-older-with-functional-constipation-fc.md 2026-05-27 https://biopharmsignal.com/news/MNKD/mannkind-to-showcase-new-data-at-ada-2026-advancing-understanding-of-inhaled-insulin-afrezzar-in-pediatric-care-pregnancy-and-use-with-automated-insulin-delivery-aid-systems.md 2026-05-27 https://biopharmsignal.com/news/PRVA/privia-health-enters-new-jersey.md 2026-05-27 https://biopharmsignal.com/news/FMS/fresenius-medical-care-highlights-new-renal-research-and-innovation-at-era-congress-2026.md 2026-05-27 https://biopharmsignal.com/news/JAGX/jaguar-health-compliant-with-nasdaq-bid-price-rule.md 2026-05-27 https://biopharmsignal.com/news/GDRX/goodrx-launches-goodrx-companion-a-new-subscription-designed-to-lower-everyday-healthcare-costs.md 2026-05-27 https://biopharmsignal.com/news/ANGO/angiodynamics-to-present-at-the-goldman-sachs-47th-annual-global-healthcare-conference.md 2026-05-27 https://biopharmsignal.com/news/LQDA/liquidia-corporation-to-present-at-2026-jefferies-global-healthcare-conference.md 2026-05-27 https://biopharmsignal.com/news/RIGL/rigel-to-present-at-the-jefferies-global-healthcare-conference.md 2026-05-27 https://biopharmsignal.com/news/APVO/aptevo-and-niowave-launch-strategic-collaboration-for-radiopharmaceutical-therapeutic-development-includes-strategic-equity-investment-by-niowave-at-closing.md 2026-05-27 https://biopharmsignal.com/news/COGT/cogent-biosciences-announces-participation-in-the-2026-jefferies-global-healthcare-conference.md 2026-05-27 https://biopharmsignal.com/news/PCRX/pacira-biosciences-reports-real-world-study-showing-exparelr-use-was-associated-with-reduced-opioid-use-and-healthcare-costs-in-patients-undergoing-total-shoulder-arthroplasty.md 2026-05-27 https://biopharmsignal.com/news/ANNX/annexon-to-participate-in-upcoming-june-investor-conferences.md 2026-05-27 https://biopharmsignal.com/news/ATRC/atricure-to-participate-in-the-goldman-sachs-47th-annual-global-health-care-conference.md 2026-05-27 https://biopharmsignal.com/news/CORT/corcept-to-resubmit-its-new-drug-application-for-relacorilant-as-a-treatment-for-patients-with-cushing-s-syndrome.md 2026-05-27 https://biopharmsignal.com/news/BIAF/bioaffinity-technologies-announces-notification-of-mexico-patent-allowance-covering-novel-lung-cancer-detection-methods-using-cypathr-lung-technology.md 2026-05-27 https://biopharmsignal.com/news/ERAS/erasca-to-present-at-the-jefferies-global-healthcare-conference.md 2026-05-27 https://biopharmsignal.com/news/MLYS/mineralys-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference.md 2026-05-27 https://biopharmsignal.com/news/TWST/twist-bioscience-to-present-at-william-blair-46th-annual-growth-stock-conference.md 2026-05-27 https://biopharmsignal.com/news/TGTX/tg-therapeutics-announces-positive-topline-results-from-phase-3-enhance-trial.md 2026-05-27 https://biopharmsignal.com/news/CNTX/context-therapeutics-to-present-at-the-jefferies-global-healthcare-conference.md 2026-05-27 https://biopharmsignal.com/news/BCRX/biocryst-to-present-new-hae-data-from-orladeyor-berotralstat-and-navenibart-at-the-2026-european-academy-of-allergy-and-clinical-immunology-annual-meeting.md 2026-05-27 https://biopharmsignal.com/news/AVIR/atea-pharmaceuticals-presents-new-drug-drug-interaction-results-supporting-potential-best-in-class-profile-of-the-regimen-of-bemnifosbuvir-and-ruzasvir-for-the-treatment-of-hepatitis-c-virus-at-easl-congress-2026.md 2026-05-27 https://biopharmsignal.com/news/TNXP/tonix-pharmaceuticals-announces-publication-of-phase-1-clinical-data-of-tnx-1500-an-fc-modified-anti-cd40l-cd154-monoclonal-antibody-in-the-peer-reviewed-journal-of-clinical-immunology.md 2026-05-27 https://biopharmsignal.com/news/INSM/insmed-to-present-at-the-2026-goldman-sachs-annual-global-healthcare-conference.md 2026-05-27 https://biopharmsignal.com/news/ARWR/arrowhead-pharmaceuticals-presents-new-clinical-data-on-rnai-based-obesity-and-mash-candidate-aro-inhbe-at-easl-2026.md 2026-05-27 https://biopharmsignal.com/news/BMY/bristol-myers-squibb-to-participate-in-the-goldman-sachs-47th-annual-global-healthcare-conference.md 2026-05-27 https://biopharmsignal.com/news/ENLV/enlivex-treasury-portfolio-update-rain-protocol-jumps-into-top-three-global-prediction-markets-in-league-table-following-100m-in-additional-liquidity.md 2026-05-27 https://biopharmsignal.com/news/ALGS/aligos-therapeutics-presents-positive-data-at-the-easl-congress-2026.md 2026-05-27 https://biopharmsignal.com/news/DTIL/precision-biosciences-announces-new-and-late-breaking-pbgene-hbv-clinical-data-from-the-eliminate-b-study-at-european-association-for-the-study-of-the-liver-congress-2026.md 2026-05-27 https://biopharmsignal.com/news/MNOV/medicinova-announces-completion-of-last-patient-last-visit-in-the-mn-001-natg-202-clinical-trial-of-mn-001-tipelukast.md 2026-05-26 https://biopharmsignal.com/news/MDRX/veradigm-files-2023-and-2024-form-10-k.md 2026-05-26 https://biopharmsignal.com/news/ASMB/assembly-biosciences-announces-the-closing-of-its-offering-of-common-stock-and-pre-funded-warrants-and-full-exercise-of-the-underwriters-option-to-purchase-additional-shares.md 2026-05-26 https://biopharmsignal.com/news/GPCR/structure-therapeutics-announces-participation-in-upcoming-investor-conferences.md 2026-05-26 https://biopharmsignal.com/news/SEER/seer-to-showcase-ai-driven-multi-cancer-screening-approach-and-next-generation-proteomics-capabilities-at-asms-2026.md 2026-05-26 https://biopharmsignal.com/news/DCTH/delcath-systems-announces-two-asco-2026-investigator-initiated-trials-in-progress-abstracts.md 2026-05-26 https://biopharmsignal.com/news/NBIX/neurocrine-biosciences-to-present-at-upcoming-investor-conferences-in-june.md 2026-05-26 https://biopharmsignal.com/news/ARQT/arcutis-management-to-present-at-goldman-sachs-47th-annual-global-healthcare-conference.md 2026-05-26 https://biopharmsignal.com/news/ARWR/arrowhead-pharmaceuticals-presents-new-positive-clinical-cardiometabolic-data-at-the-94th-european-atherosclerosis-society-eas-congress.md 2026-05-26 https://biopharmsignal.com/news/SRRK/scholar-rock-to-present-at-the-goldman-sachs-47th-annual-global-healthcare-conference.md 2026-05-26 https://biopharmsignal.com/news/RNXT/renovorx-announces-promising-pharmacokinetic-data-using-the-tamptm-platform-presented-at-the-2026-asco-annual-meeting.md 2026-05-26 https://biopharmsignal.com/news/ABEO/abeona-therapeuticsr-announces-participation-in-upcoming-investor-conferences.md 2026-05-26 https://biopharmsignal.com/news/ALLO/allogene-therapeutics-announces-participation-in-upcoming-investor-conferences.md 2026-05-26 https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-oppenheimer-26th-annual-consumer-growth-and-e-commerce-conference.md 2026-05-26 https://biopharmsignal.com/news/HYPR/hyperfine-to-join-russell-2000r-and-russell-3000r-indexes.md 2026-05-26 https://biopharmsignal.com/news/MDRX/veradigm-to-release-business-update-may-26th-and-host-investor-call-may-27th.md 2026-05-26 https://biopharmsignal.com/news/PGNY/progyny-inc-announces-share-repurchase-program.md 2026-05-26 https://biopharmsignal.com/news/PCRX/pacira-biosciences-sets-the-record-straight-regarding-doma-s-misleading-statements-about-pacira-s-intellectual-property-strategy.md 2026-05-26 https://biopharmsignal.com/news/RANI/rani-therapeutics-holdings-inc-announces-pricing-of-20-0-million-registered-direct-offering-of-class-a-common-stock-priced-at-the-market-under-nasdaq-rules.md 2026-05-26 https://biopharmsignal.com/news/ESPR/esperion-presents-new-data-from-clear-outcomes-and-the-clear-path-phase-2-pediatric-study-at-the-european-atherosclerosis-society-congress-2026.md 2026-05-26 https://biopharmsignal.com/news/GSK/gsk-to-showcase-long-term-outcomes-and-pipeline-expansion-with-latest-oncology-research-at-asco-and-eha.md 2026-05-26 https://biopharmsignal.com/news/HUMA/humacyte-announces-presentation-at-vasa-meeting-of-research-highlighting-self-repair-of-atev-after-cannulation-for-dialysis-access.md 2026-05-26 https://biopharmsignal.com/news/YOU/clear-partners-with-samsung-bringing-clear-id-to-samsung-wallet.md 2026-05-26 https://biopharmsignal.com/news/LENZ/lenz-therapeutics-to-participate-in-upcoming-investor-conferences.md 2026-05-26 https://biopharmsignal.com/news/BNGO/bionano-announces-largest-ogm-study-of-t-cell-acute-lymphoblastic-leukemia.md 2026-05-26 https://biopharmsignal.com/news/TGTX/tg-therapeutics-announces-data-presentations-for-briumvir-at-the-2026-consortium-of-multiple-sclerosis-centers-annual-meeting.md 2026-05-26 https://biopharmsignal.com/news/DYN/dyne-therapeutics-announces-submission-of-biologics-license-application-bla-to-u-s-fda-for-z-rostudirsen-in-exon-51-duchenne-muscular-dystrophy-dmd.md 2026-05-26 https://biopharmsignal.com/news/PSTV/plus-cnside-diagnostic-platform-demonstrates-substantial-healthcare-cost-reduction-in-patients-with-leptomeningeal-metastases.md 2026-05-26 https://biopharmsignal.com/news/SNGX/suitability-of-vaccine-platform-for-bundibugyo-virus-cause-of-the-ebola-outbreak-in-congo.md 2026-05-26 https://biopharmsignal.com/news/VRAX/virax-biolabs-reports-positive-early-clinical-data-for-viraximmunetm-in-long-covid-and-related-post-acute-infection-syndromes.md 2026-05-26 https://biopharmsignal.com/news/OLMA/olema-oncology-announces-clinical-trial-collaboration-and-supply-agreement-with-bayer-to-evaluate-op-3136-in-combination-with-nubeqar-darolutamide-in-metastatic-castration-resistant-prostate-cancer.md 2026-05-26 https://biopharmsignal.com/news/TNXP/tonix-pharmaceuticals-presented-retrospective-u-s-real-world-claims-analysis-characterizing-patients-with-fibromyalgia-at-the-professional-society-for-health-economics-and-outcomes-research-ispor-2026-annual-meeting.md 2026-05-26 https://biopharmsignal.com/news/OTLK/outlook-therapeutics-wins-appeal-following-formal-dispute-resolution-process-for-ons-5010-lytenavatm-bevacizumab-vikg.md 2026-05-26 https://biopharmsignal.com/news/BRKR/champalimaud-foundation-s-neuroscience-and-oncology-research-benefits-from-18-tesla-ultra-high-field-mri.md 2026-05-26 https://biopharmsignal.com/news/UNH/corbus-pharmaceuticals-reports-updated-crb-701-phase-1-2-clinical-data-demonstrating-robust-activity-in-2l-oropharyngeal-and-cervical-cancers.md 2026-05-26 https://biopharmsignal.com/news/ALKS/alkermes-to-showcase-leadership-in-psychiatry-and-orexin-biology-with-new-data-at-the-american-society-of-clinical-psychopharmacology-annual-meeting.md 2026-05-26 https://biopharmsignal.com/news/KURA/kura-oncology-reports-strong-clinical-activity-and-safety-with-darlifarnib-adagrasib-in-kras-g12c-mutated-solid-tumors.md 2026-05-26 https://biopharmsignal.com/news/PSNL/personalis-to-highlight-breadth-of-next-personalr-ultra-sensitive-ctdna-data-at-asco-2026-annual-meeting-including-podium-presentation-from-tracerx-consortium.md 2026-05-26 https://biopharmsignal.com/news/IDYA/ideaya-biosciences-announces-participation-at-the-2026-jefferies-global-healthcare-conference.md 2026-05-26 https://biopharmsignal.com/news/FMS/fresenius-medical-care-announces-new-share-buyback-program-with-a-total-volume-of-around-eur-1-billion-with-phased-execution-over-12-months.md 2026-05-25 https://biopharmsignal.com/news/GNFT/genfit-highlights-broad-scientific-and-strategic-presence-at-easl-congress-2026.md 2026-05-25 https://biopharmsignal.com/news/GLSI/greenwich-lifesciences-announces-receipt-of-nasdaq-notice-regarding-late-form-10-q-filing.md 2026-05-22 https://biopharmsignal.com/news/SCYX/scynexis-announces-one-for-eight-reverse-stock-split.md 2026-05-22 https://biopharmsignal.com/news/AVTX/avalo-therapeutics-announces-inducement-grant-to-new-employee-under-nasdaq-listing-rule-5635-c-4.md 2026-05-22 https://biopharmsignal.com/news/IMMX/immix-biopharma-announces-closing-of-150-million-underwritten-offering-of-common-stock.md 2026-05-22 https://biopharmsignal.com/news/HYPR/hyperfine-announces-presentation-of-results-from-the-prime-study-showing-portable-mri-substantially-reduces-time-to-imaging-in-emergency-departments.md 2026-05-22 https://biopharmsignal.com/news/IBRX/immunitybio-highlights-patient-survey-data-at-ispor-2026-showing-majority-of-uk-adults-living-with-nmibc-favor-bladder-preservation.md 2026-05-22 https://biopharmsignal.com/news/IBRX/immunitybio-presents-health-economic-analysis-at-ispor-2026-showing-anktivar-plus-bcg-delivers-lower-cost-per-sustained-complete-response-versus-tar-200-in-bcg-unresponsive-nmibc-cis.md 2026-05-22 https://biopharmsignal.com/news/ASMB/assembly-biosciences-announces-pricing-of-100-million-offering-of-common-stock-and-pre-funded-warrants.md 2026-05-22 https://biopharmsignal.com/news/ASMB/assembly-biosciences-announces-expansion-of-abi-6250-clinical-development-into-cholestatic-liver-diseases.md 2026-05-22 https://biopharmsignal.com/news/REGN/otarmenitm-lunsotogene-parvec-receives-ema-filing-acceptance-for-genetic-hearing-loss.md 2026-05-22 https://biopharmsignal.com/news/MDNA/medicenna-announces-the-filing-of-its-prospectus-supplement-and-investment-term-sheet.md 2026-05-22 https://biopharmsignal.com/news/FENC/fennec-pharmaceuticals-announces-new-research-supporting-integration-and-use-of-pedmarkr-at-the-2026-asco-annual-meeting.md 2026-05-21 https://biopharmsignal.com/news/PLRX/pliant-therapeutics-announces-upcoming-presentation-at-the-2026-american-society-of-clinical-oncology-annual-meeting.md 2026-05-21 https://biopharmsignal.com/news/RIGL/rigel-announces-oral-and-poster-presentations-at-the-2026-asco-annual-meeting-and-eha2026-congress.md 2026-05-21 https://biopharmsignal.com/news/BDTX/black-diamond-therapeutics-announces-positive-phase-2-results-for-silevertinib-in-frontline-nsclc-patients-with-egfr-non-classical-mutations.md 2026-05-21 https://biopharmsignal.com/news/FLGT/fulgent-announces-rapid-oral-full-abstract-publication-for-fid-007-within-the-head-and-neck-cancer-track-session-at-the-asco-2026-annual-meeting.md 2026-05-21 https://biopharmsignal.com/news/SNDX/syndax-announces-four-revuforjr-revumenib-abstracts-accepted-for-asco-2026-including-an-oral-presentation-of-post-transplant-data.md 2026-05-21 https://biopharmsignal.com/news/REGN/lynozyficr-linvoseltamab-monotherapy-demonstrates-deep-and-rapid-responses-in-all-treated-patients-with-second-line-plus-systemic-amyloid-light-chain-amyloidosis.md 2026-05-21 https://biopharmsignal.com/news/BMY/bristol-myers-squibb-to-unveil-new-data-at-ascor-2026-demonstrating-strength-and-breadth-of-scientific-innovation-across-oncology-portfolio-and-next-generation-pipeline.md 2026-05-21 https://biopharmsignal.com/news/IMRX/immuneering-reports-17-3-months-median-overall-survival-in-first-line-metastatic-pancreatic-cancer-patients-treated-with-atebimetinib-plus-chemotherapy.md 2026-05-21 https://biopharmsignal.com/news/OLMA/olema-oncology-announces-encouraging-initial-clinical-data-from-the-phase-1-study-of-op-3136-a-kat6-inhibitor-at-2026-asco-annual-meeting.md 2026-05-21 https://biopharmsignal.com/news/EXEL/exelixis-announces-presentations-at-asco-2026-highlighting-ongoing-studies-in-diverse-tumor-types.md 2026-05-21 https://biopharmsignal.com/news/SEER/seer-board-of-directors-unanimously-rejects-further-revised-unsolicited-proposal-from-radoff-jec-group.md 2026-05-21 https://biopharmsignal.com/news/RVMD/revolution-medicines-to-host-investor-conference-call-on-positive-rasolute-302-results-following-2026-asco-presentation.md 2026-05-21 https://biopharmsignal.com/news/ELVN/enliven-therapeutics-to-present-at-upcoming-investor-conferences.md 2026-05-21 https://biopharmsignal.com/news/AZTA/azenta-publishes-2025-environmental-social-and-governance-esg-report.md 2026-05-21 https://biopharmsignal.com/news/IPHA/outcome-of-innate-pharma-s-2026-annual-general-meeting.md 2026-05-21 https://biopharmsignal.com/news/GNFT/genfit-reports-first-quarter-2026-financial-information-and-provides-a-corporate-update.md 2026-05-21 https://biopharmsignal.com/news/ISRG/intuitive-announces-innovations-to-advance-quintuple-aim.md 2026-05-21 https://biopharmsignal.com/news/MDXG/mimedx-to-participate-in-craig-hallum-23rd-annual-institutional-investor-conference.md 2026-05-21 https://biopharmsignal.com/news/FATE/fate-therapeutics-announces-presentations-at-2026-asco-and-eular-annual-meetings-highlighting-off-the-shelf-car-t-cell-therapy-pipeline-for-cancer-and-autoimmune-diseases.md 2026-05-21 https://biopharmsignal.com/news/IOVA/iovance-biotherapeutics-to-present-at-upcoming-conference.md 2026-05-21 https://biopharmsignal.com/news/AEMD/aethlon-medical-monitoring-current-ebola-outbreak-and-reaffirms-outbreak-pandemic-preparedness.md 2026-05-21 https://biopharmsignal.com/news/CTMX/cytomx-therapeutics-to-present-at-upcoming-june-investor-conferences.md 2026-05-21 https://biopharmsignal.com/news/UNH/corbus-pharmaceuticals-announces-the-appointment-of-nishant-saxena-as-chief-business-officer-and-schedules-a-pre-2026-asco-crb-701-data-conference-call.md 2026-05-21 https://biopharmsignal.com/news/ACRV/acrivon-therapeutics-to-present-at-td-cowen-s-7th-annual-oncology-innovation-summit.md 2026-05-21 https://biopharmsignal.com/news/VKTX/viking-therapeutics-to-participate-at-upcoming-investor-conferences-239640de.md 2026-05-21 https://biopharmsignal.com/news/DTIL/precision-biosciences-to-host-investor-webcast-to-discuss-late-breaking-pbgene-hbv-data-from-eliminate-b-trial-presented-at-european-association-for-the-study-of-the-liver-congress-2026.md 2026-05-21 https://biopharmsignal.com/news/ALKS/alkermes-showcases-data-from-psychiatry-portfolio-and-sleep-research-into-real-world-patient-experience-at-spring-2026-scientific-conferences.md 2026-05-21 https://biopharmsignal.com/news/ANTX/an2-therapeutics-to-present-at-2026-jefferies-global-healthcare-conference.md 2026-05-21 https://biopharmsignal.com/news/PEPG/pepgen-announces-presentations-at-the-15th-international-myotonic-dystrophy-consortium-highlighting-clinical-data-from-the-pgn-edodm1-program.md 2026-05-21 https://biopharmsignal.com/news/BDX/bd-delivers-kidney-stone-care-for-urology-teams-with-the-elyratm-thulium-fiber-laser-system.md 2026-05-21 https://biopharmsignal.com/news/IMMX/immix-biopharma-announces-pricing-of-150-million-underwritten-offering-of-common-stock.md 2026-05-21 https://biopharmsignal.com/news/IMMX/immix-biopharma-announces-95-complete-response-rate-in-interim-update-from-relapsed-refractory-al-amyloidosis-clinical-trial-nexicart-2.md 2026-05-21 https://biopharmsignal.com/news/FMS/fresenius-medical-care-annual-general-meeting-strengthening-performance-and-advancing-innovation-in-kidney-care.md 2026-05-20 https://biopharmsignal.com/news/JAGX/jaguar-health-reports-first-quarter-2026-financials.md 2026-05-20 https://biopharmsignal.com/news/CVRX/cvrx-to-present-at-the-william-blair-46th-annual-growth-stock-conference.md 2026-05-20 https://biopharmsignal.com/news/CLLS/cellectis-annual-shareholders-general-meeting-to-be-held-on-june-25-2026.md 2026-05-20 https://biopharmsignal.com/news/TCMD/tactile-medical-to-present-at-the-william-blair-46th-annual-growth-stock-conference.md 2026-05-20 https://biopharmsignal.com/news/CRVS/corvus-pharmaceuticals-to-present-at-the-2026-jefferies-global-healthcare-conference-and-goldman-sachs-47th-annual-global-healthcare-conference.md 2026-05-20 https://biopharmsignal.com/news/JAGX/jaguar-health-to-hold-investor-webcast-may-26-regarding-q1-2026-financials-and-corporate-updates-jaguar-ceo-lisa-conte-presenting-may-28-at-lytham-partners-spring-2026-investor-conference.md 2026-05-20 https://biopharmsignal.com/news/DMAC/diamedica-therapeutics-announces-75-enrollment-milestone-in-remedy2-phase-2-3-acute-ischemic-stroke-trial.md 2026-05-20 https://biopharmsignal.com/news/PYPD/polypid-to-participate-in-the-craig-hallum-23rd-annual-institutional-investor-conference.md 2026-05-20 https://biopharmsignal.com/news/PHAT/phathom-pharmaceuticals-highlights-breadth-of-independent-vonoprazan-research-at-digestive-disease-week-2026-annual-meeting.md 2026-05-20 https://biopharmsignal.com/news/TARA/protara-therapeutics-to-present-at-the-td-cowen-7th-annual-oncology-innovation-summit-insights-for-asco-and-eha.md 2026-05-20 https://biopharmsignal.com/news/SRRK/scholar-rock-to-present-at-the-2026-jefferies-global-healthcare-conference.md 2026-05-20 https://biopharmsignal.com/news/HUMA/humacyte-announces-symvessr-is-now-under-contract-with-the-strategic-acquisition-center-sac-of-the-u-s-department-of-veterans-affairs.md 2026-05-20 https://biopharmsignal.com/news/DYN/dyne-therapeutics-announces-initiation-of-phase-3-forzetto-trial-of-z-rostudirsen-in-duchenne-muscular-dystrophy-dmd-ahead-of-planned-bla-submission-for-u-s-accelerated-approval.md 2026-05-20 https://biopharmsignal.com/news/EBS/emergent-biosolutions-to-participate-in-upcoming-investor-conferences.md 2026-05-20 https://biopharmsignal.com/news/ROIV/roivant-reports-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-march-31-2026-and-provides-business-update.md 2026-05-20 https://biopharmsignal.com/news/SNDX/syndax-announces-participation-in-upcoming-investor-conferences.md 2026-05-20 https://biopharmsignal.com/news/IMVT/immunovant-provides-corporate-updates-and-reports-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-march-31-2026.md 2026-05-20 https://biopharmsignal.com/news/BMY/bristol-myers-squibb-announces-strategic-agreement-with-anthropic-to-position-claude-enterprise-as-the-shared-intelligence-platform-across-its-global-operations.md 2026-05-20 https://biopharmsignal.com/news/PCRX/pacira-biosciences-files-investor-presentation-highlighting-successful-execution-of-its-long-term-strategy-to-drive-value-for-all-stockholders.md 2026-05-20 https://biopharmsignal.com/news/PSNL/personalis-secures-fourth-medicare-coverage-decision-for-next-personalr-expanding-breast-cancer-coverage-to-pre-surgical-treatment-monitoring.md 2026-05-20 https://biopharmsignal.com/news/YOU/clear-and-gdit-announce-strategic-collaboration-agreement.md 2026-05-20 https://biopharmsignal.com/news/IBRX/immunitybio-announces-fda-acceptance-of-supplemental-bla-for-anktivar-plus-bcg-in-bcg-unresponsive-non-muscle-invasive-bladder-cancer-with-papillary-disease-pdufa-date-set-for-january-6-2027.md 2026-05-20 https://biopharmsignal.com/news/FMS/fresenius-medical-care-reappoints-chief-financial-officer-martin-fischer.md 2026-05-19 https://biopharmsignal.com/news/MNPR/monopar-announces-publication-of-phase-2-study-demonstrating-alxn1840-significantly-improves-copper-balance-in-patients-with-wilson-disease.md 2026-05-19 https://biopharmsignal.com/news/YOU/clear-partners-with-expedia-to-bring-a-more-seamless-airport-experience-to-travelers.md 2026-05-19 https://biopharmsignal.com/news/DERM/journey-medical-corporation-to-participate-in-a-g-p-s-annual-virtual-healthcare-conference.md 2026-05-19 https://biopharmsignal.com/news/DGX/quest-diagnostics-declares-quarterly-cash-dividend.md 2026-05-19 https://biopharmsignal.com/news/RXST/rxsight-inc-to-present-at-the-stifel-2026-virtual-ophthalmology-forum.md 2026-05-19 https://biopharmsignal.com/news/IRIX/iridex-reports-first-quarter-2026-financial-results.md 2026-05-19 https://biopharmsignal.com/news/KURA/kura-oncology-to-present-at-td-cowen-7th-annual-oncology-innovation-summit.md 2026-05-19 https://biopharmsignal.com/news/ACHV/achieve-life-sciences-presents-safety-data-from-52-weeks-of-continuous-cytisinicline-treatment.md 2026-05-19 https://biopharmsignal.com/news/NXGL/nexgel-reports-positive-data-from-randomized-single-center-irb-study-to-evaluate-the-effectiveness-and-safety-of-a-hydrogel-laser-treatment-patch-in-laser-hair-removal-with-a-95-6-reduction-in-plume-concentration.md 2026-05-19 https://biopharmsignal.com/news/JAGX/jaguar-health-announces-active-treatment-only-continuation-of-pivotal-multicenter-clinical-trial-in-pediatric-patients-with-microvillus-inclusion-disease-mvid-to-support-a-new-drug-application-nda-for-liquid-oral-crofelemer.md 2026-05-19 https://biopharmsignal.com/news/OGEN/oragenics-to-present-at-sidoti-s-micro-cap-virtual-investor-conference-may-20-21.md 2026-05-19 https://biopharmsignal.com/news/RNXT/renovorx-to-present-at-the-alliance-global-partners-virtual-annual-healthcare-company-showcase-on-may-20th.md 2026-05-19 https://biopharmsignal.com/news/ICCM/icecure-s-prosenser-reports-nearly-90-recurrence-free-rate-for-cryoablation-of-kidney-cancer-data-presented-at-ecio-2026-and-first-ever-breast-cryoablation-master-class-overbooked.md 2026-05-19 https://biopharmsignal.com/news/BDTX/black-diamond-therapeutics-to-host-webcast-for-investors-highlighting-updated-results-from-phase-2-trial-of-silevertinib-in-1l-egfrm-nsclc.md 2026-05-19 https://biopharmsignal.com/news/EXEL/exelixis-announces-clinical-development-collaboration-with-merck-for-phase-3-stellar-316-pivotal-trial-for-patients-with-colorectal-cancer.md 2026-05-19 https://biopharmsignal.com/news/LPCN/lipocine-announces-lpcn-1154-phase-3-data-accepted-for-oral-presentation-at-2026-ascp-annual-meeting.md 2026-05-19 https://biopharmsignal.com/news/BCLI/brainstorm-cell-therapeutics-announces-aggregate-of-400-000-in-private-placements-priced-at-premium-to-market.md 2026-05-19 https://biopharmsignal.com/news/PSTV/plus-therapeutics-partners-with-ephemeral-technologies-to-deploy-ai-execution-platform-for-cns-oncology.md 2026-05-19 https://biopharmsignal.com/news/IBRX/immunitybio-presents-favorable-comparative-effectiveness-data-in-complete-response-rates-of-nai-bcg-versus-nadofaragene-and-tar-200-at-aua-2026.md 2026-05-19 https://biopharmsignal.com/news/MDNA/medicenna-announces-the-finalization-of-the-terms-of-its-public-offering-of-securities.md 2026-05-19 https://biopharmsignal.com/news/BSX/fracture-ide-trial-of-the-boston-scientific-seismiqtm-4ce-coronary-intravascular-lithotripsy-catheter-meets-primary-safety-and-effectiveness-endpoints.md 2026-05-19 https://biopharmsignal.com/news/PTIX/protagenic-therapeutics-engages-floyd-regulatory-strategic-consulting-as-regulatory-affairs-advisor-and-danforth-health-as-strategic-operations-partner.md 2026-05-19 https://biopharmsignal.com/news/RPID/rapid-micro-biosystems-announces-pricing-of-up-to-approximately-32-million-underwritten-offering.md 2026-05-19 https://biopharmsignal.com/news/PNTG/pennant-group-to-participate-in-the-2026-rbc-global-healthcare-conference.md 2026-05-18 https://biopharmsignal.com/news/PNTG/pennant-announces-an-acquisition-of-senior-living-community-in-arizona.md 2026-05-18 https://biopharmsignal.com/news/FENC/fennec-pharmaceuticals-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4.md 2026-05-18 https://biopharmsignal.com/news/NERV/minerva-neurosciences-to-participate-in-the-2026-jefferies-global-healthcare-conference.md 2026-05-18 https://biopharmsignal.com/news/MLYS/mineralys-therapeutics-announces-presentation-of-new-data-from-the-phase-3-launch-htn-trial-of-lorundrostat-at-the-35th-european-meeting-on-hypertension-and-cardiovascular-protection-esh-2026.md 2026-05-18 https://biopharmsignal.com/news/NBIX/neurocrine-biosciences-presents-real-world-data-highlighting-functional-impact-of-mild-tardive-dyskinesia-severity-and-improvement-with-ingrezzar-valbenazine-capsules.md 2026-05-18 https://biopharmsignal.com/news/BEAM/beam-therapeutics-presents-recently-reported-topline-clinical-data-for-beam-302-in-alpha-1-antitrypsin-deficiency-aatd-at-the-american-thoracic-society-ats-2026-international-conference.md 2026-05-18 https://biopharmsignal.com/news/ARVN/arvinas-employees-give-back-during-company-wide-impact-day.md 2026-05-18 https://biopharmsignal.com/news/EBS/emergent-biosolutions-receives-saudi-food-and-drug-authority-approval-for-acam2000r-smallpox-and-mpox-vaccinia-vaccine-live.md 2026-05-18 https://biopharmsignal.com/news/NBIX/neurocrine-biosciences-completes-acquisition-of-soleno-therapeutics.md 2026-05-18 https://biopharmsignal.com/news/VIRI/dogwood-therapeutics-announces-commencement-of-halneuronr-chemotherapy-induced-neuropathic-pain-phase-2b-long-term-extension-study.md 2026-05-18 https://biopharmsignal.com/news/OGEN/oragenics-provides-investor-update.md 2026-05-18 https://biopharmsignal.com/news/FBIO/fortress-biotech-to-participate-in-a-g-p-s-annual-virtual-healthcare-conference.md 2026-05-18 https://biopharmsignal.com/news/ALHC/alignment-healthcare-to-present-at-the-goldman-sachs-47th-annual-global-healthcare-conference-2026.md 2026-05-18 https://biopharmsignal.com/news/CTMX/cytomx-therapeutics-appoints-mamata-gokhale-ph-d-rac-as-senior-vice-president-of-regulatory-affairs.md 2026-05-18 https://biopharmsignal.com/news/LPCN/lipocine-to-present-at-a-g-p-s-annual-virtual-healthcare-company-showcase.md 2026-05-18 https://biopharmsignal.com/news/TARA/protara-therapeutics-to-host-virtual-investor-webinar-to-discuss-tara-002-for-lymphatic-malformations-on-tuesday-may-19-2026.md 2026-05-18 https://biopharmsignal.com/news/IBRX/immunitybio-announces-comprehensive-u-s-patents-covering-combination-of-anktiva-with-bcg-for-cancer-treatment-with-terms-through-2035.md 2026-05-18 https://biopharmsignal.com/news/IPHA/innate-pharma-to-participate-in-the-jefferies-global-healthcare-conference.md 2026-05-18 https://biopharmsignal.com/news/DSGN/design-therapeutics-announces-four-week-iv-data-from-the-restore-fa-trial-of-dt-216p2-demonstrating-clinical-improvements-and-comprehensive-biomarker-activity-in-friedreich-ataxia.md 2026-05-18 https://biopharmsignal.com/news/AORT/artivion-completes-acquisition-of-endospan-ltd.md 2026-05-18 https://biopharmsignal.com/news/BSX/boston-scientific-enters-into-2-billion-accelerated-share-repurchase-agreement.md 2026-05-18 https://biopharmsignal.com/news/REGN/regeneron-announces-strategic-collaboration-with-parabilis-medicines-to-advance-novel-antibody-helicontm-conjugates-across-multiple-therapeutic-areas.md 2026-05-18 https://biopharmsignal.com/news/BDX/peter-menziuso-named-evp-and-president-bd-interventional.md 2026-05-18 https://biopharmsignal.com/news/CNTX/context-therapeutics-enters-into-license-agreement-amendment-with-bioatla-for-ct-202.md 2026-05-18 https://biopharmsignal.com/news/BSX/boston-scientific-announces-strategic-investment-in-mirus-llc.md 2026-05-18 https://biopharmsignal.com/news/ENLV/enlivex-announces-dosing-of-first-patient-in-the-united-states-as-part-of-its-phase-2b-trial-of-allocetra-in-age-related-primary-moderate-to-severe-knee-osteoarthritis.md 2026-05-18 https://biopharmsignal.com/news/GSK/gsk-s-rsv-vaccine-arexvy-receives-expanded-approval-in-japan-for-adults-aged-18-59-at-increased-risk.md 2026-05-18 https://biopharmsignal.com/news/DSGN/design-therapeutics-to-host-investor-webcast-to-review-data-from-restore-fa-trial-of-dt-216p2-for-friedreich-s-ataxia-on-monday-may-18-2026.md 2026-05-17 https://biopharmsignal.com/news/IBRX/immunitybio-signs-exclusive-u-s-agreement-with-japan-bcg-laboratory-for-the-tokyo-strain-of-bcg-to-enhance-bcg-supply-in-the-united-states.md 2026-05-16 https://biopharmsignal.com/news/MTLS/materialise-houdt-jaarlijkse-aandeelhoudersvergadering-op-16-juni-2026.md 2026-05-16 https://biopharmsignal.com/news/REGN/regeneron-provides-update-on-phase-3-trial-of-fianlimab-lag-3-inhibitor-combination-in-first-line-unresectable-or-metastatic-melanoma.md 2026-05-16 https://biopharmsignal.com/news/ENSC/ensysce-biosciences-reports-first-quarter-2026-financial-results.md 2026-05-15 https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-first-quarter-2026-financial-results-provides-corporate-update-announces-cfo-transition.md 2026-05-15 https://biopharmsignal.com/news/PSTV/plus-therapeutics-reports-first-quarter-2026-financial-results-and-provides-business-update-on-reyobiqtm-clinical-program-and-cnsider-commercial-rollout.md 2026-05-15 https://biopharmsignal.com/news/CADL/candel-therapeutics-reports-extended-clinical-benefit-over-multiple-clinical-endpoints-in-patients-from-phase-3-trial-of-aglatimagene-besadenovec-can-2409-in-localized-prostate-cancer-under-prolonged-follow-up-at-aua-2026-annual-meeting.md 2026-05-15 https://biopharmsignal.com/news/BCLI/brainstorm-cell-therapeutics-announces-first-quarter-2026-financial-results-and-provides-corporate-update.md 2026-05-15 https://biopharmsignal.com/news/OTLK/outlook-therapeutics-reports-second-quarter-fiscal-year-2026-financial-results-and-provides-corporate-update.md 2026-05-15 https://biopharmsignal.com/news/MTLS/materialise-to-hold-annual-shareholders-meeting-on-june-16-2026.md 2026-05-15 https://biopharmsignal.com/news/REGN/next-generation-of-scientific-leaders-awarded-more-than-7-million-at-the-2026-regeneron-international-science-and-engineering-fair.md 2026-05-15 https://biopharmsignal.com/news/ENLV/enlivex-announces-receipt-of-nasdaq-minimum-bid-price-notification.md 2026-05-15 https://biopharmsignal.com/news/PROK/prokidney-reports-first-quarter-2026-financial-results-and-business-highlights.md 2026-05-15 https://biopharmsignal.com/news/EMBC/embecta-completes-acquisition-of-owen-mumford-holdings-limited.md 2026-05-15 https://biopharmsignal.com/news/SANA/sana-biotechnology-announces-sale-of-approximately-69-million-of-shares-through-its-at-the-market-atm-facility.md 2026-05-15 https://biopharmsignal.com/news/PULM/pulmatrix-announces-first-quarter-2026-financial-results.md 2026-05-15 https://biopharmsignal.com/news/URGN/urogen-reports-94-5-six-month-duration-of-response-in-phase-3-utopia-trial-advancing-ugn-103-toward-potential-approval-in-recurrent-low-grade-intermediate-risk-nmibc.md 2026-05-15 https://biopharmsignal.com/news/PAVM/pavmed-provides-business-update-and-reports-first-quarter-2026-financial-results.md 2026-05-15 https://biopharmsignal.com/news/ATYR/atyr-pharma-announces-first-quarter-2026-results-and-provides-corporate-update.md 2026-05-15 https://biopharmsignal.com/news/IMRX/immuneering-reports-first-quarter-2026-financial-results-and-provides-business-updates.md 2026-05-15 https://biopharmsignal.com/news/SNSE/sensei-biotherapeutics-reports-first-quarter-2026-financial-results-and-provides-corporate-update.md 2026-05-15 https://biopharmsignal.com/news/BTAI/bioxcel-therapeutics-provides-business-update-and-reports-first-quarter-2026-financial-results.md 2026-05-15 https://biopharmsignal.com/news/TIL/instil-bio-reports-first-quarter-2026-financial-results-and-provides-corporate-update.md 2026-05-15 https://biopharmsignal.com/news/TARA/protara-therapeutics-announces-positive-updated-12-month-data-demonstrating-durable-responses-in-the-fully-enrolled-bcg-naive-cohort-of-the-ongoing-phase-2-advanced-2-trial-of-tara-002-in-nmibc.md 2026-05-15 https://biopharmsignal.com/news/TNYA/positive-interim-data-from-cohorts-1-and-2-of-tenaya-s-ridgetm-1-phase-1b-2-clinical-trial-of-tn-401-demonstrated-consistent-reductions-in-arrhythmia-burden-for-adults-with-pkp2-associated-arvc.md 2026-05-15 https://biopharmsignal.com/news/LIXT/lixte-biotechnology-files-first-quarter-2026-quarterly-report-on-form-10-q-provides-operational-progress-update.md 2026-05-14 https://biopharmsignal.com/news/EHC/encompass-health-issues-notice-for-partial-redemption-of-its-4-500-senior-notes-due-2028.md 2026-05-14 https://biopharmsignal.com/news/MGTX/meiragtx-announces-inducement-grant-under-nasdaq-listing-rule-5635-c-4.md 2026-05-14 https://biopharmsignal.com/news/ESPR/esperion-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4.md 2026-05-14 https://biopharmsignal.com/news/TPST/tempest-reports-first-quarter-2026-financial-results-and-provides-business-update.md 2026-05-14 https://biopharmsignal.com/news/EHC/encompass-health-announces-pricing-of-500-million-of-senior-notes-due-2034-in-a-private-offering.md 2026-05-14 https://biopharmsignal.com/news/FBIO/fortress-biotech-reports-first-quarter-2026-financial-results-and-recent-corporate-highlights.md 2026-05-14 https://biopharmsignal.com/news/AZYO/elutia-reports-first-quarter-2026-results-and-highlights-nxt-41x-progress-toward-1-5-billion-u-s-plastic-and-reconstructive-surgery-market.md 2026-05-14 https://biopharmsignal.com/news/NRIX/nurix-therapeutics-presents-new-preclinical-and-phase-1-translational-data-supporting-bexobrutideg-nx-5948-in-chronic-spontaneous-urticaria-at-the-2026-society-for-investigative-dermatology-annual-meeting.md 2026-05-14 https://biopharmsignal.com/news/OCS/oculis-publishes-results-of-2026-annual-general-meeting-and-announces-election-of-gregory-d-perry-to-its-board-of-directors.md 2026-05-14 https://biopharmsignal.com/news/RNXT/renovorx-reports-record-first-quarter-2026-increasing-revenue-by-136-quarter-over-quarter.md 2026-05-14 https://biopharmsignal.com/news/PIII/p3-health-partners-announces-first-quarter-2026-results.md 2026-05-14 https://biopharmsignal.com/news/ARTL/artelo-biosciences-provides-business-update-outlining-upcoming-milestones-and-reports-2026-first-quarter-financial-results.md 2026-05-14 https://biopharmsignal.com/news/INBX/inhibrx-reports-first-quarter-2026-financial-results.md 2026-05-14 https://biopharmsignal.com/news/ALHC/alignment-health-plan-recognized-as-one-of-four-medicare-advantage-prescription-drug-plans-in-the-u-s-for-2026-excellence-in-quality.md 2026-05-14 https://biopharmsignal.com/news/NCNA/nucana-reports-first-quarter-2026-financial-results-and-provides-business-update.md 2026-05-14 https://biopharmsignal.com/news/AZYO/elutia-to-present-at-the-16th-annual-ld-micro-invitational-on-may-18th.md 2026-05-14 https://biopharmsignal.com/news/PSNL/personalis-to-participate-in-upcoming-investor-events.md 2026-05-14 https://biopharmsignal.com/news/MGNX/macrogenics-to-participate-in-the-stifel-2026-virtual-targeted-oncology-forum.md 2026-05-14 https://biopharmsignal.com/news/MNPR/monopar-therapeutics-reports-first-quarter-2026-financial-results-and-provides-business-updates.md 2026-05-14 https://biopharmsignal.com/news/EHC/encompass-health-announces-private-offering-of-senior-notes.md 2026-05-14 https://biopharmsignal.com/news/STIM/neuronetics-and-ant-neuro-announce-strategic-collaboration-to-integrate-neuronavigation-with-neurostar-tms-treatment.md 2026-05-14 https://biopharmsignal.com/news/TARS/tarsus-and-john-cena-partner-to-raise-awareness-of-demodex-blepharitis-a-common-eyelid-disease-affecting-approximately-25-million-americans.md 2026-05-14 https://biopharmsignal.com/news/VIRI/dogwood-therapeutics-announces-first-quarter-2026-financial-results.md 2026-05-14 https://biopharmsignal.com/news/MIST/milestone-pharmaceuticals-to-present-at-the-h-c-wainwright-4th-annual-bioconnect-investor-conference-at-nasdaq.md 2026-05-14 https://biopharmsignal.com/news/CADL/candel-therapeutics-reports-first-quarter-2026-financial-results-and-recent-corporate-highlights.md 2026-05-14 https://biopharmsignal.com/news/RIGL/rigel-to-present-at-the-2026-rbc-capital-markets-global-healthcare-conference.md 2026-05-14 https://biopharmsignal.com/news/INAB/in8bio-presents-new-translational-data-demonstrating-deltex-dri-reshapes-the-immune-landscape-in-glioblastoma.md 2026-05-14 https://biopharmsignal.com/news/MGTX/meiragtx-reports-first-quarter-2026-financial-and-operational-results.md 2026-05-14 https://biopharmsignal.com/news/CVRX/cvrx-announces-humana-medicare-advantage-coverage-policy-for-barostim-therapy.md 2026-05-14 https://biopharmsignal.com/news/UNH/corbus-pharmaceuticals-appoints-pharma-industry-veteran-brent-pfeiffenberger-to-board-of-directors.md 2026-05-14 https://biopharmsignal.com/news/CMMB/chemomab-therapeutics-announces-first-quarter-2026-financial-results-and-provides-corporate-update.md 2026-05-14 https://biopharmsignal.com/news/SLS/sellas-life-sciences-to-participate-in-upcoming-investor-conferences.md 2026-05-14 https://biopharmsignal.com/news/INTS/intensity-therapeutics-recognized-with-ghp-magazine-s-2026-healthcare-and-pharmaceutical-award.md 2026-05-14 https://biopharmsignal.com/news/BNTC/benitec-biopharma-releases-third-quarter-2026-financial-results-and-provides-operational-update.md 2026-05-14 https://biopharmsignal.com/news/LUCD/lucid-diagnostics-provides-business-update-and-reports-first-quarter-2026-financial-results.md 2026-05-14 https://biopharmsignal.com/news/KPTI/karyopharm-reports-first-quarter-2026-financial-results-and-completion-of-phase-3-endometrial-cancer-trial-enrollment.md 2026-05-14 https://biopharmsignal.com/news/CCRN/cross-country-expands-ai-powered-workforce-intelligence-for-health-systems-through-exclusive-optime-solution.md 2026-05-14 https://biopharmsignal.com/news/CLRB/cellectar-biosciences-reports-first-quarter-2026-financial-results-and-provides-corporate-updates.md 2026-05-14 https://biopharmsignal.com/news/CABA/cabaletta-bio-reports-first-quarter-2026-financial-results-and-provides-business-update.md 2026-05-14 https://biopharmsignal.com/news/DTIL/precision-biosciences-presents-new-preclinical-data-supporting-the-advancement-of-pbgene-dmd-into-clinic-at-the-american-society-of-gene-and-cell-therapy-2026-annual-meeting.md 2026-05-14 https://biopharmsignal.com/news/GHRS/gh-research-reports-first-quarter-2026-financial-results-and-provides-business-update.md 2026-05-14 https://biopharmsignal.com/news/AVAH/aveanna-healthcare-holdings-announces-first-quarter-financial-results-and-revised-2026-guidance.md 2026-05-14 https://biopharmsignal.com/news/TNXP/tonix-pharmaceuticals-to-present-retrospective-u-s-real-world-claims-analysis-characterizing-patients-with-fibromyalgia-at-ispor-2026.md 2026-05-14 https://biopharmsignal.com/news/CRVS/corvus-pharmaceuticals-presents-soquelitinib-phase-1-atopic-dermatitis-data-at-the-society-for-investigative-dermatology-sid-annual-meeting.md 2026-05-14 https://biopharmsignal.com/news/LRMR/larimar-therapeutics-reports-first-quarter-2026-financial-and-business-update.md 2026-05-14 https://biopharmsignal.com/news/CABA/cabaletta-bio-presents-preconditioning-free-clinical-data-and-automated-manufacturing-translational-data-for-rese-cel-at-asgct-2026-annual-meeting.md 2026-05-14 https://biopharmsignal.com/news/FENC/fennec-pharmaceuticals-reports-first-quarter-2026-financial-results-and-provides-business-update.md 2026-05-14 https://biopharmsignal.com/news/GRI/gri-bio-reports-first-quarter-2026-financial-results-new-data-reinforcing-differentiated-profile-of-gri-0621-in-idiopathic-pulmonary-fibrosis-and-highlights-continued-advancement-of-differentiated-immune-modulating-pipeline.md 2026-05-14 https://biopharmsignal.com/news/APTO/aptose-reports-first-quarter-2026-results.md 2026-05-13 https://biopharmsignal.com/news/SRPT/sarepta-therapeutics-to-present-at-the-rbc-capital-markets-global-healthcare-conference.md 2026-05-13 https://biopharmsignal.com/news/ICCM/icecure-granted-180-day-extension-by-nasdaq-to-regain-compliance-with-minimum-bid-requirement.md 2026-05-13 https://biopharmsignal.com/news/RPID/rapid-micro-biosystems-reports-first-quarter-2026-financial-results.md 2026-05-13 https://biopharmsignal.com/news/ACRV/acrivon-reports-first-quarter-2026-financial-results-and-highlights-progress-towards-key-2026-clinical-catalysts.md 2026-05-13 https://biopharmsignal.com/news/TNGX/tango-therapeutics-reports-first-quarter-2026-financial-results-and-provides-business-highlights.md 2026-05-13 https://biopharmsignal.com/news/SEER/seer-reports-first-quarter-2026-financial-results-and-reaffirms-full-year-2026-outlook.md 2026-05-13 https://biopharmsignal.com/news/CRBU/caribou-biosciences-to-participate-in-the-h-c-wainwright-4th-annual-bioconnect-investor-conference.md 2026-05-13 https://biopharmsignal.com/news/VANI/vivani-medical-reports-first-quarter-2026-financial-results-and-provides-business-update.md 2026-05-13 https://biopharmsignal.com/news/BNGO/bionano-reports-first-quarter-2026-results-and-provides-a-business-update.md 2026-05-13 https://biopharmsignal.com/news/CLPT/clearpoint-neuro-reports-first-quarter-2026-results.md 2026-05-13 https://biopharmsignal.com/news/DRMA/dermata-therapeutics-provides-corporate-update-and-reports-financial-results-for-the-first-quarter-2026.md 2026-05-13 https://biopharmsignal.com/news/ALLO/allogene-therapeutics-reports-first-quarter-2026-financial-results-and-business-update.md 2026-05-13 https://biopharmsignal.com/news/AQST/aquestive-therapeutics-reports-first-quarter-2026-financial-results-and-provides-business-update.md 2026-05-13 https://biopharmsignal.com/news/MGNX/macrogenics-reports-first-quarter-2026-financial-results-and-highlights-business-transformation.md 2026-05-13 https://biopharmsignal.com/news/MDNA/medicenna-announces-the-launch-of-a-marketed-public-offering-of-securities.md 2026-05-13 https://biopharmsignal.com/news/BEAT/heartbeam-reports-first-quarter-2026-results.md 2026-05-13 https://biopharmsignal.com/news/FBIO/journey-medical-corporation-reports-first-quarter-2026-financial-results-and-recent-corporate-highlights.md 2026-05-13 https://biopharmsignal.com/news/ATYR/atyr-pharma-to-participate-in-upcoming-investor-conferences.md 2026-05-13 https://biopharmsignal.com/news/CLPT/clearpoint-neuro-announces-ce-marking-of-velocity-alpha-mr-high-speed-surgical-drill-system-further-expanding-drug-delivery-ecosystem-and-global-footprint.md 2026-05-13 https://biopharmsignal.com/news/SPRO/spero-therapeutics-announces-first-quarter-2026-operating-results-and-provides-business-update.md 2026-05-13 https://biopharmsignal.com/news/ANGO/angiodynamics-announces-two-year-preserve-trial-data-demonstrating-durable-nanoknife-ire-system-outcomes-in-intermediate-risk-prostate-cancer.md 2026-05-13 https://biopharmsignal.com/news/FATE/fate-therapeutics-reports-first-quarter-2026-financial-results-and-business-updates.md 2026-05-13 https://biopharmsignal.com/news/NXGL/nexgel-appoints-dave-hazard-as-vice-president-of-sales-for-bionx-surgical.md 2026-05-13 https://biopharmsignal.com/news/CADL/candel-therapeutics-to-present-at-upcoming-investor-conferences.md 2026-05-13 https://biopharmsignal.com/news/XBIO/xenetic-biosciences-reports-first-quarter-2026-financial-results-and-highlights-continued-advancement-of-dnase-oncology-platform.md 2026-05-13 https://biopharmsignal.com/news/APVO/aptevo-therapeutics-provides-a-1q26-business-update-rainier-on-track-for-2026-completion-and-phase-2-dose-selection.md 2026-05-13 https://biopharmsignal.com/news/ESPR/esperion-announces-two-new-analyses-supporting-bempedoic-acid-to-reduce-ldl-c-levels-to-be-presented-at-the-european-atherosclerosis-society-eas-congress-2026.md 2026-05-13 https://biopharmsignal.com/news/PCRX/pacira-biosciences-to-participate-in-fireside-chats-at-three-upcoming-healthcare-conferences.md 2026-05-13 https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-to-participate-in-the-h-c-wainwright-4th-annual-bioconnect-investor-conference-at-nasdaq.md 2026-05-13 https://biopharmsignal.com/news/TARA/protara-therapeutics-announces-first-quarter-2026-financial-results-and-provides-a-business-update.md 2026-05-13 https://biopharmsignal.com/news/URGN/zusduri-median-duration-of-response-still-not-reached-with-64-5-36-month-duration-of-response-in-the-pivotal-envision-trial.md 2026-05-13 https://biopharmsignal.com/news/CRL/charles-river-laboratories-and-medipost-sign-non-exclusive-mou-to-advance-gmp-testing-solutions.md 2026-05-13 https://biopharmsignal.com/news/ABUS/arbutus-reports-first-quarter-2026-financial-results-and-provides-corporate-update.md 2026-05-13 https://biopharmsignal.com/news/ABEO/abeona-therapeuticsr-reports-first-quarter-2026-results-and-provides-pipeline-update.md 2026-05-13 https://biopharmsignal.com/news/ZURA/zura-bio-expands-leadership-team-with-appointment-of-muzammil-mustufa-as-chief-business-officer.md 2026-05-13 https://biopharmsignal.com/news/PYPD/polypid-provides-corporate-update-and-reports-first-quarter-2026-financial-results.md 2026-05-13 https://biopharmsignal.com/news/MIST/milestone-pharmaceuticals-announces-first-quarter-2026-financial-results-and-provides-corporate-update.md 2026-05-13 https://biopharmsignal.com/news/SEER/seer-files-patent-infringement-lawsuit-against-nanomics.md 2026-05-13 https://biopharmsignal.com/news/BEAM/beam-therapeutics-to-present-at-2026-rbc-capital-markets-global-healthcare-conference.md 2026-05-13 https://biopharmsignal.com/news/AVIR/atea-pharmaceuticals-to-present-three-abstracts-at-easl-2026-congress-highlighting-progress-across-viral-hepatitis-pipeline.md 2026-05-13 https://biopharmsignal.com/news/BCRX/biocryst-to-present-new-real-world-evidence-underscoring-the-ongoing-burden-of-pediatric-hereditary-angioedema-at-ispor-2026.md 2026-05-13 https://biopharmsignal.com/news/NRIX/nurix-therapeutics-to-participate-in-upcoming-investor-conferences.md 2026-05-13 https://biopharmsignal.com/news/HUMA/humacyte-announces-first-quarter-2026-financial-results-and-provides-business-update.md 2026-05-13 https://biopharmsignal.com/news/PRTC/puretech-to-showcase-deupirfenidone-program-at-the-american-thoracic-society-international-conference.md 2026-05-13 https://biopharmsignal.com/news/UNH/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences.md 2026-05-13 https://biopharmsignal.com/news/AVTX/avalo-therapeutics-reports-first-quarter-2026-financial-results-and-recent-business-updates.md 2026-05-13 https://biopharmsignal.com/news/XTNT/xtant-medical-reports-first-quarter-2026-financial-results.md 2026-05-13 https://biopharmsignal.com/news/APRE/aprea-therapeutics-reports-first-quarter-2026-financial-results-and-provides-a-corporate-update.md 2026-05-13 https://biopharmsignal.com/news/VERU/veru-reports-fiscal-2026-second-quarter-financial-results-and-phase-2b-plateau-clinical-trial-progress.md 2026-05-13 https://biopharmsignal.com/news/PSNL/personalis-receives-medicare-coverage-for-next-personalr-for-immunotherapy-monitoring-across-late-stage-solid-tumors.md 2026-05-13 https://biopharmsignal.com/news/YOU/clear-expands-to-northwest-arkansas-national-airport.md 2026-05-13 https://biopharmsignal.com/news/ALGS/aligos-therapeutics-announces-ten-abstracts-accepted-for-presentation-at-the-easl-congress-2026.md 2026-05-13 https://biopharmsignal.com/news/ASMB/assembly-biosciences-to-present-topline-phase-1a-data-on-hepatitis-delta-virus-entry-inhibitor-abi-6250-at-the-easl-congress-2026.md 2026-05-13 https://biopharmsignal.com/news/ALHC/alignment-healthcare-strengthens-leadership-team-to-support-long-term-growth-and-shareholder-value-creation.md 2026-05-12 https://biopharmsignal.com/news/TNXP/tonix-pharmaceuticals-to-participate-in-two-investor-conferences-in-may.md 2026-05-12 https://biopharmsignal.com/news/ANAB/anaptys-announces-first-quarter-2026-financial-results-and-provides-business-update.md 2026-05-12 https://biopharmsignal.com/news/DMAC/diamedica-therapeutics-to-participate-in-the-2026-rbc-capital-markets-global-healthcare-conference.md 2026-05-12 https://biopharmsignal.com/news/MXCT/maxcyte-reports-first-quarter-2026-financial-results-and-reiterates-full-year-2026-guidance.md 2026-05-12 https://biopharmsignal.com/news/CBIO/gyre-therapeutics-announces-nmpa-acceptance-of-new-drug-application-for-f351-hydronidone-for-chb-induced-liver-fibrosis-treatment.md 2026-05-12 https://biopharmsignal.com/news/RANI/rani-therapeutics-to-participate-in-the-h-c-wainwright-annual-bioconnect-investor-conference.md 2026-05-12 https://biopharmsignal.com/news/AVIR/atea-pharmaceuticals-reports-first-quarter-2026-financial-results-and-provides-business-update.md 2026-05-12 https://biopharmsignal.com/news/SANA/sana-biotechnology-presents-preclinical-data-for-in-vivo-car-t-cell-therapy-sg293-surrogate-demonstrating-cell-specific-delivery-potent-car-t-cell-generation-and-deep-b-cell-depletion-in-nhps.md 2026-05-12 https://biopharmsignal.com/news/NRIX/nurix-therapeutics-announces-bexobrutideg-oral-presentation-at-the-2026-european-hematology-association-congress.md 2026-05-12 https://biopharmsignal.com/news/TELA/tela-bio-reports-first-quarter-2026-financial-results.md 2026-05-12 https://biopharmsignal.com/news/RLMD/relmada-therapeutics-reports-first-quarter-2026-financial-results-and-provides-business-update.md 2026-05-12 https://biopharmsignal.com/news/ATRA/atara-biotherapeutics-announces-first-quarter-2026-financial-results-and-operational-progress.md 2026-05-12 https://biopharmsignal.com/news/SLS/sellas-life-sciences-reports-first-quarter-2026-financial-results-and-provides-corporate-update.md 2026-05-12 https://biopharmsignal.com/news/IBIO/ibio-reports-q3-fiscal-year-2026-financial-results-and-provides-corporate-update.md 2026-05-12 https://biopharmsignal.com/news/TXMD/therapeuticsmd-announces-first-quarter-2026-financial-results.md 2026-05-12 https://biopharmsignal.com/news/CAPR/capricor-therapeutics-reports-first-quarter-2026-financial-results-and-provides-corporate-update.md 2026-05-12 https://biopharmsignal.com/news/HYPR/hyperfine-inc-reports-first-quarter-2026-financial-results.md 2026-05-12 https://biopharmsignal.com/news/PEPG/pepgen-reports-first-quarter-2026-financial-results-and-recent-corporate-highlights.md 2026-05-12 https://biopharmsignal.com/news/KURA/kura-oncology-reports-first-quarter-2026-financial-results.md 2026-05-12 https://biopharmsignal.com/news/NKTX/nkarta-reports-first-quarter-2026-financial-results-and-corporate-highlights.md 2026-05-12 https://biopharmsignal.com/news/PCRX/pacira-biosciences-sends-letter-to-stockholders-reiterating-superior-qualifications-of-its-board-nominees.md 2026-05-12 https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-reports-first-quarter-2026-financial-results.md 2026-05-12 https://biopharmsignal.com/news/LCTX/lineage-cell-therapeutics-reports-first-quarter-2026-financial-results-and-provides-business-update.md 2026-05-12 https://biopharmsignal.com/news/IKT/inhibikase-therapeutics-announces-first-quarter-2026-financial-results-and-highlights-recent-activity.md 2026-05-12 https://biopharmsignal.com/news/CRIS/curis-provides-first-quarter-2026-business-update.md 2026-05-12 https://biopharmsignal.com/news/SNDX/syndax-highlights-12-revuforjr-revumenib-abstracts-accepted-for-eha-2026-advancing-leadership-in-menin-inhibition.md 2026-05-12 https://biopharmsignal.com/news/NXGL/nexgel-to-report-first-quarter-2026-financial-results-on-may-15th.md 2026-05-12 https://biopharmsignal.com/news/ELVN/enliven-therapeutics-announces-oral-presentation-at-the-eha-2026-congress-featuring-additional-positive-phase-1-clinical-trial-data-for-elvn-001-in-cml.md 2026-05-12 https://biopharmsignal.com/news/IPHA/innate-pharma-reports-first-quarter-2026-business-update-and-financial-results.md 2026-05-12 https://biopharmsignal.com/news/KURA/kura-oncology-and-kyowa-kirin-to-present-updated-frontline-ziftomenib-7-3-combination-data-at-eha-2026-congress.md 2026-05-12 https://biopharmsignal.com/news/AQST/aquestive-therapeutics-completes-150-million-debt-refinancing-with-oaktree.md 2026-05-12 https://biopharmsignal.com/news/IRON/disc-medicine-announces-multiple-presentations-across-portfolio-at-the-european-hematology-association-eha-2026-congress.md 2026-05-12 https://biopharmsignal.com/news/CRBU/caribou-biosciences-to-highlight-vispa-cel-and-cb-011-programs-during-oral-presentations-at-the-2026-european-hematology-association-eha-annual-meeting.md 2026-05-12 https://biopharmsignal.com/news/COGT/cogent-biosciences-announces-multiple-presentations-at-the-european-hematology-association-eha-2026-congress.md 2026-05-12 https://biopharmsignal.com/news/BEAM/beam-therapeutics-to-present-updated-biomarker-data-from-phase-1-2-beacon-trial-further-underscoring-risto-cel-s-ability-to-restore-red-blood-cell-health-and-function-in-sickle-cell-disease-at-eha2026.md 2026-05-12 https://biopharmsignal.com/news/CLLS/cellectis-to-present-clinical-data-on-lasme-cel-and-eti-cel-at-eha-2026-annual-congress.md 2026-05-12 https://biopharmsignal.com/news/BIAF/bioaffinity-technologies-reports-record-monthly-cypathr-lung-unit-sales-and-significant-year-over-year-growth-in-april-2026.md 2026-05-12 https://biopharmsignal.com/news/ICCM/icecure-reports-first-quarter-2026-financial-results-prosenser-sales-increase-substantially-in-the-u-s-and-north-america.md 2026-05-12 https://biopharmsignal.com/news/PMVP/pmv-pharmaceuticals-reports-first-quarter-2026-financial-results-and-corporate-highlights.md 2026-05-12 https://biopharmsignal.com/news/LYEL/lyell-immunopharma-announces-participation-in-may-investor-conferences.md 2026-05-12 https://biopharmsignal.com/news/HUMA/humacyte-appoints-dr-todd-e-rasmussen-as-chief-surgical-officer.md 2026-05-12 https://biopharmsignal.com/news/UNH/corbus-pharmaceuticals-reports-q1-2026-financial-results-and-provides-a-corporate-update.md 2026-05-12 https://biopharmsignal.com/news/ENSC/ensysce-biosciences-announces-expansion-of-patent-protection-for-groundbreaking-mpar-r-overdose-protection-technology.md 2026-05-12 https://biopharmsignal.com/news/DCTH/delcath-systems-to-participate-at-the-h-c-wainwright-4th-annual-bioconnect-investor-conference.md 2026-05-12 https://biopharmsignal.com/news/OPKO/opko-health-s-modex-therapeutics-will-present-data-demonstrating-in-vivo-car-t-cell-generation-and-deep-b-cell-depletion-in-preclinical-studies.md 2026-05-12 https://biopharmsignal.com/news/SABS/sab-bio-reports-q1-2026-financial-results-and-recent-business-highlights.md 2026-05-12 https://biopharmsignal.com/news/AVAH/aveanna-to-participate-at-the-william-blair-46th-annual-growth-stock-conference.md 2026-05-12 https://biopharmsignal.com/news/KPTI/karyopharm-to-participate-at-upcoming-investor-conferences.md 2026-05-12 https://biopharmsignal.com/news/ARVN/arvinas-reports-first-quarter-2026-financial-results-and-provides-corporate-update.md 2026-05-12 https://biopharmsignal.com/news/ACHV/achieve-life-sciences-strengthens-board-and-commercial-leadership-with-three-senior-appointments-from-team-previously-at-verona-pharma.md 2026-05-12 https://biopharmsignal.com/news/VKTX/viking-therapeutics-presents-data-from-its-13-week-phase-2-venture-oral-dosing-trial-of-vk2735-at-european-congress-on-obesity-eco-2026.md 2026-05-12 https://biopharmsignal.com/news/UNCY/unicycive-therapeutics-announces-first-quarter-2026-financial-results-and-provides-business-update.md 2026-05-12 https://biopharmsignal.com/news/PRLD/prelude-therapeutics-reports-first-quarter-2026-financial-results-and-provides-corporate-update.md 2026-05-12 https://biopharmsignal.com/news/FHTX/foghorn-therapeutics-to-participate-in-three-upcoming-investor-conferences-in-may.md 2026-05-12 https://biopharmsignal.com/news/ARVN/arvinas-and-pfizer-enter-into-a-transaction-with-rigel-pharmaceuticals-for-the-exclusive-global-rights-of-veppanu-vepdegestrant.md 2026-05-12 https://biopharmsignal.com/news/IMTX/immatics-announces-first-quarter-2026-financial-results-and-business-update.md 2026-05-12 https://biopharmsignal.com/news/OLMA/olema-oncology-reports-first-quarter-2026-financial-and-operating-results.md 2026-05-12 https://biopharmsignal.com/news/RIGL/rigel-enters-exclusive-global-licensing-agreement-for-veppanutm-vepdegestrant-an-oral-protac-for-the-treatment-of-2l-er-her2-esr1m-advanced-or-metastatic-breast-cancer.md 2026-05-12 https://biopharmsignal.com/news/PLSE/atm-equity-purchases-by-pulse-biosciences-co-chairmen-total-approximately-13-3-million.md 2026-05-12 https://biopharmsignal.com/news/MCRB/seres-therapeutics-to-participate-in-h-c-wainwright-4th-annual-bioconnect-investor-conference.md 2026-05-12 https://biopharmsignal.com/news/MDNA/medicenna-and-fondazione-melanoma-onlus-announce-first-patient-dosed-in-the-neo-cyt-study-of-mdna11-in-neoadjuvant-melanoma.md 2026-05-12 https://biopharmsignal.com/news/ALKS/alkermes-announces-positive-topline-results-from-revitalyz-phase-3-study-evaluating-lumryzr-sodium-oxybate-extended-release-in-adults-with-idiopathic-hypersomnia.md 2026-05-12 https://biopharmsignal.com/news/ACHV/achieve-life-sciences-reports-first-quarter-2026-financial-results-and-provides-business-updates.md 2026-05-12 https://biopharmsignal.com/news/BMY/bristol-myers-squibb-and-hengrui-pharma-announce-strategic-agreements-to-advance-innovative-medicines-across-oncology-hematology-and-immunology.md 2026-05-12 https://biopharmsignal.com/news/MGNX/macrogenics-to-sell-gmp-manufacturing-operations-to-bora-pharmaceuticals.md 2026-05-11 https://biopharmsignal.com/news/BMEA/biomea-fusion-reports-first-quarter-2026-financial-results-and-corporate-highlights.md 2026-05-11 https://biopharmsignal.com/news/TNXP/tonix-pharmaceuticals-reports-first-quarter-2026-financial-results-and-operational-highlights.md 2026-05-11 https://biopharmsignal.com/news/CLLS/cellectis-reports-financial-results-for-the-first-quarter-2026.md 2026-05-11 https://biopharmsignal.com/news/EHC/encompass-health-announces-plans-to-build-a-50-bed-inpatient-rehabilitation-hospital-in-post-falls-idaho.md 2026-05-11 https://biopharmsignal.com/news/SCYX/scynexis-reports-first-quarter-2026-financial-results-and-provides-corporate-update.md 2026-05-11 https://biopharmsignal.com/news/SIBN/si-bone-inc-reports-financial-results-for-the-first-quarter-2026-and-raises-2026-guidance.md 2026-05-11 https://biopharmsignal.com/news/OCS/oculis-reports-q1-2026-financial-results-and-provides-company-update.md 2026-05-11 https://biopharmsignal.com/news/ROIV/roivant-to-report-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-march-31-2026-and-provide-business-update-on-wednesday-may-20-2026.md 2026-05-11 https://biopharmsignal.com/news/CVRX/cvrx-reports-first-quarter-2026-financial-and-operating-results.md 2026-05-11 https://biopharmsignal.com/news/SANA/sana-biotechnology-reports-first-quarter-2026-financial-results-and-business-updates.md 2026-05-11 https://biopharmsignal.com/news/PLRX/pliant-therapeutics-provides-corporate-update-and-reports-first-quarter-2026-financial-results.md 2026-05-11 https://biopharmsignal.com/news/CHRS/coherus-oncology-reports-first-quarter-2026-financial-results-and-provides-business-update.md 2026-05-11 https://biopharmsignal.com/news/OM/outset-medical-to-present-at-rbc-global-healthcare-conference.md 2026-05-11 https://biopharmsignal.com/news/IMVT/immunovant-to-report-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-march-31-2026-and-provide-business-update-on-wednesday-may-20-2026.md 2026-05-11 https://biopharmsignal.com/news/LENZ/lenz-therapeutics-reports-first-quarter-2026-financial-results-and-recent-corporate-highlights.md 2026-05-11 https://biopharmsignal.com/news/ERAS/erasca-reports-first-quarter-2026-business-updates-and-financial-results.md 2026-05-11 https://biopharmsignal.com/news/ENTA/enanta-pharmaceuticals-reports-financial-results-for-its-fiscal-second-quarter-ended-march-31-2026.md 2026-05-11 https://biopharmsignal.com/news/ANTX/an2-therapeutics-reports-first-quarter-2026-financial-results-and-recent-business-and-scientific-highlights.md 2026-05-11 https://biopharmsignal.com/news/ATYR/atyr-pharma-provides-regulatory-and-clinical-update-for-efzofitimod-in-pulmonary-sarcoidosis-following-fda-type-c-meeting.md 2026-05-11 https://biopharmsignal.com/news/GNFT/genfit-annual-combined-general-meeting-of-june-15-2026-availability-of-preparatory-documents.md 2026-05-11 https://biopharmsignal.com/news/PGNY/progyny-inc-to-present-at-bofa-securities-2026-health-care-conference.md 2026-05-11 https://biopharmsignal.com/news/ANAB/anaptys-appoints-chris-murphy-as-chief-financial-officer-and-owen-hughes-to-board-of-directors.md 2026-05-11 https://biopharmsignal.com/news/NAMS/newamsterdam-pharma-to-participate-at-upcoming-investor-conferences-in-may.md 2026-05-11 https://biopharmsignal.com/news/BEAT/heartbeam-initiates-pilot-study-of-first-on-demand-12-lead-ecg-patch-to-detect-ischemia-outside-the-clinic.md 2026-05-11 https://biopharmsignal.com/news/ABEO/abeona-therapeuticsr-announces-activation-of-children-s-hospital-of-philadelphia-as-a-new-qualified-treatment-center-for-zevaskynr.md 2026-05-11 https://biopharmsignal.com/news/FATE/fate-therapeutics-showcases-ft819-clinical-activity-in-sle-without-the-use-of-conditioning-chemotherapy-at-the-2026-asgct-annual-meeting.md 2026-05-11 https://biopharmsignal.com/news/CLRB/cellectar-biosciences-to-report-first-quarter-financial-results-and-host-a-conference-call-on-thursday-may-14-2026.md 2026-05-11 https://biopharmsignal.com/news/ASMB/assembly-biosciences-to-present-at-the-bofa-securities-2026-global-health-care-conference.md 2026-05-11 https://biopharmsignal.com/news/INBX/inhibrx-reports-interim-phase-2-data-for-inbrx-106-in-first-line-hnscc-initial-results-demonstrate-potential-costimulatory-benefit-over-pd-1-monotherapy.md 2026-05-11 https://biopharmsignal.com/news/CRL/charles-river-accelerates-digital-pathology-with-ai-powered-end-to-end-workflow.md 2026-05-11 https://biopharmsignal.com/news/XGN/exagen-inc-reports-first-quarter-2026-results.md 2026-05-11 https://biopharmsignal.com/news/GSK/gsk-enters-exclusive-collaboration-with-sbp-group-a-market-leader-in-hepatology-in-china-to-accelerate-bepirovirsen-at-launch.md 2026-05-11 https://biopharmsignal.com/news/DYN/dyne-therapeutics-reports-first-quarter-2026-financial-results-and-recent-business-highlights.md 2026-05-11 https://biopharmsignal.com/news/NTLA/intellia-therapeutics-announces-first-quarter-2026-financial-results-and-business-updates.md 2026-05-11 https://biopharmsignal.com/news/ERAS/erasca-announces-clinical-trial-collaboration-and-supply-agreement-with-merck-to-evaluate-eras-0015-in-combination-with-keytrudar-pembrolizumab.md 2026-05-11 https://biopharmsignal.com/news/LQDA/liquidia-corporation-reports-first-quarter-2026-financial-results.md 2026-05-11 https://biopharmsignal.com/news/CERT/certara-reports-first-quarter-2026-financial-results.md 2026-05-11 https://biopharmsignal.com/news/IPHA/number-of-shares-and-voting-rights-of-innate-pharma-as-of-april-16-2026.md 2026-05-11 https://biopharmsignal.com/news/MLTX/moonlake-immunotherapeutics-announces-positive-outcome-from-its-final-pre-bla-meeting-with-the-u-s-fda-and-reports-first-quarter-2026-financial-results.md 2026-05-10 https://biopharmsignal.com/news/ARQT/arcutis-biotherapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4.md 2026-05-08 https://biopharmsignal.com/news/CCEL/cryo-cell-receives-acceptance-of-compliance-plan-from-nyse-american.md 2026-05-08 https://biopharmsignal.com/news/INBX/inhibrx-to-host-webcast-presentation-to-provide-clinical-update-on-inbrx-106-hexagon-study-in-first-line-hnscc.md 2026-05-08 https://biopharmsignal.com/news/EMBC/embecta-to-participate-at-the-2026-bofa-securities-global-health-care-conference.md 2026-05-08 https://biopharmsignal.com/news/JAGX/jaguar-health-regains-compliance-with-nasdaq-s-publicly-held-shares-requirement-and-receives-additional-extension-until-may-18-2026-to-demonstrate-compliance-with-nasdaq-s-bid-price-rule.md 2026-05-08 https://biopharmsignal.com/news/BIAF/bioaffinity-technologies-reports-first-quarter-2026-results-and-expanding-adoption-and-clinical-usage-of-cypathr-lung.md 2026-05-08 https://biopharmsignal.com/news/IART/integra-lifesciences-to-present-at-the-bofa-securities-2026-health-care-conference.md 2026-05-08 https://biopharmsignal.com/news/ALXO/alx-oncology-reports-first-quarter-2026-financial-results-and-provides-corporate-update.md 2026-05-08 https://biopharmsignal.com/news/MDXG/mimedx-announces-launch-of-g4dermr-plus.md 2026-05-08 https://biopharmsignal.com/news/HUMA/humacyte-to-announce-2026-first-quarter-financial-results-and-provide-business-update-on-may-13-2026.md 2026-05-08 https://biopharmsignal.com/news/ENSC/ensysce-biosciences-ceo-presents-at-inaugural-clinical-pain-symposium-in-amsterdam.md 2026-05-08 https://biopharmsignal.com/news/PSTV/plus-therapeutics-announces-oral-presentation-highlighting-reyobiqtm-clinical-and-translational-data-demonstrating-favorable-safety-survival-and-emerging-immunomodulation-in-leptomeningeal-metastases.md 2026-05-08 https://biopharmsignal.com/news/SNGX/soligenix-announces-recent-updates-and-first-quarter-2026-financial-results.md 2026-05-08 https://biopharmsignal.com/news/IBIO/ibio-appoints-distinguished-biotech-leader-elizabeth-stoner-to-its-board-of-directors.md 2026-05-08 https://biopharmsignal.com/news/TMCI/treace-medical-concepts-reports-first-quarter-2026-financial-results.md 2026-05-08 https://biopharmsignal.com/news/PLSE/pulse-biosciences-to-present-at-the-bofa-securities-2026-healthcare-conference.md 2026-05-08 https://biopharmsignal.com/news/HLF/herbalife-and-cristiano-ronaldo-bring-performance-nutrition-to-everyday-routines-with-fuel-like-ronaldo-campaign.md 2026-05-08 https://biopharmsignal.com/news/REGN/regeneron-named-to-dow-jones-best-in-class-world-index-for-global-responsibility-leadership-for-seven-consecutive-years.md 2026-05-08 https://biopharmsignal.com/news/KPRX/kiora-pharmaceuticals-reports-first-quarter-2026-financial-results-and-provides-corporate-update.md 2026-05-08 https://biopharmsignal.com/news/BMY/bristol-myers-squibb-receives-european-commission-approval-of-sotyktu-deucravacitinib-for-the-treatment-of-active-psoriatic-arthritis-in-adults.md 2026-05-08 https://biopharmsignal.com/news/MTLS/materialise-rapporteert-resultaten-eerste-kwartaal-2026.md 2026-05-08 https://biopharmsignal.com/news/LFST/lifestance-health-group-announces-pricing-of-secondary-public-offering.md 2026-05-08 https://biopharmsignal.com/news/CAPR/capricor-therapeutics-takes-legal-action-to-protect-patient-access-to-deramiocel-for-duchenne-muscular-dystrophy.md 2026-05-07 https://biopharmsignal.com/news/INAB/in8bio-reports-first-quarter-2026-financial-results-and-recent-business-highlights.md 2026-05-07 https://biopharmsignal.com/news/NKTR/nektar-therapeutics-reports-first-quarter-2026-financial-results.md 2026-05-07 https://biopharmsignal.com/news/CTMX/cytomx-therapeutics-announces-q1-2026-financial-results-and-provides-business-update.md 2026-05-07 https://biopharmsignal.com/news/CCRN/cross-country-healthcare-announces-first-quarter-2026-financial-results.md 2026-05-07 https://biopharmsignal.com/news/ALGS/aligos-therapeutics-reports-recent-business-progress-and-first-quarter-2026-financial-results.md 2026-05-07 https://biopharmsignal.com/news/CRBU/caribou-biosciences-reports-first-quarter-2026-financial-results-and-provides-business-update.md 2026-05-07 https://biopharmsignal.com/news/GPCR/structure-therapeutics-reports-first-quarter-2026-financial-results-and-recent-highlights.md 2026-05-07 https://biopharmsignal.com/news/ABSI/absci-reports-business-updates-and-first-quarter-2026-financial-and-operating-results.md 2026-05-07 https://biopharmsignal.com/news/ORGO/organogenesis-holdings-inc-reports-first-quarter-2026-financial-results.md 2026-05-07 https://biopharmsignal.com/news/INTS/intensity-therapeutics-reports-first-quarter-2026-financial-results-and-provides-corporate-update.md 2026-05-07 https://biopharmsignal.com/news/AORT/artivion-reports-first-quarter-2026-financial-results-and-announces-exercise-of-option-to-acquire-endospan.md 2026-05-07 https://biopharmsignal.com/news/ELVN/enliven-therapeutics-reports-first-quarter-financial-results-and-provides-a-business-update.md 2026-05-07 https://biopharmsignal.com/news/EXEL/exelixis-to-webcast-fireside-chats-as-part-of-upcoming-investor-conferences-in-may.md 2026-05-07 https://biopharmsignal.com/news/SYK/stryker-completes-acquisition-of-amplitude-vascular-systems-to-add-next-generation-ivl-technology-to-peripheral-vascular-portfolio.md 2026-05-07 https://biopharmsignal.com/news/LPCN/lipocine-announces-financial-results-for-the-first-quarter-ended-march-31-2026.md 2026-05-07 https://biopharmsignal.com/news/INGN/inogen-announces-first-quarter-2026-financial-results.md 2026-05-07 https://biopharmsignal.com/news/OM/outset-medical-reports-first-quarter-results.md 2026-05-07 https://biopharmsignal.com/news/PGNY/progyny-inc-announces-first-quarter-2026-results.md 2026-05-07 https://biopharmsignal.com/news/ANNX/annexon-reports-first-quarter-2026-financial-results-portfolio-progress-and-key-anticipated-milestones.md 2026-05-07 https://biopharmsignal.com/news/XENE/xenon-reports-q1-2026-financial-results-and-provides-business-update.md 2026-05-07 https://biopharmsignal.com/news/AMRX/amneal-reports-first-quarter-2026-financial-results.md 2026-05-07 https://biopharmsignal.com/news/PTCT/ptc-therapeutics-provides-corporate-update-and-reports-first-quarter-2026-financial-results.md 2026-05-07 https://biopharmsignal.com/news/BJDX/bluejay-diagnostics-provides-first-quarter-2026-corporate-update.md 2026-05-07 https://biopharmsignal.com/news/CRVS/corvus-pharmaceuticals-provides-business-update-and-reports-first-quarter-2026-financial-results.md 2026-05-07 https://biopharmsignal.com/news/PSNL/personalis-reports-first-quarter-results-and-recent-highlights.md 2026-05-07 https://biopharmsignal.com/news/ANTX/an2-therapeutics-to-participate-in-2026-stifel-virtual-targeted-oncology-forum.md 2026-05-07 https://biopharmsignal.com/news/ARWR/arrowhead-pharmaceuticals-reports-fiscal-2026-second-quarter-results.md 2026-05-07 https://biopharmsignal.com/news/ASMB/assembly-biosciences-reports-first-quarter-2026-financial-results-and-recent-highlights.md 2026-05-07 https://biopharmsignal.com/news/RCKT/rocket-pharmaceuticals-reports-first-quarter-2026-financial-results-and-highlights-recent-progress.md 2026-05-07 https://biopharmsignal.com/news/EHC/encompass-health-declares-dividend-on-common-stock.md 2026-05-07 https://biopharmsignal.com/news/BEAT/heartbeam-expands-commercial-presence-across-four-key-u-s-markets-with-addition-of-premier-concierge-practice.md 2026-05-07 https://biopharmsignal.com/news/TBPH/theravance-biopharma-inc-reports-first-quarter-2026-financial-results-and-provides-corporate-update.md 2026-05-07 https://biopharmsignal.com/news/VIRI/dogwood-therapeutics-to-report-first-quarter-2026-financial-results-on-thursday-may-14-2026.md 2026-05-07 https://biopharmsignal.com/news/OGEN/oragenics-signs-letter-of-intent-to-license-cardiodialysistm-technology-from-sigyn-therapeutics-to-target-tbi-induced-systemic-inflammation.md 2026-05-07 https://biopharmsignal.com/news/PRME/prime-medicine-reports-first-quarter-2026-financial-results-and-provides-business-updates.md 2026-05-07 https://biopharmsignal.com/news/ALXO/alx-oncology-s-evorpacept-in-combination-with-zanidatamab-generates-promising-durable-response-in-patients-with-advanced-her2-positive-breast-cancer-and-high-cd47-expression.md 2026-05-07 https://biopharmsignal.com/news/SYK/stryker-declares-an-0-88-per-share-quarterly-dividend-6211bc27.md 2026-05-07 https://biopharmsignal.com/news/PRAX/praxis-precision-medicines-provides-corporate-update-and-reports-first-quarter-2026-financial-results.md 2026-05-07 https://biopharmsignal.com/news/DCTH/delcath-systems-reports-first-quarter-2026-results-and-business-highlights.md 2026-05-07 https://biopharmsignal.com/news/XTNT/xtant-medical-to-announce-first-quarter-2026-financial-results-on-may-13-2026.md 2026-05-07 https://biopharmsignal.com/news/URGN/urogen-pharma-to-present-at-upcoming-investor-conferences.md 2026-05-07 https://biopharmsignal.com/news/BDTX/black-diamond-therapeutics-reports-first-quarter-2026-financial-results-and-provides-corporate-update.md 2026-05-07 https://biopharmsignal.com/news/PSTV/plus-therapeutics-receives-medicare-enrollment-approval-for-cnside-diagnostic.md 2026-05-07 https://biopharmsignal.com/news/HRMY/harmony-biosciences-reports-q1-financial-results-and-confirms-2026-net-revenue-guidance-of-over-1-billion-reinforces-2026-strategic-priorities.md 2026-05-07 https://biopharmsignal.com/news/ASND/ascendis-pharma-reports-first-quarter-2026-financial-results.md 2026-05-07 https://biopharmsignal.com/news/IBRX/immunitybio-reports-record-q1-2026-results-net-product-revenue-increased-nearly-2-7x-year-over-year-to-44-million-in-q1-2026-expanding-on-the-2025-full-year-700-year-over-year-revenue-growth-cash-and-marketable-securities-total-381-million.md 2026-05-07 https://biopharmsignal.com/news/ZURA/zura-bio-reports-first-quarter-2026-financial-results-and-recent-corporate-updates.md 2026-05-07 https://biopharmsignal.com/news/KPTI/karyopharm-to-report-first-quarter-2026-financial-results-on-may-14-2026.md 2026-05-07 https://biopharmsignal.com/news/USNA/usana-s-people-first-culture-earns-spot-on-usa-today-top-workplaces-list.md 2026-05-07 https://biopharmsignal.com/news/IRWD/ironwood-pharmaceuticals-reports-strong-first-quarter-2026-results-with-97-year-over-year-linzess-u-s-net-sales-growth-maintains-full-year-2026-financial-guidance.md 2026-05-07 https://biopharmsignal.com/news/IOVA/iovance-biotherapeutics-highlights-positive-first-quarter-2026-results-business-achievements-and-corporate-updates.md 2026-05-07 https://biopharmsignal.com/news/FHTX/foghorn-therapeutics-provides-first-quarter-2026-financial-and-corporate-update.md 2026-05-07 https://biopharmsignal.com/news/NAMS/newamsterdam-pharma-provides-corporate-update-and-reports-first-quarter-financial-results.md 2026-05-07 https://biopharmsignal.com/news/BEAM/beam-therapeutics-reports-first-quarter-2026-financial-results-and-recent-business-updates.md 2026-05-07 https://biopharmsignal.com/news/DCTH/delcath-systems-announces-presentation-of-new-data-on-percutaneous-hepatic-perfusion-with-melphalan-in-liver-dominant-metastatic-breast-cancer-at-esmo-breast-cancer-2026.md 2026-05-07 https://biopharmsignal.com/news/XERS/xeris-biopharma-reports-first-quarter-2026-financial-results.md 2026-05-07 https://biopharmsignal.com/news/SRRK/scholar-rock-reports-first-quarter-2026-financial-results-and-recent-business-highlights.md 2026-05-07 https://biopharmsignal.com/news/INSM/insmed-reports-first-quarter-2026-financial-results-and-provides-business-update.md 2026-05-07 https://biopharmsignal.com/news/CRL/charles-river-laboratories-announces-first-quarter-2026-results.md 2026-05-07 https://biopharmsignal.com/news/FENC/fennec-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-may-14-2026.md 2026-05-07 https://biopharmsignal.com/news/BDX/bd-appoints-vitor-roque-chief-financial-officer.md 2026-05-07 https://biopharmsignal.com/news/BDX/bd-reports-second-quarter-fiscal-2026-financial-results.md 2026-05-07 https://biopharmsignal.com/news/CBIO/gyre-therapeutics-reports-first-quarter-2026-results-and-provides-business-update.md 2026-05-07 https://biopharmsignal.com/news/LFST/lifestance-reports-first-quarter-2026-results.md 2026-05-07 https://biopharmsignal.com/news/PRVA/privia-health-reports-first-quarter-2026-financial-results.md 2026-05-07 https://biopharmsignal.com/news/OCS/oculis-announces-agreement-with-fda-on-a-special-protocol-assessment-spa-for-optic-neuritis-registrational-trial.md 2026-05-07 https://biopharmsignal.com/news/MTLS/materialise-reports-first-quarter-2026-results.md 2026-05-07 https://biopharmsignal.com/news/USNA/usana-hosts-inspiring-spa-and-wellness-retreat-to-empower-women-across-asia-pacific.md 2026-05-07 https://biopharmsignal.com/news/SCYX/scynexis-announces-inducement-awards-under-nasdaq-listing-rule-5635-c-4.md 2026-05-07 https://biopharmsignal.com/news/RVMD/revolution-medicines-announces-publication-in-new-england-journal-of-medicine-of-phase-1-2-clinical-data-on-daraxonrasib-in-pancreatic-cancer.md 2026-05-06 https://biopharmsignal.com/news/CCRN/cross-country-healthcare-to-be-acquired-by-knox-lane-in-all-cash-transaction-valued-at-437-million.md 2026-05-06 https://biopharmsignal.com/news/SUPN/supernus-pharmaceuticals-to-participate-in-the-bank-of-america-2026-health-care-conference.md 2026-05-06 https://biopharmsignal.com/news/BNGO/bionano-announces-leadership-transition.md 2026-05-06 https://biopharmsignal.com/news/INSM/insmed-and-ty-pennington-team-up-to-drive-awareness-and-proper-diagnosis-of-bronchiectasis.md 2026-05-06 https://biopharmsignal.com/news/DMAC/diamedica-therapeutics-reports-first-quarter-2026-financial-results-and-provides-business-highlights.md 2026-05-06 https://biopharmsignal.com/news/CNTX/context-therapeutics-reports-first-quarter-2026-operating-and-financial-results.md 2026-05-06 https://biopharmsignal.com/news/RPID/rapid-micro-biosystems-to-announce-first-quarter-2026-financial-results-on-may-13-2026.md 2026-05-06 https://biopharmsignal.com/news/PRI/primerica-reports-first-quarter-2026-results.md 2026-05-06 https://biopharmsignal.com/news/HLF/herbalife-reports-first-quarter-2026-net-sales-growth-and-adjusted-ebitda-above-guidance-raises-full-year-2026-constant-currency-net-sales-and-adjusted-ebitda-guidance-midpoints.md 2026-05-06 https://biopharmsignal.com/news/OSUR/orasure-announces-first-quarter-2026-financial-results.md 2026-05-06 https://biopharmsignal.com/news/TNYA/tenaya-therapeutics-reports-first-quarter-2026-financial-results-and-provides-business-update.md 2026-05-06 https://biopharmsignal.com/news/ADMA/adma-biologics-reports-first-quarter-2026-financial-results-and-provides-business-update.md 2026-05-06 https://biopharmsignal.com/news/TARS/tarsus-reports-first-quarter-2026-financial-results-and-recent-business-achievements.md 2026-05-06 https://biopharmsignal.com/news/LYEL/lyell-immunopharma-reports-business-highlights-and-financial-results-for-the-first-quarter-2026.md 2026-05-06 https://biopharmsignal.com/news/CLOV/clover-health-reports-first-quarter-2026-results.md 2026-05-06 https://biopharmsignal.com/news/RXST/rxsight-inc-reports-first-quarter-2026-results-and-reiterates-full-year-sales-outlook.md 2026-05-06 https://biopharmsignal.com/news/SGHT/sight-sciences-reports-first-quarter-2026-financial-results-and-raises-full-year-2026-revenue-guidance.md 2026-05-06 https://biopharmsignal.com/news/PCVX/vaxcyte-reports-first-quarter-2026-financial-results-and-provides-business-update.md 2026-05-06 https://biopharmsignal.com/news/PNTG/pennant-reports-first-quarter-2026-results.md 2026-05-06 https://biopharmsignal.com/news/BTMD/biote-reports-first-quarter-2026-financial-results.md 2026-05-06 https://biopharmsignal.com/news/MLYS/mineralys-therapeutics-reports-first-quarter-2026-financial-results-and-provides-corporate-update.md 2026-05-06 https://biopharmsignal.com/news/INVA/innoviva-reports-first-quarter-2026-financial-results-highlights-recent-company-progress.md 2026-05-06 https://biopharmsignal.com/news/GDRX/goodrx-reports-first-quarter-2026-results.md 2026-05-06 https://biopharmsignal.com/news/SRPT/sarepta-therapeutics-announces-first-quarter-2026-financial-results-and-recent-corporate-developments.md 2026-05-06 https://biopharmsignal.com/news/LFVN/lifevantage-announces-financial-results-for-the-third-quarter-of-fiscal-2026.md 2026-05-06 https://biopharmsignal.com/news/HYPR/hyperfine-inc-to-participate-in-upcoming-2026-jefferies-global-healthcare-conference.md 2026-05-06 https://biopharmsignal.com/news/SERA/sera-prognostics-reports-first-quarter-2026-financial-results.md 2026-05-06 https://biopharmsignal.com/news/RVMD/revolution-medicines-reports-first-quarter-2026-financial-results-and-update-on-corporate-progress.md 2026-05-06 https://biopharmsignal.com/news/ASND/new-2-year-data-from-pivotal-approach-trial-of-transconr-cnp-navepegritide-show-pronounced-gains-in-growth-outcomes-in-children-with-achondroplasia-aged-5-years.md 2026-05-06 https://biopharmsignal.com/news/AXON/axon-reports-q1-2026-revenue-of-807-million-up-34-year-over-year.md 2026-05-06 https://biopharmsignal.com/news/FBIO/journey-medical-corporation-to-announce-first-quarter-2026-financial-results-on-may-13-2026.md 2026-05-06 https://biopharmsignal.com/news/MNKD/mannkind-reports-first-quarter-2026-financial-results-and-provides-business-update.md 2026-05-06 https://biopharmsignal.com/news/MDRX/veradigm-launches-health-network-architecture-to-level-the-playing-field-for-independent-practices.md 2026-05-06 https://biopharmsignal.com/news/ARQT/arcutis-announces-first-quarter-2026-financial-results-and-provides-business-update.md 2026-05-06 https://biopharmsignal.com/news/NXGL/nexgel-appoints-brian-kieser-and-kevin-harris-from-new-strategic-partner-sequence-lifesciencetm-to-board-of-directors.md 2026-05-06 https://biopharmsignal.com/news/JAGX/jaguar-health-announces-preliminary-discussion-with-fda-to-evaluate-breakthrough-therapy-designation-for-crofelemer-for-treatment-of-microvillus-inclusion-disease-mvid.md 2026-05-06 https://biopharmsignal.com/news/PLRX/pliant-therapeutics-to-participate-in-the-rbc-capital-markets-global-healthcare-conference.md 2026-05-06 https://biopharmsignal.com/news/ICCM/icecure-medical-to-report-first-quarter-2026-financial-and-operating-results-on-may-12-2026.md 2026-05-06 https://biopharmsignal.com/news/LQDA/liquidia-corporation-to-participate-in-upcoming-investor-conferences.md 2026-05-06 https://biopharmsignal.com/news/ALLO/allogene-therapeutics-to-report-first-quarter-financial-results-and-provide-business-update.md 2026-05-06 https://biopharmsignal.com/news/CRSP/crispr-therapeutics-to-present-at-the-bank-of-america-securities-2026-global-healthcare-conference.md 2026-05-06 https://biopharmsignal.com/news/NBIX/neurocrine-biosciences-announces-publication-of-expert-recommendations-for-glucocorticoid-dose-reduction-after-initiating-crenessityr-crinecerfont-for-the-treatment-of-classic-congenital-adrenal-hyperplasia.md 2026-05-06 https://biopharmsignal.com/news/VERU/veru-to-report-fiscal-2026-second-quarter-financial-results-on-may-13th.md 2026-05-06 https://biopharmsignal.com/news/APVO/aptevo-reports-87-clinical-benefit-and-81-remission-in-31-evaluable-frontline-aml-patients-through-cohort-5-substantially-outperforming-benchmark-rainier-on-track-for-2026-completion-and-phase-2-dose-selection.md 2026-05-06 https://biopharmsignal.com/news/MDRX/veradigm-survey-independent-practices-rely-on-technology-to-stay-independent.md 2026-05-06 https://biopharmsignal.com/news/TSHA/taysha-gene-therapies-reports-first-quarter-2026-financial-results-and-provides-corporate-update.md 2026-05-06 https://biopharmsignal.com/news/INAB/in8bio-to-showcase-next-generation-t-cell-engager-platform-and-new-clinical-data-at-upcoming-randd-day-and-medical-conferences.md 2026-05-06 https://biopharmsignal.com/news/ANNX/annexon-to-present-at-the-bank-of-america-securities-health-care-conference-2026.md 2026-05-06 https://biopharmsignal.com/news/GSK/gsk-presents-latest-respiratory-research-to-advance-patient-care-at-ats-2026.md 2026-05-06 https://biopharmsignal.com/news/XTNT/xtant-medical-expands-triviumtm-portfolio-with-the-commercial-launch-of-triviumtm-shaped.md 2026-05-06 https://biopharmsignal.com/news/URGN/urogen-reports-zusduritm-revenue-more-than-doubled-quarter-over-quarter-and-provides-first-quarter-2026-financial-results-and-highlights.md 2026-05-06 https://biopharmsignal.com/news/ERAS/erasca-to-present-at-the-bank-of-america-securities-health-care-conference.md 2026-05-06 https://biopharmsignal.com/news/PYPD/polypid-to-report-first-quarter-2026-financial-results-and-operational-highlights-on-may-13-2026.md 2026-05-06 https://biopharmsignal.com/news/MIST/milestone-pharmaceuticals-to-announce-first-quarter-2026-financial-results-on-may-13-2026.md 2026-05-06 https://biopharmsignal.com/news/KURA/kura-oncology-to-participate-in-bank-of-america-securities-healthcare-conference.md 2026-05-06 https://biopharmsignal.com/news/AQST/aquestive-therapeutics-to-report-first-quarter-2026-financial-results-and-recent-business-highlights-on-may-13-and-host-conference-call-on-may-14-at-8-00-a-m-et.md 2026-05-06 https://biopharmsignal.com/news/TGTX/tg-therapeutics-reports-first-quarter-2026-financial-results-and-raises-briumvi-revenue-guidance.md 2026-05-06 https://biopharmsignal.com/news/TPST/tempest-presents-clinical-update-at-isct-2026-annual-meeting.md 2026-05-06 https://biopharmsignal.com/news/BCRX/biocryst-reports-first-quarter-2026-financial-results-and-provides-business-update.md 2026-05-06 https://biopharmsignal.com/news/IMCR/immunocore-reports-first-quarter-financial-results-and-provides-a-business-update.md 2026-05-06 https://biopharmsignal.com/news/RLMD/relmada-therapeutics-to-report-first-quarter-2026-financial-results-on-tuesday-may-12-2026.md 2026-05-06 https://biopharmsignal.com/news/TNXP/tonix-pharmaceuticals-secures-commercial-payer-coverage-for-tonmyar-providing-access-for-35-million-u-s-patients.md 2026-05-06 https://biopharmsignal.com/news/BMY/bristol-myers-squibb-to-participate-in-the-bank-of-america-securities-healthcare-conference-2026.md 2026-05-06 https://biopharmsignal.com/news/MNKD/mannkind-announces-ralinepag-dry-powder-inhalation-dpi-program-to-be-pursued-for-pulmonary-hypertension-and-fibrotic-lung-diseases.md 2026-05-06 https://biopharmsignal.com/news/PRGO/perrigo-reports-first-quarter-2026-financial-results-from-continuing-operations.md 2026-05-06 https://biopharmsignal.com/news/BRKR/bruker-reports-first-quarter-2026-financial-results.md 2026-05-06 https://biopharmsignal.com/news/TECH/bio-techne-declares-dividend.md 2026-05-06 https://biopharmsignal.com/news/TECH/bio-techne-releases-third-quarter-fiscal-2026-results.md 2026-05-06 https://biopharmsignal.com/news/YOU/clear-announces-first-quarter-2026-financial-results.md 2026-05-06 https://biopharmsignal.com/news/AVTX/avalo-therapeutics-announces-pricing-of-375-million-public-offering.md 2026-05-06 https://biopharmsignal.com/news/BMEA/biomea-fusion-announces-poster-presentations-of-icovamenib-at-the-american-diabetes-association-ada-86th-scientific-sessions.md 2026-05-05 https://biopharmsignal.com/news/MLYS/mineralys-therapeutics-reports-inducement-awards-under-nasdaq-listing-rule-5635-c-4.md 2026-05-05 https://biopharmsignal.com/news/CRIS/curis-to-report-first-quarter-2026-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-12-2026.md 2026-05-05 https://biopharmsignal.com/news/AZTA/azenta-reports-second-quarter-results-for-fiscal-2026-ended-march-31-2026-updates-full-year-fiscal-2026-guidance-and-extends-long-range-plan-to-2029.md 2026-05-05 https://biopharmsignal.com/news/EHC/encompass-health-rehabilitation-hospital-of-concordville-now-open-in-pennsylvania.md 2026-05-05 https://biopharmsignal.com/news/PCRX/pacira-biosciences-mails-letter-to-stockholders.md 2026-05-05 https://biopharmsignal.com/news/USNA/usana-health-sciences-reports-first-quarter-2026-results.md 2026-05-05 https://biopharmsignal.com/news/ADPT/adaptive-biotechnologies-reports-first-quarter-2026-financial-results.md 2026-05-05 https://biopharmsignal.com/news/CRBU/caribou-biosciences-to-participate-in-the-bofa-securities-2026-health-care-conference.md 2026-05-05 https://biopharmsignal.com/news/SANA/sana-biotechnology-to-present-at-the-bofa-securities-2026-healthcare-conference.md 2026-05-05 https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-announces-upcoming-presentation-of-phase-2-data-highlighting-the-potential-abscopal-effects-of-vp-315-in-the-treatment-of-basal-cell-carcinoma-at-the-2026-society-for-investigative-dermatology-sid-annual-meeting.md 2026-05-05 https://biopharmsignal.com/news/EXEL/exelixis-announces-first-quarter-2026-financial-results-and-provides-corporate-update.md 2026-05-05 https://biopharmsignal.com/news/SUPN/supernus-announces-first-quarter-2026-financial-results.md 2026-05-05 https://biopharmsignal.com/news/AVTX/avalo-therapeutics-announces-proposed-public-offering-of-common-stock-and-pre-funded-warrants.md 2026-05-05 https://biopharmsignal.com/news/IRIX/iridex-to-report-first-quarter-2026-financial-results-on-may-19-2026.md 2026-05-05 https://biopharmsignal.com/news/ATRC/atricure-reports-first-quarter-2026-financial-results.md 2026-05-05 https://biopharmsignal.com/news/NBIX/neurocrine-biosciences-reports-first-quarter-2026-financial-results.md 2026-05-05 https://biopharmsignal.com/news/AVTX/avalo-therapeutics-achieves-positive-topline-results-in-phase-2-lotus-trial-of-abdakibart-avtx-009-in-moderate-to-severe-hidradenitis-suppurativa.md 2026-05-05 https://biopharmsignal.com/news/PRAX/praxis-precision-medicines-inc-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4.md 2026-05-05 https://biopharmsignal.com/news/RIGL/rigel-reports-first-quarter-2026-financial-results.md 2026-05-05 https://biopharmsignal.com/news/SPRO/spero-therapeutics-to-report-first-quarter-2026-financial-results-and-provide-business-update-on-may-13-2026.md 2026-05-05 https://biopharmsignal.com/news/IPHA/innate-pharma-announces-conference-call-and-webcast-for-q1-2026-business-update.md 2026-05-05 https://biopharmsignal.com/news/NBIX/neurocrine-biosciences-to-present-at-the-bank-of-america-health-care-conference-2026.md 2026-05-05 https://biopharmsignal.com/news/SABS/sab-bio-to-host-first-quarter-2026-financial-results-conference-call-and-webcast-on-may-12-2026-08-30-am-et.md 2026-05-05 https://biopharmsignal.com/news/IRON/disc-medicine-reports-first-quarter-2026-financial-results-and-provides-business-update.md 2026-05-05 https://biopharmsignal.com/news/FATE/fate-therapeutics-selected-for-u-s-fda-chemistry-manufacturing-and-controls-development-and-readiness-pilot-program-to-support-manufacturing-readiness-of-ft819.md 2026-05-05 https://biopharmsignal.com/news/OGEN/oragenics-activates-second-site-in-phase-iia-clinical-trial-of-onp-002-for-concussion-and-mild-traumatic-brain-injury.md 2026-05-05 https://biopharmsignal.com/news/ICCM/icecure-showcases-prosenser-cryoablation-at-american-society-of-breast-surgeons-2026-annual-meeting-as-commercial-momentum-accelerates-in-the-u-s-market.md 2026-05-05 https://biopharmsignal.com/news/ACHV/achieve-life-sciences-to-announce-first-quarter-2026-financial-results-and-host-conference-call-and-webcast-on-may-12-2026.md 2026-05-05 https://biopharmsignal.com/news/NERV/minerva-neurosciences-provides-first-quarter-2026-financial-results-and-business-updates.md 2026-05-05 https://biopharmsignal.com/news/COGT/cogent-biosciences-reports-recent-business-highlights-and-first-quarter-2026-financial-results.md 2026-05-05 https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-to-report-first-quarter-2026-financial-results-and-provide-a-corporate-update-on-may-12-2026.md 2026-05-05 https://biopharmsignal.com/news/UNH/corbus-pharmaceuticals-to-host-in-person-and-virtual-kol-event-at-asco-2026.md 2026-05-05 https://biopharmsignal.com/news/BNGO/bionano-announces-a-56-increase-in-publications-describing-the-utility-of-ogm-in-rare-diseases-in-q1-2026-vs-q1-2025.md 2026-05-05 https://biopharmsignal.com/news/MLYS/mineralys-therapeutics-to-participate-in-the-bank-of-america-securities-health-care-conference.md 2026-05-05 https://biopharmsignal.com/news/TWST/twist-bioscience-corporation-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4.md 2026-05-05 https://biopharmsignal.com/news/ARWR/arrowhead-pharmaceuticals-licenses-clinical-mash-program-targeting-pnpla3-to-madrigal-pharmaceuticals.md 2026-05-05 https://biopharmsignal.com/news/LCTX/lineage-cell-therapeutics-to-report-first-quarter-2026-financial-results-and-provide-business-update-on-may-12-2026.md 2026-05-05 https://biopharmsignal.com/news/STIM/neuronetics-reports-first-quarter-2026-financial-and-operating-results.md 2026-05-05 https://biopharmsignal.com/news/SNSE/sensei-biotherapeutics-doses-first-patient-in-phase-1b-2-trial-of-piktor-in-hr-her2-advanced-breast-cancer.md 2026-05-05 https://biopharmsignal.com/news/KURA/kura-oncology-to-report-first-quarter-2026-financial-results.md 2026-05-05 https://biopharmsignal.com/news/NTLA/intellia-therapeutics-to-participate-in-upcoming-investor-conferences.md 2026-05-05 https://biopharmsignal.com/news/IBRX/immunitybio-to-present-new-comparative-data-scientific-advances-in-non-muscle-invasive-bladder-cancer-cis-and-an-update-on-bcg-naive-registrational-trial-at-american-urological-association-annual-meeting.md 2026-05-05 https://biopharmsignal.com/news/CLRB/cellectar-biosciences-reports-positive-12-month-follow-up-data-from-phase-2b-clover-wam-study-demonstrating-durable-responses-and-efficacy-of-iopofosine-i-131-in-r-r-waldenstroem-macroglobulinemia.md 2026-05-05 https://biopharmsignal.com/news/VKTX/viking-therapeutics-announces-two-poster-presentations-at-european-congress-on-obesity-eco-2026.md 2026-05-05 https://biopharmsignal.com/news/SHC/sotera-health-delivers-strong-first-quarter-2026-results-and-reaffirms-2026-outlook.md 2026-05-05 https://biopharmsignal.com/news/DTIL/precision-biosciences-reports-first-quarter-2026-financial-results-and-provides-business-update.md 2026-05-05 https://biopharmsignal.com/news/SHC/sotera-health-announces-leadership-transition.md 2026-05-05 https://biopharmsignal.com/news/AVIR/atea-pharmaceuticals-to-host-first-quarter-2026-financial-results-and-business-update-conference-call-on-may-12-2026.md 2026-05-05 https://biopharmsignal.com/news/BCRX/biocryst-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4.md 2026-05-05 https://biopharmsignal.com/news/ARVN/arvinas-to-report-first-quarter-2026-financial-results-on-may-12-2026.md 2026-05-05 https://biopharmsignal.com/news/REGN/dupixentr-dupilumab-demonstrates-improved-esophageal-function-in-eosinophilic-esophagitis-eoe-phase-4-trial.md 2026-05-05 https://biopharmsignal.com/news/CLRB/cellectar-biosciences-announces-oversubscribed-financing-up-to-140-million.md 2026-05-05 https://biopharmsignal.com/news/MCRB/seres-therapeutics-reports-first-quarter-2026-financial-results-and-provides-business-updates.md 2026-05-05 https://biopharmsignal.com/news/CCRN/cross-country-healthcare-and-florida-atlantic-university-s-christine-e-lynn-college-of-nursing-release-purpose-under-pressure-the-state-of-nursing-in-2026.md 2026-05-05 https://biopharmsignal.com/news/RLMD/relmada-therapeutics-to-present-ndv-01-abstracts-at-aua2026.md 2026-05-05 https://biopharmsignal.com/news/ALKS/alkermes-plc-reports-first-quarter-2026-financial-results.md 2026-05-05 https://biopharmsignal.com/news/BDX/bd-and-wellstar-advance-patient-care-and-safety-with-medication-management-powered-by-ai.md 2026-05-05 https://biopharmsignal.com/news/EMBC/embecta-corp-reports-second-quarter-fiscal-2026-financial-results.md 2026-05-05 https://biopharmsignal.com/news/EMBC/embecta-announces-quarterly-cash-dividend.md 2026-05-05 https://biopharmsignal.com/news/IART/integra-lifesciences-reports-first-quarter-2026-financial-results.md 2026-05-05 https://biopharmsignal.com/news/IART/integra-lifesciences-announces-leadership-transition.md 2026-05-05 https://biopharmsignal.com/news/IDYA/ideaya-biosciences-reports-first-quarter-2026-financial-results-and-provides-business-update.md 2026-05-05 https://biopharmsignal.com/news/MD/pediatrix-medical-group-reports-first-quarter-results.md 2026-05-05 https://biopharmsignal.com/news/OCS/latest-findings-from-dme-aware-delphi-study-presented-at-arvo-2026-annual-meeting.md 2026-05-05 https://biopharmsignal.com/news/FMS/fresenius-medical-care-delivers-strong-operating-income-growth-in-q1-2026-while-advancing-the-u-s-rollout-of-5008x-caresystems-at-speed.md 2026-05-05 https://biopharmsignal.com/news/ABSI/absci-announces-inducement-grant-under-nasdaq-listing-rule-5635-c-4.md 2026-05-05 https://biopharmsignal.com/news/PNTG/pennant-announces-first-quarter-2026-earnings-release-and-call.md 2026-05-04 https://biopharmsignal.com/news/TNGX/tango-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4.md 2026-05-04 https://biopharmsignal.com/news/CVRX/cvrx-announces-first-patient-enrollment-in-benefit-hf-a-landmark-heart-failure-trial-evaluating-barostim-in-significantly-expanded-population.md 2026-05-04 https://biopharmsignal.com/news/OLMA/olema-oncology-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4.md 2026-05-04 https://biopharmsignal.com/news/CLLS/cellectis-to-report-first-quarter-financial-results-on-may-11-2026.md 2026-05-04 https://biopharmsignal.com/news/HSTM/healthstream-announces-first-quarter-2026-results.md 2026-05-04 https://biopharmsignal.com/news/CRSP/crispr-therapeutics-provides-business-update-and-reports-first-quarter-2026-financial-results.md 2026-05-04 https://biopharmsignal.com/news/ANAB/anaptys-to-participate-at-the-h-c-wainwright-2nd-annual-royalty-company-virtual-conference.md 2026-05-04 https://biopharmsignal.com/news/ORIC/oricr-pharmaceuticals-reports-first-quarter-2026-financial-results-and-operational-updates.md 2026-05-04 https://biopharmsignal.com/news/CAPR/capricor-therapeutics-to-report-first-quarter-2026-financial-results-and-provide-recent-corporate-update-on-may-12.md 2026-05-04 https://biopharmsignal.com/news/ZURA/zura-bio-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4.md 2026-05-04 https://biopharmsignal.com/news/TCMD/tactile-systems-technology-inc-reports-first-quarter-2026-financial-results.md 2026-05-04 https://biopharmsignal.com/news/OPCH/option-care-health-to-participate-in-the-bank-of-america-health-care-conference.md 2026-05-04 https://biopharmsignal.com/news/PRAX/praxis-precision-medicines-to-report-first-quarter-2026-financial-results-on-thursday-may-7-2026-and-participate-in-upcoming-investor-conference.md 2026-05-04 https://biopharmsignal.com/news/CHRS/coherus-oncology-to-report-first-quarter-2026-financial-results-on-may-11-2026.md 2026-05-04 https://biopharmsignal.com/news/FATE/fate-therapeutics-announces-three-presentations-at-the-2026-asgct-annual-meeting-highlighting-off-the-shelf-car-t-cell-therapy-pipeline-for-cancer-and-autoimmune-diseases.md 2026-05-04 https://biopharmsignal.com/news/GYRE/gyre-therapeutics-completes-acquisition-of-cullgen-to-create-u-s-and-china-based-fully-integrated-biopharmaceutical-company.md 2026-05-04 https://biopharmsignal.com/news/NBIX/neurocrine-biosciences-announces-new-survey-results-showing-significant-burden-of-tardive-dyskinesia-on-employment.md 2026-05-04 https://biopharmsignal.com/news/JAGX/jaguar-health-expands-neonorm-franchise-with-introduction-of-neonorm-dog-for-companion-animal-gut-health.md 2026-05-04 https://biopharmsignal.com/news/ABEO/abeona-therapeuticsr-announces-date-of-first-quarter-financial-results.md 2026-05-04 https://biopharmsignal.com/news/FBIO/fortress-biotech-to-participate-in-the-h-c-wainwright-2nd-annual-royalty-company-virtual-conference.md 2026-05-04 https://biopharmsignal.com/news/LQDA/liquidia-corporation-to-report-first-quarter-2026-financial-results-on-may-11-2026.md 2026-05-04 https://biopharmsignal.com/news/CADL/candel-therapeutics-to-host-investor-conference-call-following-presentation-of-extended-data-from-phase-3-trial-of-aglatimagene-besadenovec-in-localized-prostate-cancer-at-the-american-urological-association-2026-annual-meeting.md 2026-05-04 https://biopharmsignal.com/news/LENZ/lenz-therapeutics-to-report-first-quarter-2026-financial-results-and-recent-corporate-highlights-on-may-11-2026-and-attend-upcoming-investor-conference.md 2026-05-04 https://biopharmsignal.com/news/BSX/boston-scientific-announces-participation-in-bernstein-s-42nd-annual-strategic-decisions-conference-and-conference-call-discussing-second-quarter-2026-results.md 2026-05-04 https://biopharmsignal.com/news/PTCT/ptc-therapeutics-to-participate-in-upcoming-investor-conferences.md 2026-05-04 https://biopharmsignal.com/news/LCTX/opregenr-3-year-results-in-patients-with-ga-presented-at-foundation-fighting-blindness-retinal-innovation-summit-2026.md 2026-05-04 https://biopharmsignal.com/news/MGNX/macrogenics-and-sagard-healthcare-partners-enter-into-expanded-zynyzr-royalty-purchase-agreement.md 2026-05-04 https://biopharmsignal.com/news/KURA/kura-oncology-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4.md 2026-05-04 https://biopharmsignal.com/news/ARWR/arrowhead-pharmaceuticals-to-participate-in-upcoming-may-2026-events.md 2026-05-04 https://biopharmsignal.com/news/NBIX/neurocrine-biosciences-announces-initiation-of-phase-1-clinical-study-evaluating-nbip-2118-a-corticotropin-releasing-factor-type-2-receptor-agonist.md 2026-05-04 https://biopharmsignal.com/news/TWST/twist-bioscience-expands-clonal-genes-offering-to-include-long-and-complex-sequences.md 2026-05-04 https://biopharmsignal.com/news/TWST/twist-bioscience-announces-fiscal-2026-second-quarter-financial-results.md 2026-05-04 https://biopharmsignal.com/news/IRWD/ironwood-survey-findings-at-ddw-2026-underscore-need-for-therapies-that-address-multiple-dimensions-of-total-parenteral-nutrition-tpn-burden-in-short-bowel-syndrome-sbs.md 2026-05-04 https://biopharmsignal.com/news/KTTA/pasithea-therapeutics-announces-appointment-of-kartik-krishnan-m-d-ph-d-as-chief-medical-officer.md 2026-05-04 https://biopharmsignal.com/news/ADMA/adma-biologics-announces-fda-approval-to-expand-the-label-for-ascenivtm-to-include-pediatric-immune-compromised-patients-two-years-of-age-and-older.md 2026-05-04 https://biopharmsignal.com/news/SEER/seer-announces-appointment-of-anthony-bazarko-as-chief-commercial-officer.md 2026-05-04 https://biopharmsignal.com/news/BCRX/biocryst-announces-european-licensing-agreement-with-irish-affiliate-of-neopharmed-gentili-for-navenibart-in-hereditary-angioedema.md 2026-05-04 https://biopharmsignal.com/news/MCRB/seres-therapeutics-presents-preclinical-data-at-digestive-disease-week-ddw-2026-supporting-ser-603-a-next-generation-cultivated-live-biotherapeutic-candidate-for-inflammatory-bowel-disease.md 2026-05-04 https://biopharmsignal.com/news/ENTA/enanta-pharmaceuticals-to-present-data-for-its-respiratory-syncytial-virus-and-stat6-inhibitor-programs-at-the-american-thoracic-society-international-conference-2026.md 2026-05-04 https://biopharmsignal.com/news/INSM/insmed-to-present-data-across-its-respiratory-portfolio-including-late-breaking-arikaycer-results-from-phase-3b-encore-study-at-the-american-thoracic-society-international-conference-2026.md 2026-05-04 https://biopharmsignal.com/news/TECH/bio-techne-to-present-at-the-bank-of-america-securities-2026-global-healthcare-conference.md 2026-05-04 https://biopharmsignal.com/news/PLSE/pulse-biosciences-reports-business-updates-and-first-quarter-2026-financial-results.md 2026-05-04 https://biopharmsignal.com/news/BMY/bristol-myers-squibb-launches-won-t-lose-media-campaign-ahead-of-fifa-world-cup-2026tm.md 2026-05-04 https://biopharmsignal.com/news/CABA/cabaletta-bio-announces-pricing-of-150-million-underwritten-offering.md 2026-05-04 https://biopharmsignal.com/news/PNTG/pennant-acquires-senior-living-communities-in-arizona-and-wisconsin.md 2026-05-01 https://biopharmsignal.com/news/NKTR/nektar-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4.md 2026-05-01 https://biopharmsignal.com/news/ORIC/oric-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4.md 2026-05-01 https://biopharmsignal.com/news/TSHA/taysha-gene-therapies-announces-inducement-grant-under-nasdaq-listing-rule-5635-c-4.md 2026-05-01 https://biopharmsignal.com/news/CADL/candel-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4.md 2026-05-01 https://biopharmsignal.com/news/NBIX/neurocrine-biosciences-presents-new-two-year-crenessityr-crinecerfont-data-demonstrating-durable-hormone-control-reduced-glucocorticoid-exposure-and-meaningful-clinical-improvements-in-pediatric-patients-with-classic-congenital-adrenal-hyperplasia.md 2026-05-01 https://biopharmsignal.com/news/FATE/fate-therapeutics-reports-new-employee-inducement-award-under-nasdaq-listing-rule-5635-c-4.md 2026-05-01 https://biopharmsignal.com/news/XENE/xenon-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4.md 2026-05-01 https://biopharmsignal.com/news/NTLA/intellia-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4.md 2026-05-01 https://biopharmsignal.com/news/ARVN/arvinas-announces-fda-approval-of-veppanu-vepdegestrant-for-the-treatment-of-esr1m-er-her2-advanced-breast-cancer.md 2026-05-01 https://biopharmsignal.com/news/RVMD/revolution-medicines-statement-on-fda-expanded-access-authorization-for-daraxonrasib-in-patients-with-previously-treated-metastatic-pancreatic-cancer.md 2026-05-01 https://biopharmsignal.com/news/PAVM/pavmed-to-hold-first-quarter-2026-business-update-conference-call-and-webcast-on-may-15-2026.md 2026-05-01 https://biopharmsignal.com/news/ABEO/abeona-therapeuticsr-announces-new-employee-inducement-grants-under-nasdaq-listing-rule-5635-c-4.md 2026-05-01 https://biopharmsignal.com/news/GDRX/goodrx-expands-offerings-to-now-include-ozempicr-pill-for-type-2-diabetes-patients.md 2026-05-01 https://biopharmsignal.com/news/PHAT/phathom-pharmaceuticals-to-highlight-voqueznar-vonoprazan-at-ddw-2026-annual-meeting.md 2026-05-01 https://biopharmsignal.com/news/SYK/stryker-to-participate-in-the-bank-of-america-securities-2026-global-healthcare-conference.md 2026-05-01 https://biopharmsignal.com/news/USNA/during-national-show-your-smile-month-kevin-guest-urges-leaders-to-lift-others-daily.md 2026-05-01 https://biopharmsignal.com/news/ARWR/arrowhead-pharmaceuticals-receives-tga-approval-of-redemplor-plozasiran-in-australia-expanding-global-access-for-patients-with-familial-chylomicronemia-syndrome-fcs.md 2026-05-01 https://biopharmsignal.com/news/ESPR/esperion-to-be-acquired-by-archimed.md 2026-05-01 https://biopharmsignal.com/news/FLGT/fulgent-reports-first-quarter-2026-financial-results.md 2026-05-01 https://biopharmsignal.com/news/OCS/oculis-to-present-at-upcoming-association-for-research-in-vision-and-ophthalmology-arvo-annual-meeting.md 2026-05-01 https://biopharmsignal.com/news/PRTC/puretech-founded-entity-seaport-therapeutics-announces-pricing-of-upsized-initial-public-offering.md 2026-05-01 https://biopharmsignal.com/news/TELA/tela-bio-announces-strategic-board-refreshment-with-four-highly-experienced-commerical-leaders-to-accelerate-growth-and-drive-path-to-profitability-the-company-also-reports-preliminary-first-quarter-2026-revenues.md 2026-04-30 https://biopharmsignal.com/news/EBS/emergent-biosolutions-reports-first-quarter-2026-financial-results.md 2026-04-30 https://biopharmsignal.com/news/PRGO/perrigo-completes-divestiture-of-dermacosmetics-business.md 2026-04-30 https://biopharmsignal.com/news/EHC/encompass-health-reports-results-for-first-quarter-2026.md 2026-04-30 https://biopharmsignal.com/news/SIBN/si-bone-to-present-at-bofa-securities-2026-healthcare-conference-on-may-12-2026.md 2026-04-30 https://biopharmsignal.com/news/AZYO/elutia-to-report-first-quarter-2026-financial-results-on-thursday-may-14-2026.md 2026-04-30 https://biopharmsignal.com/news/ALGS/aligos-therapeutics-to-announce-1st-quarter-2026-financial-results-on-may-7-2026.md 2026-04-30 https://biopharmsignal.com/news/LRMR/larimar-therapeutics-publishes-cross-species-findings-supporting-skin-as-a-surrogate-for-the-measurement-of-frataxin-in-tissues-clinically-relevant-to-friedreich-s-ataxia.md 2026-04-30 https://biopharmsignal.com/news/IRWD/ironwood-pharmaceuticals-to-host-first-quarter-2026-investor-update-call.md 2026-04-30 https://biopharmsignal.com/news/SYK/stryker-reports-first-quarter-2026-operating-results.md 2026-04-30 https://biopharmsignal.com/news/CORT/corcept-phase-2-study-of-dazucorilant-demonstrates-two-year-overall-survival-benefit-in-patients-with-amyotrophic-lateral-sclerosis.md 2026-04-30 https://biopharmsignal.com/news/CORT/corcept-therapeutics-announces-first-quarter-financial-results-and-provides-corporate-update.md 2026-04-30 https://biopharmsignal.com/news/ALHC/alignment-healthcare-delivers-strong-first-quarter-2026-results-demonstrating-disciplined-growth-and-margin-expansion.md 2026-04-30 https://biopharmsignal.com/news/PCRX/pacira-biosciences-reports-first-quarter-2026-financial-results.md 2026-04-30